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SUMMARY
Four immunisation protocols were compared for their 
ability to produce avid polyclonal antisera against 
L.pneumophila so that Legionella urinary antigen, if excreted 
from patients with L.D., could be detected in an ELISA.
Results from this work indicate that one of the four 
protocols examined produces avid capture antibody in 75% of 
NZW rabbits immunised, which can be collected on the 35th 
day after the priming immunisation. This was before the end 
point of the protocol. The capture antibodies (IgG) produced 
by this method were highly specific for Legionella antigen 
with no cross reactions recorded with the many urines 
collected from patients with no evidence of Legionella 
infections. The sensitivity of the test equalled that of an 
RIA (Dupont) for the detection of Legionella antigen but 
this kit is licensed only for sale in the U.S.A.. The 
reagents for the ELISA test have the advantage of having an 
indefinite shelf life compared with that of the RIA. Also 
shown is an urinary antigen excretion profile from a patient 
throughout his illness where capture antibody produced 
during this work enabled a diagnosis of Legionnaires' 
disease to be made before culture or serological methods 
provided any evidence of the cause of the patient's 
pneumonia. Other animal protocols tested were less 
successful in the production of avid capture antibody.
Ill
One urine collected from a patient with L.D. shown to 
contain urinary antigen by ELISA, was concentrated and then 
analysed by SDS-PAGE with a lipopolysaccharide profile (LPS) 
produced. Further attempts to establish the antigen in other 
ELISA-"positive" urines to be LPS by the same procedure were 
unsuccessful. Immunoblotting of concentrated urinary 
components in antigen and non-antigen containing urine to 
identify the antigen detected by avid capture antibody was 
unsuccessful. However, a proteinase-K digest of 
L.pneumoohila SG 1 cells was electrophoresed in SDS-PAGE and 
after transfer to nitrocellulose, stained with 4 different 
avid IgG preparations "effective" in the ELISA and produced 
smooth banding patterns typical of LPS in each case. Two 
bands at 80 and 60kD were detected on the same immunoblots, 
although their importance is unclear.
A reproducible system for growth, extraction and 
analysis of both FA and ubiquinones from the Leaionellaceae 
is described.
A comprehensive "library" of FA profiles is presented.
The need for expensive HPLC equipment to analyse 
complex mixtures of ubiquinones may not be necessary in view 
of the reproducible results obtained from 36 Legionella 
species by the method of thin-layer chromatography using 
high performance reversed-phase plates. Some Legionella 
species could be differentiated as they produced consistent
differences in FA and ubiquinone profiles. When results of 
FA and ubiquinones from type strains were compared with the 
FA and ubiquinone profiles of some environmental and patient 
isolates, it was found that in most cases, these were 
similar.
Finally, as a result of investigative work to identify 
a number of legionellae whose identities beyond family level 
were unknown, a probable new subspecies of L .quinlivanii is 
reported.
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INTRODUCTION
The Family Legionellaceae
1.1 Historical Background
Since the isolation of a rod-shaped Gram-negative 
bacterium, from the lungs of a patient who died of 
"Legionnaires'" disease (L.D.) in the original outbreak at 
the 58th Annual Convention of the American Legion in 
Philadelphia in July of 197 6 , similar organisms have been 
isolated from both patients and from environmental specimens 
in many parts of the world. This originally unidentified 
bacterium, which came to be known as the Legionnaires' 
disease bacterium (LDB), was discovered after intensive 
research (McDade et al. 1977), which included efforts to 
isolate rickettsial forms by intraperitonial inoculation of 
guinea pigs followed by the transfer of infectious extracts 
to the yolk sac of developing chick embryos. No rickettsial 
forms were seen but a Gram-negative bacillus, difficult to 
grow on ordinary laboratory culture media was revealed, and 
this organism came to be known as Legionella pneumophila 
serogroup (SG) 1.
Unclassified organisms isolated in previous years were 
grown on enriched culture medium (McDade et al. 1979) and 
resembled the "Philadelphia" bacterium. One of the two 
strains identified came from a sudden, short outbreak 
of febrile disease among staff and visitors of a health 
department in Pontiac, Michigan, in 1968. Now classed as the 
"Pontiac strain" it was identified in 1977 after its
recovery from the stored frozen lung tissue of guinea pigs. 
These animals had been placed in various parts of the 
departmental building to allow their exposure to aerosols, 
later to be traced to their source, the evaporative 
condenser of the air conditioning system. The strain was 
also recovered from the cooling water itself (Glick et al., 
1978, Kaufmann et al., 1981) .
Similarly the other strain named "Olda" was isolated 
by guinea pig inoculation from the blood of a patient with 
a febrile respiratory illness (McDade et al.. 1979) .
1.2 Nomenclature and Taxonomy of Legionella species
At the first International Symposium on Legionnaires' 
disease, Atlanta, USA, in November 1978 a number of 
techniques, most prominently deoxyribonucleic acid (DNA) 
homology, in addition to phenotypic and serological 
characteristics (Brenner et al., 1979) enabled this newly 
recognised pathogen to be designated as a new family 
(Legionellaceae), genus (Legionella) after the Philadelphia 
victims and species (pneumophila), after the affinity of the 
bacteria for the lung. Serological diversity within the 
species had already been recognised by the time the 
nomenclature was established (McKinney et al.. 197 9).
Since then, many species and serotypes have been 
discovered. At the time of writing this thesis, these number 
42 species (including 7 proposed and 6 possible new species 
) with L.pneumophila represented by 15 serogroups (including
one proposed new unnumbered serogroup) and L.bozemanii.
L .lonqbeacheae. L .feeleii. and L. hackeliae each represented 
by two serogroups (see table 1, Materials and Methods). 
Legionellae are rod-shaped being 0.3-0.9um in diameter and 
2-6um long. Filamentous forms up to 90um may be found after 
growth on agar media, are less common in yolk sac material, 
and very rarely observed in human or guinea pig lung tissue 
(Weaver and Feeley, 1979, Chandler et al.. 1979) .
Electron microscopical examination reveals filamentous 
nucleoids, ribosomes and vacuoles thought to represent poly 
beta-hydroxybutyrate granules (Chandler et al., 1979). Cells 
are enclosed by an envelope composed of two three-layered 
unit membranes; a peptidoglycan layer has been demonstrated 
for L.pneumophila, and for L.micdadei (Flesher et al., 1979, 
Pasculle, Myerowitz and Rinaldo, 1979, Gress et al. . 1930) .
Electron microscopy shows the cells to have a rugose 
surface with fimbriae present and also a single polar or 
sub-polar flagellum (Rogers et al.. 1980) .
Legionellae are not acid-fast by the Ziehl-Neelsen 
staining procedure for mycobacterium (Hebert et al., 1980) 
but L.micdadei may appear acid-fast in tissue preparations 
when stained by methods which use weak acids as decolorising 
agents (Pasculle et al., 1979).
1.3 Clinical features of pneumonia caused by L.pneumophila 
Legionnaires' disease (L.D.) is a potentially fatal 
pneumonia which in 96% of all cases is caused by
3
L.pneumophila SG 1. The initial symptoms usually consist of 
malaise and headache, followed within 24 h by the sudden 
onset of high non-remittent fever. In some patients the 
onset is more gradual. Gastro-intestinal symptoms may also 
appear in the early stages of the illness. Nausea, vomiting, 
abdominal pain and diarrhoea may occur.
On the second or third day of illness a dry cough 
begins producing small amounts of mucoid sputum.
High fever continues until the institution of 
antimicrobial therapy. Spontaneous resolution of the 
infection may begin on the eighth to tenth day.
Confusion and disorientation are present in some 
patients with their occurrence indicating some degree of 
toxic encephalopathy (Bartlett et al.. 1986) .
1.4 Radiographic Features
Radiography can be of use to complement other 
diagnostic measures in the identification of L.D. The 
radiographic appearance is variable, but commonly patchy 
lung infiltrates are seen initially. A characteristic 
feature of the pneumonia is that it may become extensive 
involving more than one lobe of the lung.
The resolution of radiographic infiltrates often lags 
behind clinical recovery. Complete resolution usually 
requires many months, even in previously healthy patients 
(Bartlett et al.. 1986).
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1.5 Pontiac Fever
This is the non-pneumonic form of Legionella 
respiratory infection (Glick et al., 1978) and was . 
identified in the influenza-like epidemic in the County 
Health Department building in Pontiac, Michigan.
A Legionella infection may either manifest itself as a 
Legionella pneumonia, with a low attack rate and high 
mortality or as a Pontiac fever, often with a high attack 
rate and no mortality.
The reason for the manifestation of one or other forms 
of infection is not clear. L.pneumophila, causing both 
types of illness, has shown no difference in virulence in 
animal models (Huebner et al., 1984) .
Examination reveals a fever greater than 39.5°C, and 
only modest respiratory symptoms. The illness usually 
resolves within 2-5 days after the initial incubation.period 
of 36-48 h. The clinical diagnosis is retrospective by 
serological testing, but Legionella pneumophila antigen has 
been reported in patients' with Pontiac fever (Freidman £t. 
ad., 1987) and treatment is symptomatic as the disease is 
self-limiting.
1.6 Legionella and other respiratory pathogens
Four patients, in a total of seven described from one 
institution, died. These patients had a severe pneumonia and 
a dual infection with L.pneumonia SG 1 and L.micdadei. Most 
of these seven patients were markedly immunocompromised
(Muder et al., 1983, 1984) . Also reported are mixed 
infections with L.pneumophila and viruses (Helms et al..
1984), Mycobacterium tuberculosis (Milder and Rough,
1982), Mycoplasma pneumoniae (Helms et al., 1984), Coxiella 
burnetii (Domaradzki et al.. 1984), Klebsiella species 
(Kirby et al., 1980) and Streptococcus pneumoniae 
(Macfarlane et al.. 1982) . A mixed infection should be 
suspected if a patient is not improving as expected.
Important clues in the differentiation of Legionella 
pneumonia from other pneumonias include high fever, 
unexplained confusion, multi-system involvement (eg. central 
nervous system, gastro-intestinal systems, liver, renal, 
heart and skeletal muscle), sparse mucoid sputum with scanty 
pus cells on staining and no predominant pathogens on 
culture. There is also a lack of response to beta-lactam and 
aminoglycoside antibiotics. Community-acquired pneumonias 
that can produce a clinical picture similar to Legionella 
infection, include Q fever, psittacosis and pneumococcal 
infection especially when complicated by bacteraemia. In 
addition, the awareness of cyclic epidemics (eg.
Mycoolasma pneumoniae every 3-5 years) and seasonal 
variations, should be borne in mind.
1.7 Pathology
When the lungs are examined macroscopically, a 
multifocal pneumonia with a tendency for coalescence of 
lesions, is most common. The exudates contain large amounts
of fibrin, producing a granular white appearance after 
fixation with formaldehyde solution.
Microscopically, there is an abundant inflammatory ' 
exudate in the distal airspaces, alveoli and bronchioles.
The exudate is composed of a mixture of polymorphonuclear 
leukocytes (PMNL) and macrophages, with one or other 
predominating in some cases. This appearance is not confined 
to Legionella pneumonias. Legionella bacteraemia has been 
demonstrated (Edelstein et al., 1979) and may be more common 
in severely ill patients, although this has never been 
demonstrated in our laboratory.
1 .8 Patient management
This is divided between antibiotic therapy and equally 
important general supportive therapies.
1.8.1 Antimicrobial Therapy
In-vitro, Legionella species are susceptible to a 
variety of antimicrobial agents using available methods to 
determine minimal inhibitory concentrations (MIC's).
In-vitro, Legionella are most sensitive to rifampicin 
and in guinea pigs (lowest MIC of 0.03>n\g/L) tested against 
these organisms (Ristuccia et al.. 1984) but they are 
sensitive in-vitro to erthromycin (MIC of about 0.2Trg/L), 
aminoglycosides, sulfamethoxazole-trimethoprim, 
chloramphenicol, cefotixin, doxycycline (the most active of 
the tetracyclines), and minocycline (Thornsberry et al., 
1978). Almost all Legionella species produce beta-lactamase
and other enzymes capable of hydrolysing beta-lactam 
substrates.
However, these in-vitro studies have uncertain 
relevance to the treatment of human infection as, in-vivo, 
the legionellae are intracellular pathogens. Many of the 
bacteria can survive and multiply in pulmonary macrophages.
Clinical experience indicates that intravenous 
erythromycin therapy is associated with the lowest mortality 
and it is, at present, the recommended antibiotic for 
treating Legionella pneumonia. Use of rifampicin, together 
with erythromycin, is recommended in patients with 
Legionella pneumonia who are critically ill or 
immunosuppressed and the earlier the diagnosis can be 
established, the sooner specific treatment can be commenced. 
Importantly, the response of severely ill patients to these 
antibiotics is rapid, but these antibiotics are different 
from those normally administered when pneumonia is diagnosed 
and a Legionella infection is not suspected.
1.8.2 General supportive measures
Patients may require intensive care. The two most 
important factors affecting the outcome include the state of 
the patient's health before the infection and the therapy 
given for the infection. The prognosis for previously 
healthy individuals is good and the fatality rate low 
(10-15%). Predisposing factors including smoking, age ( 
where infection is greatest in the 40-70 years old bracket),
and prior chronic diseases raises the fatality rate and can 
be as high as 70-80 % in immuno-suppressed patients.
1.9 Environmental sources of infection and modes of 
transmission
The occurrence of L.D. cases have been mainly sporadic 
and the source of these infections have not been identified. 
However, investigations into outbreaks of L.D. and Pontiac 
fever indicated that aerosols were responsible for infection 
and many different sources of these have been identified.
Recent outbreaks of L.D. in England include London 
where several outbreaks have been reported. In January 
1989 there were 33 confirmed cases of Legionella infection 
with 5 deaths recorded. Infection in these cases were linked 
to cooling towers at two sites in Piccadilly (House of 
Commons; Employment Committee (session 1989-'90) 1st Report 
L.D.: Further Developments). The other outbreak, discussed 
in the same report, occurred in April 1989 with the Imperial 
College and the Science Museum both being implicated as the 
source of the outbreak where 5 fatalities were recorded. 
Legal proceedings are underway. Another outbreak, again 
described in the same report was at Nottingham University 
and resulted in 2 deaths. This time the outbreak was 
associated with the hot-water system. Finally, again in the 
London area, an investigation in the Spring of 1988 into an 
outbreak where of 55 people who fell ill, 3 died, was linked 
with the retirement of one man at the BBC headquarters who
was responsible for the maintenance of the building's 
cooling towers. This provoked anger as it was due entirely 
to "a period of confusion" after the man's retirement 
where the "safety arrangements were appalling" (House of 
Commons; Employment Committee (session 1989-1990); 1st 
Report: Legionnaires' disease at the BBC). In Scotland, an 
outbreak was recorded in November 1985 where a number of 
hospital-associated cases of L.D. were reported, the 
result of aerosol infection originating from the cooling 
tower of Glasgow Royal Infirmary (Timbury et al., 1988).
Also the largest outbreak of Pontiac fever outside North 
America and the first ever attributable to L.micdadei 
occurred between 31st December 1987 and 4th January 1988 at 
Lochgoilhead on the West coast of Scotland, where about 200 
individuals who were visitors to a hotel and leisure complex 
developed symptoms consistent with Pontiac fever. L.micdadei 
was isolated from a whirlpool spa and antibodies to 
L.micdadei were found in 180 individuals (Goldberg et al., 
1989) who had visited the complex whereas no antibodies were 
found in 31 local residents who had not visited the complex. 
Legionella urinary antigen was detected in one individual 
(S.Toma, communication).
In other outbreaks, cooling towers for wet 
air-conditioning systems (Dondero et al., 1980), piped water 
systems in hospitals and hotels, particularly hot-water 
circuits, cooling systems employed for industrial purposes,
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spas and whirlpools have been identified as the sites of 
origin of infection. One unusual source was identified when 
a new species, L .feeleii (WO-44C), was isolated from cutting 
oil at an automobile plant in Ontario, Canada, after a 
number of workers reported ill with symptoms of Pontiac 
fever (Herwaldt et al., 1984) . Other sources include natural 
and potable water supplies, so that the ubiquity of this 
family of organisms must be recognised. As Legionella 
species occur in many aquatic habitats it is interesting to 
note that outbreaks are more limited than perhaps would be 
expected. It is not understood why a Legionella infection 
may result in L.D. or in Pontiac fever. However, in either 
infection there must be a reservoir of bacteria where 
amplifying factors allow legionellae to grow from low to 
high concentration. There must be a mechanism for 
dissemination of legionellae, which must be virulent for 
humans and finally these organisms must be inoculated at an 
appropriate site on a host susceptible to a Legionella 
infection.
1.10 Laboratory diagnosis
1.10.1 Clinical Material
In patients with a suspected Legionella infection, 
specimens are taken to demonstrate bacterial antigen or 
antibody. Clinical material for examination may be sputum, 
tracheal and bronchial aspirates or washings, pleural 
exudate, lung tissues, blood for culture, urine and serum
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taken in life or at post mortem.
The rate of recovery of Legionella species from sputum 
of patients by the use of selective media is quite high 
and should be attempted routinely, assuming sufficient 
sputum can be obtained. This is often not the case. Tracheal 
aspirates are claimed to be the optimal source for the 
recovery of Legionella species (Zuravleff et al.. 1983). 
However, bronchial washings obtained by bronchoscopy, when 
this is warranted on clinical grounds, are also valuable. 
Pleural fluid has enabled early isolation of L.pneumophila 
(Dumoff, 1979) but the recovery of legionellae is very low. 
Lung biopsies are not usually required but may be taken from 
seriously ill patients. Although the various manifestations 
of legionellosis are not due to spread via the blood, 
bacteraemia has been demonstrated.
The low recovery rates of Legionella are probably due 
in part to the lack of reliable liquid culture media and 
better results are said to be obtained by lysing and 
centrifuging blood and inoculating the deposit onto BCYE. 
This method may also recover intracellular organisms in 
monocytes and macrophages.
Berdal et al. (1979) first demonstrated the potential 
use of enzyme-linked immunosorbent assay (ELISA) to detect 
the soluble antigens of L.pneumophila in patient's specimens 
(e.g. urine and sputum). The majority of subsequent 
published data has been presented in a series of papers by
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Kohler and colleagues. The first of these (Kohler et a1..
1981) reported the use of a solid-phase radioimmunoassay to 
detect Legionella antigen in urine. The specificity of this 
test was investigated by Kohler and colleagues and found to 
be almost 100%. In a later publication (Sathapatayavongs
et al., 1982) antigen was detected in 83% of urine specimens 
where these were taken retrospectively from 39 L.D. patients 
during an outbreak. In these studies, one of the most 
important findings was the demonstration of urinary antigen 
in most patients 1-3 days after onset of symptoms and that 
this excretion of antigen may persist for many weeks. The 
RIA was adapted, first as an ELISA (Sathapatayavongs et al.,
1982) and then as a latex agglutination (Sathapatayavongs 
et al. , 1983) . The ELISA took longer to perform but had 
comparable specificity and sensitivity as the RIA. The latex 
agglutination, although simple to perform, was not as 
specific or sensitive as either the ELISA or RIA. The value 
of a specific test for the detection of soluble Legionella 
antigens in urine is important in the early diagnosis of 
Legionnaires' disease. Also, patients infected with
L.pneumophila other than SG 1 may excrete urinary antigen 
which can be detected by ELISA or RIA (Tang et al., 1989) 
Finally, other species of Legionella may give rise to 
antigenuria (Tang and Toma, 1986).
Serum is routinely examined for the development of 
specific antibodies. These do not appear until at least
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eight days after the onset of illness and their appearance 
may be delayed for many weeks (Bartlett et al., 1986).
1.10.2 Bacterial culture
For the investigation of clinical material this method 
is very sensitive and specific (Edelstein et al.r 1980,
1984, Zuravleff 1983). It is the definitive indication of 
infection. Pinpoint-size colonies appear on buffered- 
charcoal yeast extract (BCYE) agar in 2-3 days on primary 
culture, the colony diameter reaching 3-4 mm after 5-7 days 
of incubation at 36 +/- 1°C.
Colonies are usually greyish-white but may appear 
green, yellow (unpublished observation) or pink on 
microscopical examination with young colonies having a 
characteristic "cut-glass" appearance when observed under 
a plate microscope in all except one species (L.moravica).
Legionellae do not grow on standard blood agar, 
nutrient broth or other commonly employed laboratory culture 
media. Mueller-Hinton agar supplemented with 1 % haemoglobin 
and 1 % Isovitalex (MH-IH) was first used by Weaver for 
cultivation of L.pneumophila (Feeley et al.. 1978) but 
better media are now available. Charcoal yeast extract (CYE) 
agar was subsequently developed and found superior to 
Feeley-Gorman agar and the addition of ACES buffer (Sigma) 
greatly improved its performance as did the addition of 
alpha-ketoglutarate (Pasculle et al., 1980). More recently, 
the addition of 1% (w/v) BSA has been reported to increase
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the success of isolation of L.bozemanii and L.micdadei from 
clinical specimens (Morrill et al.. 1990). In all of these 
media, soluble ferric pyrophosphate replaces haemoglobin and 
L-cysteine-HCl replaces Isovitalex as growth factors for 
legionellae.
1.10.3 Serological detection of Legionella antigen
The direct fluorescent antibody (DFA) test using 
polyclonal antiserum which is suitably absorbed or with 
specific monoclonal antibodies is sensitive for the 
serological identification of legionellae at both species 
and serogroup level. It is used both to determine whether 
legionellae are present in clinical and environmental 
samples and as a rapid presumptive test for the 
identification of legionellae (Cherry et al., 1978, Cherry 
and McKinney, 197 9) . The use of the indirect fluorescent 
antibody test (IFA) to detect Legionella antigens has the 
advantages that the specific antisera is used at a very high 
dilution with the result that any cross reactions are almost 
eliminated, a problem sometimes encountered with DFA 
(Orrison et al., 1983).
When compared with culture, DFA is reported to be the 
more sensitive as only 15 % of DFA-positive environmental 
samples proved culture-positive for Legionella (Fliermans 
et al., 1981).
An alternative to DFA is a commercially available DNA 
probe (Gen-probe) for the detection of Legionella species
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and this has been evaluated (Edelstein, 1986., Pasculle 
et al. / 1989) and deemed a satisfactory replacement for DFA 
with a specificity of up to 99.2% and-a sensitivity of 68.9 
to 69.2%. This has obvious value for laboratories with 
limited DFA capability.
Legionellae share a number of immunologically cross­
reactive flagellar antigens (Thomason et al., 1979) but this 
property is not used as a diagnostic test as flagella are 
rarely seen in isolates from respiratory tract infections.
1.10.4 Detection of antibodies to Legionella
The indirect fluorescent (IFA) antibody test for the 
detection of antibodies in patients' sera was first 
developed by Wilkinson et al., (1979) who used heat-killed
bacterial suspensions as antigen. Later, Taylor et al.,
(1979) reported the successful use of formalin-treated 
Legionella-infected yolk sac of the embryonated hen's eggs 
(FYSA) as an alternative. Both antigens are in wide use but 
most laboratories in the U.K. use FYSA to aid in the 
diagnosis of legionellosis.
A four-fold or greater rise in titre to 128 in paired 
acute and convalescent sera in a clinically suspicious case 
is considered definitive evidence of infection with 
L.pneumophila SG 1. With other serogroups and species this 
is still a tentative indication of infection. In a single 
serum sample from a patient with suspected L.D., titres of 
256 or more are considered "presumptive” evidence of
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infection. Unfortunately, IFA reagents are not commercially 
available for all serotypes and species of Legionella and 
"in-house" manufactured reagents may differ widely between 
laboratories.
Despite the many new species of Leaionellaceae being 
identified (Brenner 1984, Brenner et al.. 1985), the 
organism most commonly responsible for the severe pneumonia 
is still L.pneumophila SG 1. The factors responsible for the 
virulence of L.pneumophila SG 1 are presently under 
investigation.
Other tests for the detection of antibodies to 
legionellae include the microagglutination test which was 
developed by Harrison and Taylor (1982), who claimed it to 
have sensitivity equivalent to that of the IFA test. An 
ELISA which utilises soluble or EDTA-extracted antigen from 
Legionella species adsorbed to polystyrene microtitre 
plates has been described (Farshy et al., 1978, Wreghitt 
et al.. 1982, Zuravleff et al., 1983) as has an indirect 
haemagglutination test with the antigens adsorbed to turkey 
erythrocytes (Yonke et al.-. 1981) .
1.10.5 Detection of urinary antigen bv ELISA and RIA
The study of urine as an antigen reservoir has provided 
evidence of soluble or particulate microbial antigens being 
excreted during many infections (Coonrod, 1983) .
Both polysaccharide and protein antigens have been 
detected in urine by immunological methods for different
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infections including bacterial, viral and parasitic 
diseases (e.g. H .influenzae type b, bovine Leukaemia virus 
in cattle and humans infected with Schistosoma mansoni). 
Detection of a thermostable antigen in the urine 
of Legionnaires' disease patients by ELISA, radioimmunoassay 
(RIA) or latex agglutination has been an important advance. 
An enzyme-linked immunospecific assay "sandwich" technique 
was developed for detecting soluble antigen from the 
Legionnaires' disease bacterium (L .pneumophila) (Berdal 
et al., 1979) . With this technique, antigen was detected in 
urine specimens from guinea pigs inoculated 
intraperitoneally with heat-killed L.pneumophila and in 
urine specimens from three of four patients who attended the 
American Legion Convention in Philadelphia in 1976. A fifth 
patient, who was a dubious seroconverter, was negative 
(Berdal et al., 1979). Goat antiserum used in the test, was 
diluted but unfractionated and the test sensitivity was such 
as to detect as little as 3 pg of LPS/protein complex. These 
early results were published without delay because of the 
potential usefulness of the test, even though only four 
patients were examined.
Interest in the rapid diagnosis of Legionnaires' 
disease by urinary antigen detection grew and a number of 
laboratories became active, notably Kohler and his 
associates, in an effort to consolidate this non-invasive 
and simple test. Initially, RIA was more sensitive, but
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doubling of the IgG conjugate (IgG-horse radish peroxidase) 
concentrations from 5 to 10 ug/ml raised the sensitivity of 
the ELISA to that approaching the RIA test 
(Sathapatayavongs et al., 1982). Both ELISA and RIA
(Sathapatayavongs et al., 1983) revealed that of 47 patients 
with L.D. tested, antigen was detected in 39. In the case of 
ELISA visual analysis of the test plate gave 35 clear 
positive results, the remaining four requiring 
spectrophotometric verification. Another 17 8 urine specimens 
from patients with non-Legionella associated pulmonary 
infections proved to be negative. Conclusions drawn were 
that the ELISA was a rapid, sensitive and specific means for 
the rapid diagnosis of L.D. that can be performed in 
clinical laboratories unwilling or unable to use 
radio-isotopes.
The antiserum used by Sathapatayavongs et al. (1983)
was not directly compared with that used by Berdal et al.
(1979) and was obtained using a different immunisation 
schedule consisting of multiple inoculations over a fifteen 
month period with a "many-month" rest period. This 
extended period, it was claimed, was the reason for a more 
sensitive antiserum when compared to Berdal's antiserum 
taken 6-7 weeks post immunisation. This claim is only 
speculative though as a direct comparison with Berdal's 
antiserum which was obtained in six weeks was never 
performed. Serendipitous animal immunoresponsiveness alone
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could have played a major role in the length of time for a 
working antiserum to be obtained and sensitivity of the 
antiserum could be due to other factors.
Another survey of clinical specimens of urine and 
serum from an outbreak in Burlington, Vermont, compared the 
sensitivity of RIA with that of DFA and culture (Kohler 
al. r 1984). Twenty-six (76%) of 34 patients had detectable 
urinary antigen. Antigen was detected by RIA (a test similar 
to ELISA except that the IgG conjugate was labelled with 
125I instead of an enzyme) in 14 (93%) of the 15 patients 
with positive cultures and 12 (63%) of the 19 with 
serological but not cultural evidence of infection (Kohler 
et al. , 1981) . It would appear that when RIA or ELISA 
examination of urine is used together with DFA it is 
possible to make a diagnosis in most cases of clinically 
suspected pneumonias due to L.pneumophila SG 1.
Monoclonal antibodies (IgG), to L.pneumophila SG 1 
specific antigen have been bound to horseradish peroxidase 
and used as detecting antibody in an indirect ELISA allowing 
serogroup identification to sub-typing level after well- 
coating with fractionated rabbit anti-L.pneumophila SG 1 
antiserum as capture antibody. It was noted (Bibb et al..
1984) that by a combination of mouse monoclonals conjugated 
to horseradish peroxidase and rabbit antisera raised to 
"Knoxville-1" and "Olda" used as capture antibody that the 
rabbit antisera raised to "Knoxville-1" gave the more
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sensitive ELISA system for urinary antigen detection. These 
antisera were tested using specimens from three cases of
legionellosis confirmed by culture of the organism from
respiratory secretions or lung tissue.
To enable an ELISA test to be used in the diagnostic 
laboratory for the detection of antigenuria, the actual 
onset and duration of the excretion of urinary antigen 
itself must be investigated.
A study designed to determine whether antigen is 
excreted by patients with Legionnaires' disease early enough 
after the onset of symptoms to be useful for making 
therapeutic decisions and whether antigen excretion ends 
when successful treatment is concluded was carried out by 
Kohler et al. (1984). Specific antigen was detected by
ELISA in the urine of 14 (8 6 %) of 16 patients with 
Legionnaires' disease during days 1 to 3 after the onset of
symptoms, 33 (80%) of 41 during days 4 to 7, 25 (89%) of 28
during days 8 to 14 and 11 of 11 patients after day 14.
Antigen excretion persisted for 42 days or longer in 15 of 
the 16 patients. Conclusions drawn were that antigen can 
be detected early after symptoms thus allowing meaningful 
therapeutic decisions to be made, but that prolonged antigen 
excretion (the longest documented duration was 32 6 days) may 
negate the diagnostic value of urinary antigen detection for 
relapsing or recurrent L.pneumophila pneumonia.
Preparation of the immunogen for raising rabbit
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antisera differed between studies (Berdal et al., 1979, 
Kohler et al., 1983, Kohler et al., 1985) . These workers 
used autoclaved or boiled standardised suspensions of whole 
cells of L.pneumophila SG 1, and mixed them with equal 
volumes of Freund's adjuvant for vaccination of rabbits. 
Formalin-treated whole cells of L .pneumophila SG 1 can also 
be used to produce a suitable antiserum (McKinney et al., 
1979, Tang and Toma, 1986,) . Again, in other studies (Conlan 
and Ashworth, 1986, Williams and Featherstone, 1988) saline 
extracts from whole cells of L .pneumophila SG 1 were 
successful immunogens, although, difficulties in raising an 
avid and specific antiserum routinely have been acknowledged 
(Samuel et al., 1990, Fehrenbach et al., 1986, 
Sathapatayavongs et al., 1982) .
Antisera to L.pneumophila SG 1 may be of use in the 
detection of urinary antigen produced by serogroups of 
L.pneumophila other than SG 1 (Kohler et al., 1985), 
and this has recently been documented (Tang et al., 1989) 
where the first Canadian case of L .pneumophila serogroup 12 
causing Legionnaires' disease in a 52 year-old male was 
identified using a "broad-spectrum" capture antibody in an 
ELISA to detect urinary antigen. Also a solid phase 
radioimmunoassay was developed to detect antigens of 
L.pneumophila SG 4. Antigen in the urine of two patients, 
one infected with the Leiden-1 strain (SG 10) and another 
with a L.pneumophila SG 1 infection was detected using the
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antiserum to SG 4 . Urinary antigen in patients with 
SG 1 and Leiden-1 Lecrionella infections may therefore 
contain components serologically cross-reactive to 
L.pneumophila SG 4.
Hence, a number of reports have been published since 
197 9 about the application of the rapid techniques for 
demonstrating Legionella antigens in body fluids, using 
monoclonal or polyclonal antibodies produced in the rabbit 
and other animals against legionellae. These assays differ 
individually in methodology, specificity, sensitivity and 
may react to a range of individual serogroups or subtypes. 
The number of specimens investigated ranged from a few cases 
to a large group of patients. However, antigen assays of the 
ELISA and RIA type have not been widely used. The major 
drawback with these tests is the preparation of suitable 
working antiserum for antigen capture (the binding of 
antigen to a solid phase).Kohler and Sathapatayavongs 
(1933) reported that of six rabbits inoculated only one 
produced an avid antiserum. The difficulty of producing 
large quantities of suitable antiserum has prevented the 
establishment of this as a routine diagnostic test in most 
laboratories.
There must be no doubt though, that the diagnostic 
panel of tests used by reference laboratories for diagnosis 
of legionellosis should include, in addition to their 
conventional diagnostic tests, ELISA or RIA procedures for
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urinary antigen detection.
1.11 Characterisation of urinary antigen
A number of Legionella antigens have been identified 
and described in the literature.
A species-specific antigen in L.oneumoohila was 
identified by a monoclonal antibody in enzyme-linked 
immunosorbent and immunofluorescent assays of serogroups 1 
through to 8 (Gostino et al.. 1984). The species-specific 
antigen was a heat-stable protein and the molecular weight 
of the major band was 29,000 kD by immunoblot analysis. In 
direct immunofluorescence assays, the antigen was cryptic or 
only partially exposed by treating with detergent and EDTA 
(Gosting et al., 1984). Antigens of six serogroups of 
L.pneumophila were compared in two dimensional (crossed) 
immunoelectrophoresis using rabbit antisera to serogroups 
1,2,3 and 4. The close relationship between the serogroups 
was shown by the fact that 27 of the 31 antigens 
demonstrated were common (Joly and Kenny, 1982). However, 
distinctive group-specific antigens with slow 
electrophoretic mobility were observed for serogroups 1 , 2 , 
3, and 4. When intact serogroup 1 organisms were extracted 
with EDTA, the group-specific antigen was recovered in a 
virtually pure form. The group-specific antigen was pronase 
resistant, heat-stable, ampiphilic and had a surface 
location, all of which suggest lipopolysaccharide (Joly 
and Kenny, 1982). Since urinary antigen has been detected by
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ELISA with antiserum raised to boiled or autoclaved cells 
(Berdal et al.. 1979, Kohler et al., 1983. Kohler et al.,
1985), the excreted antigen may be heat-stable '
lipopolysaccharide (LPS). Most surface protein epitopes 
would be denatured by this method of antigen preparation. A 
method described by Conlan and Ashworth (1986) involved the 
treatment of a saline extract of the "Corby " strain of 
L.oneumoohila SG 1 with deoxyribonuclease-1, ribonuclease-1 
and pronase and was utilised for the preparation of 
immunogen for raising antiserum for an ELISA to detect 
urinary antigen in patients with L.pneumophila SG 1 
infections (Williams and Featherstone, 1988) . This proved to 
be an effective way of obtaining a working antiserum and 
showed that the urinary antigen was resistant to each of 
these enzymes, providing further evidence that the antigen 
found in urine is indeed LPS, possibly in a low molecular 
weight form. Microbial polysaccharide antigens up to 70kD 
have been reported in urine (Coonrod, 1983). This may be the 
size exclusion limit beyond which particles greater than 
70kD are not excreted through the kidneys.
1.12 Other techniques for urinary antigen detection
As previously noted, latex agglutination and reverse 
passive haemagglutination tests have also been described 
for the rapid diagnosis of Legionnaires' disease by 
detecting antigen in human urine (Sathapatayavongs et al. , 
1982, Mangiafico et al.f 1981 and Tang et al.. 1982) . Latex
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agglutination is a simple, rapid and inexpensive method for 
the diagnosis of infections but again relies on the 
availability of avid and specific antiserum. These authors 
have previously published data on working ELISA and RIA 
diagnostic procedures. When compared with RIA and ELISA 
using serial dilutions of a single antigen-containing urine, 
latex agglutination was 16-fold less sensitive 
(Sathapatyavongs et al.. 1982). Reverse passive 
haemagglutination (RPHA) has been used successfully in the 
past for detection or assay of both tetanus toxin and 
staphylococcal enterotoxin B in culture filtrates and in 
food samples. RPHA has not been directly compared with RIA 
or ELISA, but has been quantitatively evolved to detect as 
little as 200 pg of total antigen (Mangiafico et al. 1981).
None of these alternative methods has yet been 
routinely applied in diagnosis of Legionella infection.
1.13 Definition of Legionella species
The generally accepted classification of the family 
Legionellaceae is based on the work of Brenner and 
colleagues (1984). These workers take the definition of a 
"genetic" species as a group of strains whose DNAs are 7 0% 
or more related at optimal reassociation conditions; 55% or 
more related at stringent conditions and have 6 % or less 
divergence in their related sequences. The identification of 
legionellae outwith genetic means is an exhaustive task 
and includes the observation of colonial morphology; with
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convex, round-edged colonies and a "cut-glass" appearance 
under a plate microscope; by microscopy after Gram staining 
or flagellar staining; testing for nutritional requirements; 
biochemical testing for catalase; this being positive for 
all legionellae when carried out according to the Howie Code 
of Practice (1978); oxidase which varies considerably within 
the family; gelatin liquefaction with most species producing 
a gelatinase in BCYE where the agar is substituted with 3% 
gelatin; nitrate reduction negative in all legionellae 
enabling them to be distinguished from members of the 
Enterobacteriaceae; hippurate hydrolysis allows 
L .oneumoohila to be distinguished from other legionellae 
(except L .feeleii [+/-]); beta-lactamase production positive 
with most legionellae and easily seen with a chromogenic 
cephalosporin (Nitrocefin); urease production all 
legionellae are reported to be urease negative; browning of 
tyrosine-supplemented medium varies within the family; and 
colony autofluorescence which, when seen can be observed as 
as blue/white, red or yellow (unpublished observation), the 
colour being species dependent.
These phenotypic characteristics can be supplemented 
by analysis of whole cell fatty acids by gas-liquid 
chromatography (GLC), by the analysis of the composition of 
their ubiquinones and by using serological methods.
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1.13.1 GLC of whole cell fatty acid methvl esters (FAMES)
in identification
The use of GLC in clinical and diagnostic bacteriology 
laboratories has increased significantly in recent years. 
This is most probably as a result of the vast technical 
advances in column manufacturing resulting in consistency of 
the highest order particularly with "capillary-type" 
columns. GLC is a simple and powerful method for the 
separation and quantitation of volatile organic compounds by 
partitioning these components between a mobile carrier gas, 
and a liquid stationary phase bound to an open tubular 
column. Separated components are detected and quantified 
using a detector (FID) and recorded on a computer 
integrator. In the analysis of metabolic products from 
bacterial growth and chemical components of bacterial cells, 
GLC has provided useful information for rapid identification 
of bacteria assigning them to genus or even to species level 
e.g. Lecrionellaceae have a very complex nonhydroxy FA 
profile compared with the simple FA profile found in the 
genus Bordetella and where Bordetella pertussis (FA content 
is unaffected by phase variation) may be differentiated 
from B.bronchiseotica (Kawai and Moribayashi, 1982) .
Members of the genus Legionella contain large amounts 
of branched-chain fatty acids released from the cell 
envelope with both quantitative and compositional 
differences reported between some species. Reported
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quantitative differences in cellular fatty acids within a 
species are small (2-4 %) e.g. variations in the amount 
of dl-cis 9,10 methylhexadecanoate (17:0A) in the Pontiac 
and Philadelphia-2, Philadelphia-3, and Philadelphia-4 
strains (Moss et al. 1977, Moss and Dees, 1979). Other 
reported quantitative differences in environmental and 
control strains of Legionella pneumophila (Philadelphia-1 
and Dallas-1E/ species 1) (Selander et al., 1985) fall 
within this range. No major differences in cellular fatty 
acid composition have been shown between serogroups of 
L.pneumophila or within a serogroup for either environmental 
or patient strains (Moyer et al.; 1984) .
Bacterial FA's analysed and identified by GLC should have 
their identity confirmed through structural analyses by mass 
spectrometry.
Epidemiological studies may be enhanced by the 
identification of new species as well as known species by 
their characteristic fatty acid methyl ester (FAME) profile 
(Moyer et al., 1984) . There are many published chromatograms 
and discussions of saponified and methylated fatty acids 
(Edwards and Feltham, 1983, Mayberry 1981, 1984) of the more 
commonly found Legionella species. More recent publications 
report unidentified species as a result of combined 
gas-liquid chromatographic, genetic and serological tests 
(Lindquist et al., 1988, Thacker et al., 1988 and Gorman 
et al. , 1985). The role of GLC is therefore contributory to
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the identification of Legionella species and also to help 
classify new isolates. The analysis of cellular fatty acids 
of all known Legionella reference strains to investigate the 
possibility of identifying isolates from man and the 
environment to species level is investigated in this thesis.
1.13.2 Reversed-ohase thin laver chromatography of 
ubiquinones
The Legionellaceae possess an unusual pattern of 
respiratory quinones, which differs between the few species
oytnA.
previously investigated in this wayNmay be used in 
identification (Wait, 1988). This is more fully 
investigated in this thesis. Isoprenoid quinones 
(2,3-dimethoxy-5-methyl-6-multi-prenyl-l,4 benzoquinones 
(figure 1 ) are found in bacterial plasma membranes where 
they are the electron acceptors and donators of 
the oxidative phosporylation process in the Tricarboxylic 
acid cycle. The more common classes of quinone are the 
menaquinones and the ubiquinones. Only ubiquinones are 
present in detectable quantities in the Legionellaceae and 
using reversed-phase thin layer chromatography (RPTLC) 
and mass spectrometry, Karr et al.r 1982 identified Q-ll 
(where the number refers to the length of the carbon chain 
linked to carbon- 6 on the benzoquinone ring), Q-12 and Q-13. 
These observations were extended (Collins and Gilbart,
1983), and the presence of Q-14 and Q-15 was demonstrated as 
well as information of ubiquinone content in 5 species;
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Figure 1 Structure of ubiquinone (Q-n)
O
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L .dumoffii, L .aormanii, L .iordanis, L.micdadei and 
L.pneumophila by high performance liquid chromatography 
(HPLC, Gilbart and Collins, 1985). HPLC is not always 
available and reversed-phase thin-layer chromatography 
(RPTLC) was investigated as an alternative technique to 
provide a complete library of ubiquinone profiles for all 
known legionellae (Mitchell and Fallon, 1990). Ubiquinone 
profiles, by this method, together with the GLC of fatty 
acids of the Legionellaceae have been compiled in this 
thesis to compare these with both patient and environmental 
Legionella isolates. To confirm the presence and/or identity 
of ubiquinones in preparations made from cells and used for 
either RPTLC or HPLC, samples should be analysed by mass 
spectrometry.
1.13.3 Identification of Legionellae bv Serological Methods 
The use of biochemical reactions, GLC and isoprenoid 
quinone profiles can confirm that an isolate is a Legionella 
and sometimes to which species it belongs, but DNA 
hybridisation studies are needed for a definitive 
identification where this may also be supplemented by 
restriction enzyme digestion of cellular DNA to determine 
the restriction fragment patterns (Saunders et al.r 1990) .
As these techniques are not available in most laboratories, 
a presumptive identification is usually made using 
serological methods. Legionellae can be subdivided into 
serogroups by their reaction with hyperimmune rabbit
antisera containing antibodies directed against the heat- 
stable somatic lipopolysaccharide (LPS) or "0" antigens. 
Slide agglutinating antisera have also been used for the 
rapid identification of legionellae (Wilkinson and Fikes, 
1980). However, many species and serogroups within the 
family Legionellaceae have antigens in common and cross­
reactions are seen and therefore the serological 
identification of legionellae is not always simple. However, 
the identification and detection of L.pneumophila is now 
possible in most laboratories with the availability of 
monoclonals to a species-specific antigen (e.g. Genetic 
system, U.S.A.) and also the detection of L.pneumophila SG 1 
also using a monoclonal (ICN ImmunoBiologicals Ltd.) to a 
unique antigen common only to all strains of this serogroup.
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1.14 Aims of Research
Legionnaires' disease, a potentially lethal pneumonia 
and hence the more serious form of Legionellosis, is caused 
in 96% of cases by, L .pneumophila SG 1. Rapid diagnostic 
techniques are necessary for the prompt recognition and 
treatment of infection. Thus two aims of this project were:
a) to produce specific antiserum to L.pneumophila SG 1 
which will bind urinary antigen to plastic microtitre trays 
used in the ELISA test thus enabling a valuable service to 
be offered to Scotland and for the possible distribution of 
this antiserum to other laboratories for their use.
b) to investigate and characterise the heat stable antigen 
detectable in urine from most patients in the early stages 
of L.D..
Species Recognition
Speciation of isolates where phenotypic observations 
leave doubt or serological cross-reactions have occurred 
may be supported by other investigations including a variety 
of analytical techniques. Further aims were:
c) to develop a library of fatty acid methyl ester 
(FAME) profiles of Legionella species by capillary 
gas-liquid chromatography.
d) to develop a library of ubiquinone (Co-enzyme Q) 
profiles of Legionella species by the separation and 
analysis of these components by high performance 
reversed-phase thin-layer chromatography.
e) To compare the results obtained from the libraries with 
a number of environmental and patient isolates.
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MATERIALS AND METHODS
2.1 Bacterial strains
The following Lecrionella strains obtained from the -70°C
stocks of frozen bacterial suspensions at the Department of
Laboratory Medicine at Ruchill Hospital are recognised
reference strains. The strain numbers are given together
with the original source of each culture in table 1 .
Other strains used in these studies are of
environmental origin obtained mainly through the Wolfson
Laboratory or isolated from patients and are designated by
laboratory assigned numbers. These are :
86/35784 (L .cruinlivanii-subspecies)
87/31871 L.pneumophila
88/1058 L.micdadei-responsible for the Lochgoilhead
outbreak - February 1988 (Goldberg et al., 1989)
88/24485 L .anisa (patient isolate)
88/42783 L.pneumophila SG 12 
88/42784 L.pneumophila SG 1 (Olda)
88/42785 L.pneumophila SG 6
88/42787 ‘L.pneumophila SG 1 (Olda)
88/42788 L.pneumophila SG 6
88/42791 L .pneumophila SG 1 (Bellingham strain)
88/428 69 L .lonabeachae SG 2
88/46768 L.pneumophila (patient isolate)
ML-76 Serovar of L .soiritensis (Harrison et al.. 1988)
(Colindale)
P185 (L.pneumophila strain, SG 9 ?)
89/032 89 L .pneumophila SG 5 
89/13077 L .hackeliae SG 1 
8 9/207 94 L . cruateriensis 
89/29805 L.pneumophila SG 5
89/42151 L.pneumophila SG 10
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Table 1 Recognised Legionella strains
SPECIES SEROGROUP STRAIN SOURCE
L .adelaidensis - F/636 IMVS
L . anisa - - CH-47-C-1 CDC
L.birminahamensis - 1407-AL-H CDC
L.bozemanii 1 WIGA CDC
L.bozemanii 2 Toronto-3 CDC
L.brunensis - 444-1 CDC
L.cherrii - ORW CDC
L . cincinnatiensis - 70-OH-H CDC
L .dumof f i i - TEX-KL CDC
L.erytha - SE-32A-C8 CDC
L .feeleii 1 WO-44-C3 CDC
L.feeleii 2 691-W1-H CDC
'L.aeestiae" - 1308 CAMR
L .aormanii - LS-13 CDC
L.aratiana - ATCC 49413 Lyon
L .hackeliae 1 Lansing-2 CDC
L.hackeliae 2 7 98-PA-H CDC
L .israelensis - Bercovier-4 CDC
L .iamestowniensis - JA-26-G1-E2 CDC
L .iordanis - BL-540 CDC
'L.londoniensis" - 1224 CAMR
L . lonabeachae 1 Longbeach-4 CDC
L . lonabeachae 2 Tucker-1 CDC
L.macheachernii - PX-1-G2-E2 CDC
L.micdadei - TATLOCK CDC
L.moravica - 316-36 CDC
'L.nautarum" - 1477 CAMR
L . oakridaensis - OR-10 CDC
L.oarisiensis - PF-20 9C-C2 CDC
L .oneumophila 1 (Camperdown) NCTC 12098
L .oneumoohila 1 (Knoxville-1) CDC
L.pneumophila 1 (Olda la) 2129 CAMR
L .pneumoohila 1 (Olda lc) 2143 CAMR
L.oneumophila 1 (Philadelphia-1) CDC
L .oneumophila 1 (Pontiac-1) NCTC 11191
L.oneumoohila 1 (Bellingham-type, Hastings
strain) Nott. PHL
L .oneumophila 1 (Corby) RH
L.oneumophila 2 Togus-1 CDC
L .oneumoohila 3 Bloomington-2 CDC
L.oneumoohila 4 Los-Angeles-1 CDC
L.oneumophila 4 Leiden-3 CDC
L .oneumophila 5 Cambridge-2 Camb.PHL
L.oneumophila 5 Dallas-IE CDC
L .oneumophila 5 MICU-B Columbia
L.oneumophila 5 U7W Columbia
L.oneumophila 5 U8W Columbia
L.oneumoohila 6 Oxford-1 CDC
L .oneumophila 7 Chicago- 8 CAMR
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Table 1 cont.
SPECIES SEROGROUP STRAIN SOURCE
L.pneumoohila 8 Concord-3 CDC
L.pneumoohila 9 IN-23-G1-C2 CDC
L .oneumophila 10 Leiden-1 CDC
L.pneumoohila 1 1 7 97-PA-H CDC
L .oneumoohila 1 2 570-CO-H CDC
L.oneumoohila 13 Seattle-1 CDC
L .oneumoohila 14 1169-MN-H CDC
L.pneumoohila - Lansing 3 CDC
11L . quateriensis" 1335 CAMR
L .quinlivanii 1442-AUS-E CDC
L .quinlivanii 144 8 -AUS-E CDC
L . cruinlivanii 144 9-AUS-E CDC
L .auinlivanii 1450-AUS-E CDC
L .quinlivanii 1451-AUS-E CDC
L .quinlivanii 1452-AUS-E CDC
L .quinlivanii 2359-AUS-E CDC
L .rubrilucens 1267 CAMR
L .sainthelensi Mt.St.Helens -4 CDC
L .santicrucis SC-63-C7 CDC
L .soiritensis Mt.St.Helens -9 CDC
L .steiaerwaltii SC-18-CD CDC
L .tucsonensis 1087-AZ-H CDC
L .wadsworthii 81-716A CAMR
"L.worsleiensis" 1347 CAMR
A 36* - IMVS
B 8 6 * - IMVS
C 449* - IMVS
D 500* - IMVS
D 532* - IMVS
E 594* - IMVS
KEY
I! II
I MVS
CDC
CAMR
RH
Camb.PHL 
Nott. PHL 
Columbia
Proposed new species.
Possible new species as described in 
Wilkinson et al., (1990)
Institute of Medical and Veterinary Science, 
Adelaide, South Australia.
Centers for Disease Control, Atlanta, Georgia. 
Centre for Applied Microbiological Research, 
Porton Down, Salisbury.
Dept, of Laboratory Medicine, Ruchill Hospital 
Cambridge Public Health Laboratory.
Nottingham Public Health Laboratory.
Wm. Jennings Bryan Dorn Veteran's Hospital, 
Columbia, USA.
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2.2 Culture media 
BCYE
All except three Legionella strains (L .aeestiae.
L .adelaidensis and 86/35784) were grown on a solid charcoal 
yeast extract medium (Feeley et al..1978) modified by the 
incorporation of N-2 acetamido-2-amino-ethanosulfonic acid 
(ACES) buffer. To 10 g of ACES buffer (Sigma), 900 ml of 
distilled water at 50°C was added. Further additions were;
2.8 g of KOH pellets (BDH), 1.5 g of Norit A activated 
charcoal (Serva), 10 g of yeast extract (Difco) and 17 g of 
agar (Bacto). Distilled water was added to make up the 
volume to 1 1 and the mixture stirred and boiled to 
dissolve the soluble components and the pH was then adjusted 
to 6.85-6.95 with KOH pellets if required. The medium was 
autoclaved at 121°C for 15 min and allowed to cool to 56°C 
before the additions of filter-sterilised (0 . 2 0  urn) 
alpha-ketoglutarate (10 ml of 10% w/v), L-cysteine HC1 as a 
source of sulphur (10 ml of 4% w/v), and ferric 
pyrophosphate as a source of soluble Fe++ ions (10 ml of 
2.5% w/v) per litre and the medium poured.
"Oxoid" BCYE
One environmental strain No. 86/35784 failed to grow on 
in-house BCYE but a commercial BCYE (Oxoid) did support its 
growth. Also after passaging, the growth of L .aeestiae and 
L.adelaidensis was not supported by in-house BCYE and were 
subsequently grown on Oxoid BCYE.
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Briefly, 2.5 g of Legionella CYE Agar Base was
suspended in 90 ml of distilled water and gently boiled to
dissolve completely. Sterilisation was by autoclaving at'
121°C for 15 min. After cooling to 50°C, one vial of
Legionella BCYE Supplement Code SR110 reconstituted with
1 0 ml of sterile distilled water, was added aseptically,
and after gentle mixing, plates were poured.
Columbia blood aaar
Columbia Agar Base (39g, Oxoid) was suspended in 1 1
of distilled water containing 8 % (w/v) NaCl and.boiled .
After sterilisation by autoclaving at 121°C for 15 min., the medium was 
until the contents dissolved. ^ cooled to 50°C, sterile
5% (v/v) defibrinated horse blood was added and after gentle
mixing, plates were poured.
2.3 Growth conditions
All Legionella strains were incubated at 37°C + /- 1°C
in C02 jars on solid media in an atmosphere of air (unless
stated) for 48-72 h except where whole-cell fatty acid
analyses were carried out when the incubation time was
standardised to 96 h.
2.4 Maintenance of cultures
Stock cultures were held as frozen bacterial
suspensions at -7 0°C in peptone water (see Appendix IV).
However for day to day use all Legionella strains were
inoculated onto BCYE slopes incubated for 24-48 h at 37°C
and then stored at 4°C until required. These BCYE slope
cultures were passaged every 4-6 months to ensure continued
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viability, inoculated onto a blood agar plate to ensure 
purity and examined by Gram-stain to show the presence of 
weakly staining Gram-negative rod-shaped bacteria. All 
plates were also examined under a plate microscope for a 
characteristic "cut-glass" appearance (Dournon, 1988) which 
all Legionellae with the exception of L .moravica exhibit.
2.5 Production of rabbit antisera for the detection of 
urinary antigen
2.5.1 Method of McKinney et al., (1979)
Legionella pneumophila SG 1 (Knoxville-1) were grown on 
BCYE medium, harvested in 0.85% NaCl (w/v) containing 
0.5% (v/v) formalin and fixed overnight at 37°C. The cell 
suspension was then centrifuged at 1350 g and resuspended in 
0.1% (v/v) formol saline to 40 International Units of 
turbidity or approximately 4 x 109 bacterial cells/ml. Two 
strains of rabbit were inoculated, young adult New Zealand 
Whites and Half Lops reared from crossing a New Zealand 
White male and a French Lop-Eared female in our own animal 
house. Following a pre-immunisation bleed of 10 ml the first 
injection consisted of 2 ml equal volumes of cell suspension 
and Freund complete adjuvant (Difco Bacto Adjuvant, Difco 
Labs. Detroit, Mich.) administered intracutaneously into the 
sub-scapular region (i.e. 1 ml under each scapula). After 21 
days, injection of a mixture of 2 ml of equal volumes of 
cell suspension and Freund's incomplete adjuvant (Difco) was 
given intramuscularly into the hind quarters. Seven days
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later, approximately 50 ml of blood was taken from the 
marginal ear vein and 2 ml of cell suspension was injected 
intravenously. This procedure was repeated after 7 days. The 
rabbits were exsanguinated under anaesthesia 7 days later.
2.5.2 Method of Kohler et al.. (1981)
The Knoxville-1 strain of L.pneumoohila SG 1 was 
inoculated onto BCYE and incubated at 37°C in a 3% C02 
atmosphere in sealed C02 jars. After 7 days incubation the 
organisms were scraped from the agar, resuspended in 
phosphate-buffered saline pH 7.2 and autoclaved at 101°C 
for 1 h. The cells were removed by centrifugation and 
resuspended in 10 ml of phosphate-buffered saline per 0.5 ml 
of packed cells, repacked by centrifugation at 1350 g for 10 
min and left at 4°C for 14 days. For immunisation the 
packed organisms were resuspended and 1 ml mixed with an 
equal volume of Freund's complete adjuvant (Difco) . After 
taking a pre-immunisation blood sample the immunogen was 
injected subscapularly and intramuscularly (0.5ml per site) 
into the hindquarters of the rabbit. Subsequent injections 
of the same inoculum and volume but mixed with incomplete 
Freund adjuvant (Difco) were given twice weekly for 2 weeks 
then once weekly for 2 weeks. Antiserum (10-20ml) was taken 
14 and 21 days after the sixth injection and tested by IFA 
and ELISA.
2.5.3 Method of Tana and Toma (198 6 )
The RH strain (Bellingham-type) of L.oneumophila SG 1
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was grown on BCYE at 37°C for 48 h in a 3% C02 atmosphere in 
sealed containers and harvested in 1% (v/v) formalin in PBS 
pH 7.4. After 18 h at 22°C, the cells were washed by 
centrifugation three times in PBS, and the packed cells 
adjusted to a density of 40 IU in 0.1% (v/v) formalin in 
PBS. A sample of pre-immune blood (15 ml) was taken before 
the immunisation of a New Zealand White rabbit with 
intradermal injections of 1 ml of antigen into 1 2 dorsal 
sites. After 30 days, 1 ml of antigen in was injected 
intramuscularly at one site. Then, monthly intravenous 
injections of 1 ml were begun 7 days later and continued for 
8 months. Blood samples (10ml) were taken at monthly 
intervals 14 days after each monthly intravenous injection 
and tested by IFA and ELISA.
2.5.4 Method of Conlan and Ashworth (1986)
Antisera to serogroup antigen of L.pneumoohila 
SG 1 was obtained by immunising New Zealand White rabbits 
with purified saline extracts (section 2.14.). After a 
pre-immunisation blood sample had been taken, each rabbit 
was inoculated with 1 ml of antigen (estimated at 16 ug of 
carbohydrate, unless otherwise stated) in incomplete 
Freund's adjuvant (Difco) distributed between two 
intramuscular and two dorsal subcutaneous sites. A boost was 
given with the same dose 2 weeks later. Starting one week 
after that, blood samples (1 0 ml) were taken at weekly 
intervals, assessed for antibody by IFA and purified for IgG
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to test its suitability as a capture antibody.
After the 12th week from the start of the protocol a 
further intravenous boost of antigen (1ml) was given, 
followed two weeks later by exsanguination under 
anaesthesia.
2.6 IctG preparation
2.6.1 Ammonium sulphate precipitation of immunoglobulins
This procedure was carried out for all test bleeds
taken up to number 148, after which Protein-A Fast Flow
(Pharmacia LKB Ltd.) was employed for IgG purification 
directly from whole sera. Test bleeds were placed 
immediately in a 37°C hot room for 30 min to allow clotting 
to take place and then left overnight at 4°C. After 
centrifugation at 3500 rpm for 15 min (1350g), the serum was 
carefully removed and 1ml of this used to determine the 
antibody titre by indirect immunofluorescence (IFA). The 
remainder was transferred to visking tubing (24/32 
Scientific Instrument Centre Ltd.) and dialysed overnight, 
with stirring against 50% saturated ammonium sulphate (291 g 
per litre of distilled water at 0°C, BDH Ltd.) at 4°C. The 
contents of the sac was then centrifuged at 3500 rpm for 15 
min on an MSE centaur 2 (1350g) and the supernate discarded.
The precipitate was washed with 50% saturated ammonium
sulphate to remove any lysed red blood cell products and 
centrifuged as before. The pellet was recovered and 
dissolved in 2 ml of 0.01M phosphate buffer (pH 7.5) and
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dialysed with stirring for 24h or for 8h with several 
changes of buffer at 4°C. A sample from the sac contents was 
assayed for protein by the Biuret method and the volume 
noted to ensure the total protein concentration did not 
exceed the capacity of the DEAE 52 column. The sample was 
concentrated by transferring it to a length of visking 
tubing and placing it on a bed of polyethylene glycol 4000 
(BDH Ltd.) at 4°C until the volume was less than 1 ml.
2.6.2 Purification of serum IaG on DEAE 52
A column (6 x 2cm) containing 8 g (wet weight) of 
DEAE 52 (Whatman Chemical Separation Ltd.) was equilibrated 
with 5 column volumes of 0.01 M phosphate buffer (pH 7.5) 
and the level of buffer allowed to drain to the top of the 
bed before application of the serum sample to the column.
IgG eluted in the void volume with 0.01 M phosphate buffer 
(pH 7.5) as a single peak. Other serum proteins were eluted 
with 0.1 M and 0.3 M phosphate buffers (pH 7.5).
2.6.3 Purification of serum IaG on Protein-A Seoharose Fast 
Flow
The method of Miller and Stone (1978) was employed to 
isolate IgG rapidly from whole serum using insolubilised 
protein A.
A column of Protein-A Sepharose Fast Flow (7.9 x 
0.9cm, Pharmacia LKB Biotech.) was
equilibrated at 4°C with buffer A (See Appendix I) 
containing 0.1 mM phenylmethylsulfonyl fluoride (PMSF, BSA,
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Sigma) and 0.02 % (w/v) sodium azide, (pH 8.0). Rabbit 
immune serum (2ml) prepared as previously described, was 
mixed with an equal volume of buffer A and applied directly 
to the column. The column was then washed with 5-10 volumes 
of buffer A (flow rate of 40 ml/ h) and bound IgG was eluted 
from the column using buffer B (See Appendix I) containing 
0.1 mM PMSF and 0.02 % (w/v) sodium azide (flow rate of 
40 ml/h). An elution profile of IgG was obtained by 
measuring A2g0 of each fraction. Proteins eluted with 
buffer B were then dialysed with stirring at 4°C against 
three changes (each of 1L) of buffer A without PMSF and 
sodium azide.
PMSF is required in buffers to inhibit proteolytic 
activity found in whole serum so that column deterioration 
is prevented.
2.6.4 Coupling polyclonal rabbit antibodies to 
CNBr-activated-Seoharose 4B
The method described by Pharmacia (1988) was followed. 
Briefly, 3g of freeze-dried cyanogen
bromide-activated-Sepharose 4B, (Pharmacia Ltd., Separation 
Division) was swollen for 15 min in ImM HC1 and washed on 
a sintered glass filter (G3) with the same solution. Each 
gram of freeze-dried powder gives a gel volume of 
approximately 3.5ml. A total of 200ml per gram dry gel was 
added in a number of aliquots, the supernatant being sucked 
off between successive additions. The use of HC1 preserves
the activity of the reactive groups which hydrolyze at high 
pH. The gel was then washed with 0.1 M NaHC03 coupling 
buffer (pH8.3), containing 0.5 M NaCl (5ml per gram dry gel) 
and immediately transferred to a solution of the rabbit 
antibody at a concentration of 5-10mg protein (antibody) 
per ml of gel. Four antibody solutions were used where IgG's 
were Protein-A purified. These were Nos. 43, 221, 228, and a 
control gifted by Fehrenbach (raised by the Kohler method of 
antibody production and used at 3mg/ml concentration). These 
solutions were prepared by dialysis against the coupling 
buffer with 3 changes of buffer over a period of 24 h at 
4°C with stirring to dialyse out the Tris buffer and their 
protein concentrations determined by the method of Biuret. 
The CNBr-activated Sepharose-4B and antibody solution in 
coupling buffer was gently mixed for 2 h at room temperature 
(at a gel: buffer ratio of 1:2). After this time, any 
remaining active sites were blocked by transferring each 
gel/antibody mixture to a solution of 0.2 M glycine (pH 8.0) 
for 2 h at room temperature. Excess uncoupled protein was 
washed away on a sintered glass filter (G3) with coupling 
buffer followed by acetate buffer (0.1 M, pH 4.0) containing 
0.5 M NaCl followed by coupling buffer. The 
antibody/Sepharose reagents were stored at 4°C until use.
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2.7 Chemical analyses
2.7.1 Protein determination
Method of Biuret (peptide bond estimation in serum 
P.rg.t.e in
This test was employed to estimate the amount of serum 
protein prepared by ammonium sulphate precipitation in 
rabbit blood samples to prevent overloading either DEAE 52 
and Protein-A columns and to estimate the quantity of pure 
IgG for ELISA testing.
Either serum protein or IgG (0.1 ml) was mixed with 5ml 
of Biuret reagent (BDH Ltd.) and left for 30 min for the 
colour to develop. This was read at A540 on a Corning 
Colorimeter 253. BSA standards ranged from 0-100 mg/ml.
2.7.2 Method of Lowry
To 0.5 ml of sample, 0.5 ml of IN NaOH was added and 
the mixture placed in a water bath at 100°C for 5 minutes. 
After the sample had cooled, 2.5 ml of reagent A (2 ml of 
0.5% (w/v) CuS04 .5H20 in 1% (w/v) sodium potassium 
tartarate added to 50 ml of 5% (w/v) Na2C03) was added, the 
sample vortex mixed and allowed to stand for 10 min. Folin 
and Ciocalteu's phenol reagent (0.5ml) previously diluted 
1:1 in distilled H20 was added carefully and the contents 
vortex mixed. The colour was allowed to develop for 30 min 
and the A750 was measured on a Pye-Unicam PU- 8 620 
spectrophotometer. Reagent blanks consisted of 0.5 ml 
distilled water substituted for the protein sample and a
standard curve was obtained with dilutions of bovine serum 
albumin (BSA, Sigma) containing 500, 400, 300, 200, 100 and 
50 ug/ml. The protein concentration in the standard was 
assessed by measuring the A28o (1 mg/ml = 0.660) .
2.7.3 Method of Bradford
To a 100 mm by 15 mm test tube , 0.1 ml of standard or 
sample was added. Coomassie Blue reagent (5ml, Bio-rad) 
made up to the manufacturers' instructions was added to each 
tube and the mixture of reagent and sample vortex mixed and 
left at room temperature for 10 min. The colour development 
was determined at A595 on a Cecil CE292 spectrophotometer 
and the total protein estimated from standards of 20, 15, 10 
and 5 mg/ml of BSA (Sigma).
2 .8 Carbohydrate determination
The carbohydrate content in a sample of purified 
LPS from L.oneumophila SG 1 (Knoxville-1) was determined by 
the method of (Dubois et al. 1956)
Briefly, 2 ml samples of sugar-containing solution were 
transferred to test tubes (14 x 150 mm) and 0.05 ml of 80% 
(w/w) phenol added followed by the rapid addition of 5 ml of 
concentrated sulphuric acid (sp.gr 1.84) to each tube. The 
tubes were allowed to stand for 1 0 min, vortex mixed, then 
placed for 20 min in a water bath at 30°C. The A 480 was 
measured in a Cecil Instruments CE 292 UV spectrophotometer.
Blanks were prepared by substituting distilled water 
for the sugar solution and a standard curve was prepared
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from dilutions of glucose (Mannheim Boehringer 1 mg/ml) at 
25, 50, 75 and 100 ug\ml final concentration. All solutions 
were prepared in triplicate to minimise errors resulting 
from contamination with cellulose fibres.
2.9 Detection and semi-quantitation of endotoxin
The Limulus amoebocyte lysate test (LAL) for 
endotoxins, developed by Bang and Levin (1968), was utilised 
to determine the presence of lipopolysaccharide in CIE 
precipitates and as an aid in assessing the sensitivity of 
the ELISA by providing a quantitative value for the amount 
of LAL-reactive material in ELISA-positive urine.
The E-Toxate kit (Sigma) was employed and all glassware 
was treated with 1% E-Toxa-Clean (Sigma), rinsed with tap 
water, distilled water and lastly with pyrogen-free water 
(Baxter Healthcare Ltd.), autoclaved for 1 h and heated at 
180°C for a further 3 h before use. The test was carried out 
according to Sigma Technical Bulletin No. 210 (4-86), using 
a positive control of lipopolysaccharide from E . coli 055 :
B5 standardised against USP Reference Standard Endotoxin 
(RSE). Dilutions of this standard, ranging from 0.08 ng/ml 
to 0.005 ng/ml were used to estimate the sensitivity of the 
Limulus amoebocyte extract and results expressed as 
Endotoxic units/ml (EU).
2.10 SDS-Polvacrvlamide gel electrophoresis (SDS-PAGE)
Gels were poured as 16 x 20 x 0.1 cm vertical slabs
and were run using the discontinuous buffer system of
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Laemmli (1970) . The separating gels contained 10% (w/v) 
acrylamide, 0.3% (w/v) NN'-methylenebisacrylamide (Electran 
grade, BDH Ltd.), 0.375 M Tris-HCl, pH 8.3, 0.1% (w/v) SDS, 
0.125% (v/v) TEMED, and 0.02% (w/v) ammonium persulphate.
The stacking gels contained 4.5% (w/v) acrylamide, 0.125% 
(w/v) bisacrylamide, 0.125 M Tris-HCl, pH 6 .8 , 0.1% (w/v)
SDS, 0.15% (w/v) TEMED, and 0.04% (w/v) ammonium 
persulphate.
The running buffer consisted of 186 mM glycine, 25 mM 
Tris-HCl, pH 8.9, and 0.1% (w/v) SDS. Gels were run at 
20-25 mA until the bromophenol blue tracking dye reached 
1 cm from the bottom of the gel.
Molecular weights of unknown proteins were determined 
by construction of a standard curve plotting the mobility of 
protein standards (No. SDS-6H, Sigma) against the log10 of 
their molecular weights. These were :
Proteins Mol. Wt.
Myosin 205,000
Beta-galactosidase 116,000
Phosphorylase B 97,400
Albumin (Bovine Plasma) 65,000
Albumin (Ovalbumin) t 45,000
Carbonic anhydrase 29,000
2.10.1 Silver staining for' proteins
All SDS-PAGE gels were silver stained either by
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the method of Hitchcock and Brown (1983) or, for LPS, by the 
method of Tsai and Frasch (1982).
Before silver staining, the SDS-PAGE gel was fixed in a 
solution containing 10% (v/v) acetic acid and 30% (v/v) 
methanol with gentle agitation for 30 min. After rinsing in 
distilled water the gel was transferred to 1 0 0 ml of 1 0 %
(v/v) glutaraldehyde for 30 min and rinsed several times 
with distilled water. The gel was then agitated gently in a 
large volume of distilled water overnight. After removal of 
the glutaraldehyde by the rinsing procedure, the gel was 
then shaken in a solution of 5 ug/ml dithioerythritol 
(Cleland's reagent, Sigma) for 30 min. Without rinsing, the 
gel was transferred to 1 0 0 ml of 0 .1 % (w/v) silver nitrate 
in H20 and gently agitated for 30 min before the silver 
nitrate solution was poured off and the gel rinsed first 
with H20, then with 100 ml 3% (w/v) Na2C03 containing 50 ul 
formaldehyde while being gently agitated by hand. The gel is 
rinsed again in 3% Na2C03 with formaldehyde (50 ul/100 ml) 
and then allowed to develop in the same solution until the 
bands appeared. The reaction was stopped by adding 5 ml of
2.3 M citric acid and left for at least 10 min to prevent 
over development before being photographed.
2.10.2 Silver staining for LPS
The following procedure described by Tsai and Frasch 
(1983) was used for specific LPS staining of SDS-PAGE 
gels. Overnight fixation in 200 ml of 25 % (v/v). isopropanol
54
in 7% (v/v) acetic acid was followed by 5 min oxidation in 
150 ml distilled water with 1.05 g of periodic acid (GPR 
from BDH Ltd.) and 4 ml of 25 % (v/v) isopropanol in 
7 % (v/v) acetic acid (made up just before use). Eight 
washes, each time in 200 ml distilled water for 30 min, was 
followed by 1 0 min silver staining in a solution consisting 
of 0.1 N NaOH (28 ml), concentrated (29.4%) ammonium 
hydroxide (1 ml), 20% (w/v) silver nitrate (5 ml) and 
distilled water (115 ml) (made up just before use 
and stirred constantly on a magnetic stirrer). After 
staining, gels were given four 1 0 -min washes, each in 2 0 0  ml 
distilled water, was followed by a 1 0 - 2 0  min period of 
development at 25°C in 250 ml of developing solution (citric 
acid (12.5 mg), 37% formaldehyde (0.125 ml) and distilled 
water to 250 ml. This was made up just before use and gently 
heated to the optimal temperature of 25°C before addition to 
the gel (proteins are also stained at lower temperatures). 
One hour in a stop bath (200 ml of distilled water and 10 ml 
of 7% (v/v) acetic acid) was followed by a final wash in 
2 0 0 ml of distilled water before the gel was photographed.
Use of ammonium hydroxide is essential for the 
preferential staining of LPS and to prevent the oxidation of 
the ammonium hydroxide reagent it was transferred into small 
bottles thus excluding air until use.
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2.11 Serological assays
2.11.1 Determination of antibody titre in rabbit antisera
The level of antibody was determined by the indirect 
immunofluorescent antibody test (IFAT) modified from 
Wilkinson et al., 1979. This test is based on the 
immunospecific reaction of rabbit antiserum with a heat- 
killed suspension of legionellae, in which the coating of 
organisms by the rabbit's antibody is revealed by staining 
with f luorescin-con juga.ted anti-rabbit globulin. Multispot 
PTFE-coated microscope slides were used (Hendley-Essex).
A drop of heated legionellae organisms (5ul), sufficiently 
diluted to show discrete bacteria under a x40 objective lens 
and x6 eyepiece lens combination (Fallon and Abraham, 1982) 
was added to each well.
The slides were dried under tungsten lighting and fixed 
in acetone for 10 min at room temperature. Doubling 
dilutions of test antisera were made in PBS starting at 1/16 
to 1/32000 and 10 ul of each dilution was spotted onto an 
individual well on the slide which was then incubated at 
37°C in a humid chamber for 30 min. The slides were then 
washed in PBS for 10 min and dried by blotting between 
sheets of Whatman No. 1 filter paper.
The anti-rabbit IgM\IgG FITC conjugate (Nordic 
Immunology, Norway) at a working dilution of 1/40 was then 
spotted onto the slides, 5 ul to each well and incubated at 
37°C in a humid chamber for 30 min and washed as before.
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After drying the preparations were mounted in polyvinyl 
alcohol mounting medium (Serva), and covered with a glass 
cover slip.
Fluorescent microscopical examination was carried out 
using a Leitz Dialux EB fluorescence microscope fitted with 
an ultra-high pressure mercury lamp and an H2 filter block, 
consisting of a BP390-490 exciting filter, RKP-510 dichroic 
mirror and LP 515 suppression filter. The result was scored 
according to the level of fluorescence, the end point (titre) 
being the reciprocal of the dilution of the antiserum giving 
a level of 1 +, where the degrees of fluorescence are +++, ++, 
+, +/-,and
2.11.2 Slide agglutination test
The method of Thacker et al (1985) was followed to test 
rapidly the ability of antibody in test bleeds to react with 
whole cells of L.pneumophila SG 1 (Knoxville-1). Briefly ten 
fold dilutions up to 1 / 1 0 0 0  were made from the antisera of' 
interest and these spotted onto a clean glass microscope 
slide (75 x 26 mm). A drop (25ul) of bacterial suspension 
(made up in 10 % (v/v) formol saline and incubated at 37°C 
overnight) was spotted alongside each antiserum dilution.
The adjacent drops were ■ each mixed with a clean glass rod 
and the glass slide gently rocked and any agglutination 
within 30 s was noted.
2.11.3 Ouchterlonv double diffusion test
Gel diffusion medium was made by adding 15g Ionagar
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No.2 (Oxoid), 16 g NaCl to 11 of distilled water and placed 
in a steamer for 45 min. Molten gel (12ml) diffusion medium 
was carefully pipetted onto a level glass plate (8 x 8 cm) 
until it was evenly coated and then allowed to set. After 
refrigeration for 1 h, wells (4mm in diameter) were cut in 
the agar with a cork borer (No.l) to the desired pattern.
The wells positioned 10 mm apart were each loaded with neat 
antisera (0 .0 2 ml) and run against sonicated bacteria or 
concentrated urine (0.02ml) prepared as in section 2.13.1 
except that these were not proteinase-K treated. These 
were prepared by scraping one BCYE plate of lawn culture 
of Legionella into 0.85% (w/v) saline and sonicating at full 
power on a Soniprep 150 MSE at 8-10 microns for 5x 1 min 
bursts, with cooling for 30 s between each sonication. After 
loading, the plates were incubated in a moist chamber at
3Soc for 24 h before results were noted.
2.11.4 Two-dimensional (crossed) immunoelectroohoresis (CIE)
Electrophoresis was performed in 1% (w/v) agarose 
(Type A-Sigma, with a setting temperature of about 35°C)
1.5 mm deep, on glass plates (5 x 5 cm). Barbital buffer 
(Appendix V), pH 8 .6 , ionic strength 0.1, specific 
conductivity = 7 mS (23°C) was used for agarose preparation 
and with 1% (v/v) Triton X-100 (Sigma) added when used as a 
running buffer during electrophoresis.
First dimension electrophoresis was performed in 
electrophoresis tanks (V. Holm-Nielson Aps, Copenhagen),
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using 10 ul of Tris-saline EDTA (T.S.E.) extract, sonicated 
whole cell preparations (Collins et al., 1983) of 
L.pneumophila SG 1 (Knoxville-1) or concentrated positive 
(by ELISA) antigen-containing urine. A current of 40 mA 
(80 V) was applied for 45 min or until ovalbumin (100 ug/ul) 
labelled with bromophenol blue migrated a distance of 30 mm 
in the first dimension. Temperature was maintained at 
10-12°C.
Second-dimension electrophoresis was performed at 12°C, 
applying a current of 30 mA for 20-24 h. The antisera used 
were a) dialysed against 50 % saturated ammonium sulphate to 
salt out immunoglobulins b) salted out as in a) followed 
by DEAE 52 chromatography to isolate IgG or c) added 
directly to Protein-A Fast Flow (Pharmacia LKB Ltd) to 
isolate IgG. Antigens were reacted with each serum at 0.1, 
0.2 and 0.4 ml diluted in 3 ml of 1 % (w/v) agarose.
The agarose gels were removed and washed for 24 h 
in saline and then transferred to distilled water for 
further washing with several changes over 24 h. Where 
staining was required, the washed agarose gels were pressed 
with care to prevent air bubbles by four alternate wet and 
dry sheets of chromatography paper (Whatman), layers of 
tissue and a 2 kg weight for 15 min. The layers of wet 
tissue and chromatography paper were removed carefully and 
the film of agarose gel adhering to the glass plate stained 
in 0.1% (w/v) amido black in methanol: acetic acid : dH20
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(3:1:6) for 1 min. After removal, the agarose film was 
destained for 48 h in 5 % (v/v) acetic acid with several 
changes and pressed again if necessary. Final drying of the 
agarose film was at 37°C overnight.
Where antigen-antibody precipitates were assayed 
for lipopolysaccharide, the sonicate was prepared from 
L.pneumophila SG 1 (Knoxville-1) grown on medium made with 
pyrogen-free water (Baxter Healthcare Ltd.). All glassware 
and electrophoresis tanks were pre-treated with 1 % E-Toxa- 
Clean (Sigma) and rinsed with pyrogen-free water. Also, 
barbital buffer (Appendix V) was prepared with pyrogen-free 
water and the wicks and glassware were treated as described 
in section 2.9.
2.12 Enzyme-linked immunosorbent assay (ELISA)
The original method (personal communication, McKinney, 
R.) was followed. To each well of a 96 well microtitre 
tray (Immulon III / I from Dynatech microelisa systems.)
0 . 1 ml of capture antibody (20 ug/ml) was added at either 
1/50 or 1/100 dilutions in 0.01 M phosphate buffered saline 
with 0.01% (w/v) merthiolate (pH 7.4) and incubated in a 
37°C water bath for 2 h. BSA (0.2 ml of 2% (w/v)) in 0.01 M 
PBS was then added and the plates incubated again at 37°C in 
a water bath for 2 h. The plates were then washed twice with 
0.01 M PBS (pH 7.4) and 0.1 ml of neat urine added.
Two wells of control antigen, known positive and 
negative urines against capture antibody (McKinney) at a
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dilution of 50 were included as controls for all test 
plates set up to examine either purified IgG from rabbit 
test bleeds or urinary or purified antigen.
The plates were washed with 0.01 M PBS (PH 7.4) before 
0 . 1 ml of conjugate (consisting of capture antibody 
conjugated to horse radish peroxidase) at a working dilution 
of 1/800 in 0.01 M PBS containing 2% (w/v) BSA was added to 
each well and incubated for lh at 37°C. The plates were then 
washed with 0.01 M PBS (pH 7.4) and 0.1 ml of substrate 
added to each test well. The substrate was made up fresh 
from 8.5 ml of distilled water, 0.5 ml of 4% (w/v) 
orthophenylenediamine (prepared in advance and stored in 
0.5 ml amounts at -20°C), 1 ml of substrate buffer 
(containing 17 0 mM citric acid, 650 mM Na2HP04, and 
0.1% (w/v) merthiolate), and 50 ul of 3% (v/v) H202. 
Following addition, plates were incubated at 
37°C in a water bath for 30 min before 4.5 M H2S04 (0.05 ml 
per well) was added to stop the reaction.
Each plate was read in a Titertek Multiscan Plus ELISA 
plate reader with a 492 nm filter and Vers. 1.4 software 
installed. Blank values were recorded for wells in column A 
where pre-immune sera or 0.1ml of 2% (w/v) BSA in 0.01 M PBS 
(pH 7.4) were substituted for capture antibody.
Positive control antigen was extracted from 
L.pneumophila SG 1 (Knoxville-1) by the method described 
later in section 2.16.3.
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Peroxidase was shown to be a good choice of enzyme 
for conjugation by Nakane and Pierce (1966) and Nakane and 
Kawaoi (1974). It has high activity, is cheaper than 
alkaline phosphatase, and yields a visible (brown) reaction 
product. Conjugation of high titre antisera, determined by 
IFA, to horseradish peroxidase was achieved by the one step 
glutaraldehyde method described by Voller et al., (1976) .
IgG raised against L.pneumophila SG 1 (2mg in 1ml of PBS pH 
7.2) was added to 5 mg of horse radish peroxidase (HRP-4, 
Bioenzyme Labs. Ltd.) and mixed at room temperature. The 
mixture was then dialysed against PBS for 18 h at 4°C with 
three changes of buffer. Glutaraldehyde (25% v/v) was added 
to give a final concentration of 0 .2 % (v/v) and the mixture 
was incubated at room temperature for 2-3 h before dialysis 
against PBS overnight at 4°C with several changes of buffer. 
The conjugate-containing dialysis sac was transferred to 
0.05 M Tris-HCl, pH 8.0 and dialysed overnight with several 
changes of buffer. The sac contents were then diluted to 4ml 
with 0.05 M Tris-HCl, pH 8.0 buffer containing 1% (w/v) BSA 
and 0.02% (w/v) NaN3 to give the stock conjugate which was 
stored at 4°C in the dark until use. The working strength of 
the conjugate was determined by chess-board titration in the 
ELISA system using working capture antibody and both control 
antigen and antigen-containing urine. Usually, the 
conjugates had a working dilution of > or = 500.
62
2.13 Immunoblotting
Electrophoretic transfer of LPS from polyacrylamide 
gels to Hybond-C nitrocellulose (Amersham International 
pic.) or to Immobilon-P polyvinylidene difluoride 
(Millipore), both of pore size 0.45um, was accomplished in a 
Bio-Rad transfer tank (transfer buffer made up of 7.5 g 
Tris-HCl, 36.0 g glycine, 500 ml of methanol made up to 2.5 
1 with distilled water). Nitrocellulose paper of the same 
size as the gel was presoaked in transfer buffer, positioned 
next to the gel and sandwiched between 3 MM chromatography 
paper (Whatman) and Scotchbrite pads and retained in a 
plastic holder. The polyvinylidene difluoride membrane was 
treated similarly except that it was presoaked in methanol 
for 1-3 s, immersed in distilled water for 2 min and finally 
equilibrated in transfer buffer for 2 min before use. A 
current of 0.02 A was applied overnight across the buffer in 
the transfer tank, which was water-cooled. After transfer of 
the components from the gel, the membranes were immersed in 
TTS (20 mM Tris-HCl with 1% (v/v) Tween 20 (Sigma) in 0.85% 
(v/v) saline, pH 7.2/5% (w/v) BSA (Sigma)) and gently shaken 
at room temperature for 2-3 h. The membranes were washed in 
TTS/ 0.1% (w/v) BSA three times with shaking for 15 min for 
each wash and then incubated with antiserum diluted to 1 0 0  
or 200 in TTS/ 1% (w/v) BSA for 2-3 h at room temperature. 
The membranes were washed three times in TTS/ 0.1% (w/v) BSA 
as before and incubated with donkey anti-rabbit IgG
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conjugated to horse radish peroxidase (SAPU) diluted to 100 
or as directed in TTS/ 1% (w/v) BSA for 2 h at room 
temperature on a shaker. The blots were then rinsed in TBS 
(20 mM Tris-HCl in 0.85% (w/v) saline pH 7.2) and the bands 
developed in 8 mM 4-chloro-l-napthol in 0.02% H202 (v/v) 
with shaking for 30 min at room temperature. The reaction 
was stopped when the blots were washed in distilled water.
2.14 Concentration of antigen-containing human urine from 
patients with a L .pneumophila SG 1 infection
Human urine to be analysed for the presence of LPS 
from Legionella pneumophila SG 1 by SDS-PAGE was 
concentrated using a Minicon macrosolute concentrator type 
B15 (Amicon). Briefly, for each human urine, 20 ml was 
divided between 4 chambers (5 ml to each chamber) and the 
unit placed at 4°C until the volume of urine was reduced to 
200 ul (50 ul for each chamber). Each concentrated urine
sample (50ul) was mixed with 100 ul of lysing buffer and
incubated with 10 ul of Proteinase-K (2.5 mg/ml) at 60°C for 
1 h. Then each urine (lOul) sample was loaded into a lane of 
an SDS-PAGE gel.
2.14.2 A modification of procedure (i) was adopted to 
concentrate human urine to detect the presence of any 
protein moiety and LPS in ELISA-positive human urines.
As before, for each urine, 20 ml in total was added to each 
chamber (5 ml at a time) and the accumulated concentrated
volume of 100 ul was removed to a sterile Eppendorf tube.
The chamber of the macrosolute concentrator was then washed 
with 1 ml of 3 % (w/v) SDS to dissolve any bound LPS and 
protein.
The combined washings and concentrate for each sample 
were freeze-dried overnight at -7 0°C and transferred to 
storage at -20°C. Each sample of urine was dissolved in 
100 ul of distilled water and 25 ul of each urine was mixed 
with an equal volume of double strength solubilising buffer 
before loading onto a gel (10 ul/track).
Samples of urines which were not concentrated before 
analysis were proteinase-K digested treated in the following 
way. Urine (25ul) were mixed with 25 ul of solubilising 
buffer and 10 ul of Proteinase-K in lysing buffer 
(2.5 mg/ml) and incubated at 60°C for 1 h. Digestion 
was terminated by placing the sample in a boiling water bath 
for 5 min.
2.14.3 Concentration bv oolvvinylalcohol
50 ml of each urine for study was also concentrated 
in dialysis tubing against polyvinyl alcohol (M.W. 125,000) 
at 4°C until the volume was < or = to 1 ml (24-36 h) .
2.14.4 Affinity chromatography
Columns (7 x 55mm) of antibodies raised to 
L.pneumophila SG 1 coupled to CNBr-activated-Sepharose 
4B as described in section 2.6.4 were poured. These were 
exposed to urine, either antigen-containing (G.L.) or 
non-antigen-containing urine from a healthy human (R.F.)
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at flow rates of 16 ml/h. After exposure to these human 
urine specimens, lOOul gel volume was taken from each 
column, mixed with 30ul of 2x solubilising buffer, 
vortex-mixed, centrifuged to deposit the gel in the buffer 
and placed in a water bath heated to 100°C for 5 min. 30ul 
samples were then loaded on to 10% SDS-PAGE gels at a 
current of 30mA for 3-4h before immunoblotting against IgG 
(antiserum Nos. 43, 59 and control McKinney each at 
dilutions of 50, 100 and 200 as described in section 2.13 
except that Immobilon-P (Millipore) was used instead of 
Hybond-C (Amersham) as the transfer membrane.
2.15 Preparation of Cellular Antigens
2.15.1 L .pneumophila - Lipopolvsaccharide
It was noted by Conlan and Ashworth (198 6 ) that 
according to the method of Westphal and Jann (1965) 
extraction of L.pneumophila SG 1 yielded LPS contaminated 
with cellular protein in the phenol phase. Therefore Conlan 
and Ashworth (1986) devised an alternative extraction method 
which was adopted in this study.
Thirty BCYE plates inoculated with L.pneumophila SG 1 
(Knoxville-1) were scraped into 0.9 % (w/v) saline and the 
suspension was adjusted so that 1 ml of saline contained 1 0 0  
mg wet weight of cells. This was stirred constantly on a 
heated magnetic stirrer in a water bath at 100°C for 1 hour. 
The cell suspension was centrifuged at 17,000 g (W50-1 Rotor 
in a Beckman Model L5-50 ultracentrifuge) at 4°C and the
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supernate dialysed against PBS (see Appendix III). Extracts 
were treated sequentially, each for 2 h at 37°C, with 
ribonuclease-1 , then deoxyribonuclease- 1 was added (in the 
presence of 0.1 M MgCl2) and finally pronase (enzymes from 
BDH Ltd.) at final concentrations of 0.01 mg/ml for each 
enzyme. At the end of this treatment (6 h in total) residual 
enzyme activity (except ribonuclease-1 ) was destroyed by 
heating to 100°C for 5 min, before centrifugation at 1,250 g 
for 2 min to remove insoluble denatured proteins. Extracts 
were then dialysed for 24h at 40C against 0.01 M Tris-HCl, 
pH 8.2 and the enzyme-treated saline extracts further 
purified by gel filtration using Sepharose 4B medium 
(Pharmacia).
The volume of the saline extract was reduced by 
rotary evaporation at 70°C on a Buchi Rotavapor-R until a 
volume of 5 ml was attained. This was then applied to a 
column (90 cm x 2.6 cm internal diameter) of Sepharose 4B 
(Pharmacia LKB) , equilibrated with 0.01 M Tris-HCl (pH 8.2) 
at a flow rate of 10 ml/hour. Eluted proteins were detected 
at A280 (LKB Bromma 2158 Uvicord). The fractions collected 
(LKB Ultrorac or Redifrac) for each peak were pooled and 
analysed for LPS by ELISA (McKinney antisera as capture 
antibody), for protein by the method of Lowry (1965) and 
also examined by SDS-PAGE.
2.15.2 L.pneumophila, Proteinase-K preparations 
L.pneumophila SG 1 LPS was prepared by
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Proteinase-K digestion of whole-cell lysates by the method 
of Hitchcock and Brown (1983). Bacteria were grown on BCYE 
agar, harvested after 48 to 72 h of incubation at 37°C, and 
suspended in distilled water to an A 660 = 1 . A 1.5 ml 
volume of this suspension was centrifuged at 14,000 rpm for 
2 min in an eppendorf microfuge. The supernate was decanted, 
and the pellets were solubilised in 50 ul of lysing buffer 
(2% SDS (w/v), 4% (v/v) 2-mercaptoethanol, 10% (v/v) 
glycerol, 1 M Tris (pH6 .8 ), and 0.05% (w/v) bromophenol blue 
by incubation in a water bath at 100°C for 10 min. A fresh 
solution of Proteinase K (Sigma) was prepared for each 
experiment at a concentration of 2.5 mg/ml in lysing buffer. 
A sample (10 ul) of this was added to each boiled lysate and 
the lysates were then incubated at 60°C for lh. The 
proteinase-K digested lysates were centrifuged for 3 min to 
remove any remaining cellular debris, and the supernates 
retained for analysis by SDS-PAGE.
2.15.3 Tris saline EDTA (T.S.E.) outer membrane extraction 
The growth of L.pneumophila SG 1 (Knoxville-1) from 
4 BCYE plates after 96 h incubation was harvested in PBS and 
bacteria were sedimented by centrifugation at 1250g for 
20 min. The supernate was decanted and 2 ml of TSE buffer, 
pH 7.4 (0.01 M Tris-HCl, 0.15 M NaCl, 0.002 M EDTA) added to 
the cell pellet and the cells gently resuspended. Glass 
beads (1ml, Sigma No. G3753, Type 1, 75-150 urn.) were then 
added and the mixture allowed to stand on ice for 45 min
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before being vortexed for 2 min. The cells were sedimented 
by centrifugation as before and the supernate removed, 
filter-sterilised (0 . 2 2 urn), aliquoted into 0 . 5 ml volumes 
and stored at - 20°C.
2.15.4 Lp I-Act preparation
LPl-Ag for L .pneumophila SG 1 was prepared by
ultrasonication following the method of Collins et al.
(1983) .
L.pneumophila SG 1 (Knoxville-1) cells were harvested 
from BCYE after 96 h growth and suspended in a minimal 
amount of sterile distilled water and transferred to an 
eppendorf tube. After centrifugation at 10,000 g for 10 
min at 4°C, the supernate was removed and the cell pellet
was weighed. A portion of the supernatant was then added
back to the cell pellet at a ratio of 2 ml/g wet weight of 
cells and the cells resuspended.
Bacterial disintegration was accomplished by sonication 
with three periods of 45 s each at 20,000 Khz/s using an 
MSE Soniprep 150 with a stainless steel probe (3mm tip). The 
suspension was cooled with ice during sonication and for 
1 min periods between each sonic treatment. Cell fragments 
were removed from the sonicate by centrifugation at 48,200 g 
for 1 h at 4°C using an SS-34 rotor in a Sorvall 
refrigerated Superspeed centrifuge. The supernate was 
filter-sterilised (0.2 urn, Millipore) and stored in 100 ul 
aliquots at - 20°C.
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2.16 Commercial kit evaluation
Two in-vitro diagnostic test kits for qualitatively 
detecting the presence of a L.pneumophila SG 1-related 
antigen in human urine have been manufactured and marketed 
within the last two years. The "Dupont" kit is only licensed 
for sale in the U.S.A. and was a generous gift for 
evaluation purposes only.
2.16.1 "Mericren" latex agglutination test 
This kit, a latex agglutination assay, consists of a 
suspension of latex particles sensitised with monoclonal 
antibody which is claimed to react specifically with "S-l 
antigen" (Merigen terminology in accompanying literature for 
L.pneumophila SG 1 antigen) when present in urine. Thus, 
the presence of this antigen is signified by no or a weak 
agglutination (i.e. a "positive" result).
The materials provided in this kit for the testing of 
specimens include 1 ) latex detection reagent which is an 
anti-L.pneumophila S-l monoclonal antibody coated onto latex 
particles in a buffer containing sodium azide as a 
preservative 2 ) a positive antigen control reagent which is
a non-viable suspension of S-l antigen in a buffer with
sodium azide 3) a negative antigen control reagent which is
a pooled human negative urine with sodium azide 4) plastic
pipette stirrers and 5) a test slide.
All specimens were allowed to reach room temperature 
before testing and urine samples were centrifuged at 1 0 0 0  g
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for 10 min. One free-falling drop of latex suspension, 
after gentle inversion to ensure even mixing, was put onto 
each marked oval on the test slide. Next to each drop of 
latex reagent 50 ul of either the specimen to be tested 
using the pipette-stir tubes or a free-falling drop of the 
positive or negative controls was added to the oval next to 
but not touching the latex reagent. Each specimen or control 
was mixed with the paddle end of its "pipette-stir" and the 
slide was rotated at 1 0 0 +/- 2 0 rpm in a moist chamber for 
15 min. After this time the slide was rocked manually 
two or three times to resuspend the latex particles in each 
of the ovals and the results were immediately recorded. A 
positive test was recorded if either a weak agglutination 
(1+) or no agglutination was observed. A negative result 
was recorded if agglutination was observed greater than or 
equal to 2+ (1 + and 2 + agglutinations were defined 
photographically in the literature accompanying the Merigen 
kit). Results were only valid if the positive and negative 
controls gave no agglutination and agglutination 
respectively. This test was evaluated purely for its 
efficacy in distinguishing between known positive antigen- 
containing and negative urines previously evaluated by 
the ELISA in this laboratory. Also some of the urines used 
in this kit evaluation have been assessed by other workers 
in addition to our own testing with the common results 
agreed between laboratories.
2.16.2 "Dupont” Legionella urinary antigen f125Il RIA kit 
This kit is a radioimmunoassay based system intended for 
in-vitro diagnostic use. It consists of 1) 50 reaction tubes 
coated with polyclonal rabbit anti-L.pneumophila SGI IgG 
ready for use 2) concentrated (x25) saline rinse with 0.8% 
(w/v) sodium azide as a preservative, 3) positive control 
human urine with 0.8% (w/v) boric acid as a preservative, 4) 
negative control human urine with 0 .8 % (w/v) boric acid and 
5) [1 2 5I] labelled antibody in 0.1M Tris (pH 8.0), 0.9%
(w/v) NaCl and 5% (w/v) BSA as a detector antibody. The 
IgG-[125Ij had an activity of less than 370 KBq (10 uCi) on 
the calibration date. All the reagents were stored with the 
appropriate precautions at 2-8°C until used before the 
expiry date. All specimens and controls were allocated four 
reaction tubes precoated with polyclonal IgG (normally two 
reaction tubes would be allocated to each specimen and four 
to each of the two controls [tested in duplicate] but a 
quality control note with the kit indicated a 1.4% incidence 
of non-coated reaction tubes) and these labelled 
accordingly. Positive and negative control urines supplied 
with the kit were added (lOOul) to their respectively 
labelled reaction tubes and the same volume of the test 
specimens to their reaction tubes without leaving 
droplets down the wall of the polystyrene tubes. Taking care 
not to disturb the tubes they were incubated at 37°C +/- 
1°C for 60 min in a water bath. After this time the
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concentrated saline rinse, diluted 25 fold with fresh 
distilled water, was used to wash out the urine samples from 
each tube by aspiration. Each tube was washed three times 
with approximately 1 ml of saline rinse. One-hundred ul of 
the [1 2 5I] detector antibody was pipetted directly to the 
bottom of each tube. Tubes were incubated as before. After 
incubation the unbound radioactive tracer was aspirated into 
a separate vacuum flask for safe disposal. Then the outside 
wall of each test tube was dried of any extraneous rinse 
whilst maintaining the tubes in an upright position. 
Disintegrations per min (dpm) over a 60 s period were 
measured on a United Technologies Packard crystal multi 
detector gamma system scintillation counter whose counting 
efficiency of 125I was > or = 75%. Duplicate background 
counts were also made over the same time period with every 
10 tubes measured for radioactivity. According to the 
manufacturers of the kit, the net (i.e. corrected for 
background) negative control urine mean dpm should be less 
than 250 dpm and the positive control urine net dpm should 
be greater than three times that of the negative control. In 
addition all four tubes must score as either positive or 
negative for the test result to be valid and if not, the 
test for that specimen must be repeated.
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2.17 SPECIES IDENTIFICATION
2.17.1 Direct extraction of cellular ubiquinones for 
analysis bv RPTLC
Direct extraction of ubiquinones (isoprenoid quinones) 
by a modified procedure of Karr et al. (1982) was employed 
for the extraction of ubiquinones from fresh whole cells.
Each species and strain to be studied was inoculated 
onto two BCYE agar plates and incubated at 37°C for 
48-72 h. Growth was then scraped off with a bent Pasteur 
pipette (0.4 g wet weight) into 3 ml of methanol-hexane 
(3:2) in a glass universal container and the mixture 
vortex mixed for 3 min. To this suspension, 8 ml of n-Hexane 
was added, the mixture was vortex mixed vigorously for 3 min 
and then centrifuged at 120 g for 10 min on an MSE' GF- 8  
centrifuge.
The hexane layer was removed, and the aqueous phase was 
re-extracted with 8 ml of n-Hexane. The hexane extracts were 
pooled, evaporated to dryness in-vacuo before the residue 
was redissolved in 0 . 1 ml ethyl acetate and analysed by 
RPTLC.
2.17.2 Extraction of ubiquinones bv saponification
A modified procedure of Abe et al. (1978) was used.
Fresh whole cells (0.4 g wet weight) were scraped from two 
BCYE agar plates and suspended in 3 ml of 1% (wt/v) 
pyrogallol in methanol in a 10 ml Quickfit flask. To this, 
0.2 ml of 50% aqueous KOH was added and the mixture refluxed
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for 10 min at 100°C followed by immediate cooling under 
running tap water. Distilled water (1ml) and n-Hexane (5ml) 
were added and the mixture shaken vigorously for 5 min and 
then centrifuged at 1 2 0 g for 1 0 min before the hexane layer 
was removed and the aqueous phase re-extracted with an 
additional 5 ml of hexane. The pooled n-hexane extracts were 
evaporated to dryness in-vacuo and the resulting residue 
redissolved in ethyl acetate before separation by RPTLC.
2.17.3 Preparative TLC purification of cellular 
ubiquinones for mass spectrometry
Ubiquinones were prepared as before except that the 
growth from eight plates of BCYE was required to provide a 
sufficient amount of crude extract for ultimate analysis by 
mass spectrometry. Each hexane extract was applied as a band 
1 cm from the bottom of an aluminium-backed TLC plate 
(10 xlO cm) coated with silica gel 60 WF2 54s (Merck from BDH 
Ltd.) along with a Q-10 standard (Sigma). Plates were eluted 
in equilibrated tanks with n-hexane : diethyl ether (85:15) 
as solvent for about 15 min or until the solvent front had 
advanced 3/4 the height of the TLC plate. The plate was 
examined under ultra violet light (wavelength 254 nm) and 
the position of the ubiquinone band marked with pencil. This 
area of silica gel was scraped off into a sintered glass 
funnel connected to a side-arm vacuum flask and the 
ubiquinones eluted with 20 ml of chloroform (AnalaR, BDH 
Ltd.) under vacuum and transferred to a conical-bottomed
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glass container.
The chloroform was evaporated in-vacuo and the dry 
sample flushed with 90% N2/10% C20, covered with aluminium 
foil and stored at -20°C until analysed by mass 
spectrometry.
2.17.4 Reversed-phase thin layer 'chromatography (RPTLC)
Each sample (20-50ul) was spotted onto a reversed-phase 
thin layer chromatography plate (Whatman octadecylsilane 
bonded reversed-phase KC18F plates, 20 x20cm, 200um layer) 
together with a control extract from L.pneumophila SG 1 
(Knoxville-1) and two ubiquinone standards, Q- 6 and Q-10 
(Sigma). The plate was developed in a mobile phase of 
acetone: water (19:1) in a Whatman TLC tank lined with 
Whatman No. 1 chromatography paper. After elution, the 
plates were sprayed from a distance of 20-25 cm with 10%
(v/v) phosphomolybdic acid in ethanol (Sigma) and placed in 
a hot air oven at 160°C for 30 to 50 s until the separated 
components could be seen after which it was removed, allowed 
to cool and photographed. A tentative identification of 
ubiquinones was made by comparing Rf values with those of 
commercial standards and of ubiquinones extracted from 
L .oneumoohila SG 1. Confirmation of the presence of 
ubiquinones and their identity in these extracts was by fast 
atom bombardment mass spectrometry.
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2.17.5 Preparation of whole-cell fatty acid methyl esters 
(FAME) bv acid methanalysis
Four plates of BCYE were inoculated with the Legionella 
species or strain of interest and incubated at 37°C for 96 h 
in C02 jars after which the growth was carefully recovered 
using a bent Pasteur pipette and transferred to a test tube 
(14 x 150 mm) containing 8 ml methanol. To this, 8 ml of 
toluene was added followed by 0.4 ml of concentrated 
sulphuric acid. The test tube was sealed with a teflon cap, 
vortex mixed for 1 min and heated overnight in a water bath 
at 54°C. After cooling, the contents were transferred to a 
glass universal container and 8 ml of n-hexane added before 
vortex mixing and centrifugation ( 1 2 0 g for 1 0 min) to 
achieve phase separation. The top hydrophobic immiscible 
layer was removed and transferred to a clean glass 
universal before washing in excess 0.3 M NaOH. Again the 
top layer containing the fatty acid methyl esters was 
removed to a clean universal and the FAME'S were 
concentrated in-vacuo to about 2 ml before transfer to 4ml 
amber-coloured sample vials (Phase Separations Ltd.) and 
evaporated to dryness. The dry sample was flushed with 
90% N2/10% C02 and sealed with an inert teflon-lined screw
cap (Phase Separations Ltd.) before storage at -20°C.
2.17.6 Whole-cell FAME analysis of the LegionellaceaQ 
bv aas-liquid chromatography (GLC)
FAME extracts were solubilised in 0.04 ml toluene
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("Special for Chromatography" BDH Ltd.) and 0.1-0.5 ul 
of each sample was injected into the GLC (Chrompack Packard 
Ltd. Model No. 437A) for analysis. The chromatographic 
conditions were as follows :
Injector temperature : 270°C
Oven temperature programme : 150°C/ 5 min, oven rise of
4°C/ min to 250°C, 250°C/
5 min.
Detector temperature : 300°C
Injector : Splitter, ratio 60—100:1 (dependent on sample
concentration)
Split flow : 47.91 ml/min (at 60 : 1 split ratio)
Carrier gas : Helium Grade A(BOC), flow rate = 0.7 9 ml/min
Make-up gas : 20 ml/ min (He)
Column : 50 M x 0.25 mm CP Sil 5 CB (Chrompack U.K. Ltd.) 
Liquid phase : 100% dimethyl polysiloxane (non-polar) 
Detector : Flame ionisation detector 
Attenuation : 210 
Range : 0 (Auto select)
On-line gas filters were used as follows :
Helium : Oxygen and moisture removing filters 
Air : Charcoal filter
H2 : Charcoal filter (All from Chrompack U.K. Ltd.)
A commercially available standard bacterial fatty acid 
mix containing 2 6 fatty acid methyl esters found in some 
members of the family Leaionellaceae (Wait, R. 1988) was 
obtained (Supelco Inc.). Tentative identification of unknown
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FAME'S in samples prepared from whole cell extracts were 
made by comparison of retention times of unknown components 
with the Supelco standards. When possible this was 
cross-referenced with fatty acid methyl esters obtained from 
Sigma. Ultimate identification was by GLC-Mass spectrometry. 
2.18 Mass spectrometry
2.18.1 Confirmation of the identity of whole-cell fatty 
acids of the Leaionellaceae by gas chromatoaraphv-mass 
spectrometry (GC-MS)
GLC-Mass spectrometry enabled the identity of each of 
the extracted, bacterial whole-cell fatty acids to be 
confirmed by the analysis of their fragmentation patterns 
and molecular ions produced after bombardment with high 
speed electrons.
Each sample was dissolved in 0.1 ml of dichloromethane 
and injected using the same technique as in previous GLC 
analyses and analysed on a HRGC\MS MFC500 Carlo Erba 
gas chromatograph interfaced with a Kratus MS80 RFA mass 
spectrometer.
The parameters used for gas-liquid chromatography were 
identical with those previously defined in section 2.16.6 
except that a 25 M x 0.25 mm BP 1 capillary column (Supelco 
Inc.) whose chemical phase is compatible with CPSil 5CB was 
employed.
Other conditions were as follows :
Ionisation mode : Electron impact
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Ionisation energy : 70 Ev 
Scan rate : 0.3 s/ decade mass 
Start mass : 600 
Accelerating voltage : 4 kV 
Temperature of the source : 230°C
2.18.2 Confirmation of the identity of ubiquinone soecies 
bv necrative-ion Fast Atom Bombardment (FAB) mass 
spectrometry
Identity of ubiquinones in cell extracts from four 
species of Legionella was provided by mass spectrometry. In 
addition, the mass spectra of two standards Q- 6 and Q-10 
(Sigma) were determined since this technique has not been 
applied previously to ubiquinones yet provides valuable data 
with good sensitivity (Wait and Hudson, manuscript in 
preparation).
The samples for analyses were dissolved in 
triethanolamine (Sigma), a liquid of low vapour pressure and 
bombarded with a beam of fast xenon atoms, causing 
ionisation and spattering directly into the gaseous phase 
where the ions are mass-analysed. A Kratos MS-80 RFA mass 
spectrometer, fitted with an Ion-Tech BNF11 fast atom gun 
with a Kratos FAB source was employed for all ubiquinone 
analyses. Conditions for analysis were: an accelerating 
voltage of -4KeV, starting mass of 1600, resolution of 1000 
and a scan rate of 30 s/ decade of mass, with the raw data 
analysed by the DS 90 software package (supplied by Kratos).
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RESULTS
3.1 Production of immunodiaanostic antisera
Sera produced by different immunisation schedules from 
twenty-six rabbits by following different immunisation 
schedules were compared to investigate the ability of rabbit 
anti-Leaionella IgG from each schedule to act as avid 
capture antibody (Cab) for detection of urinary antigen in 
the ELISA assay. Conjugate for all ELISA testing was 
supplied by McKinney and for reasons of consistency used 
throughout this research. No loss of activity of this 
reagent was observed over a 36 month period of storage at 
4°C.
3.1.1 Evaluation of rabbit IcrG as capture antibody for ELISA
After only a small number of rabbits had been used to
raise antibody for the ELISA test, evaluation of sera showed 
that only one test bleed from one rabbit produced avid IgG 
specific only for L .pneumophila SG 1 urinary antigen. This 
showed that production of such antibody appeared to be 
unpredictable as noted previously (Kohler et al., 1981, 
Fehrenbach et al., 1986, Samuel et al., 1990) .
In all these evaluatory tests, the accepted minimal 
differential A492, determined spectrophotometrically, used 
to distinguish antigen-containing "positive" urine from 
negative urine controls in the ELISA and which defined a 
capture antibody as acceptable was that the former should 
exceed the latter A 492 result by at least a factor of 2. In 
addition, the negative urine controls (from healthy donors
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with no known history of Lecrionella infection) should not 
exceed an A 492 value > 0.2 (normal values observed are >0.02 
and <0.08) . The A 492 value with the T.S.E. extract from 
L.pneumophila SG 1 (positive control antigen) should exceed 
1.751.
Rabbit-2/88, inoculated according to the McKinney 
method described in section 2.5.1 (see p45 for flowchart) 
produced effective IgG at the time of its second test bleed 
(day 35 from the first inoculation). No effective capture 
antibody was demonstrable on exsanguination one week later 
(table 2 ) so that a quicker method for the purification of 
IgG by NH4S04 precipitation followed by fractionation on a 
DEAE 52 column to avoid the 5 day or more delay in serum 
evaluation was needed. If the evaluation of working IgG 
could be established immediately or soon after blood was 
taken, the rabbit could then be exsanguinated to obtain all 
the circulating avid capture antibody produced. A number of 
tests were appraised for their ability to distinguish 
between avid (obtained infrequently) and non-avid IgG. Some 
of these tests were carried out in retrospect following 
early success in producing avid IgG. This provided the 
required effective capture antibody for the ELISA available 
as a control.
3.1.2 IFA testing
All pre-immune and post-immunised test bleeds taken
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Table 2 IFA titres and ELISA results of test bleeds from
R2/88 immunised according to the method of McKinney.
Rabbit Immunogen * Day IFA Bleed No
No. titre
(K)
2/88 (Knoxville-1) 28 32 41
(NZW) whole cells 
in 0 .1 %
formol saline.
(40 I.U.) 35 32 43
42 32 51
K£Y.
Cab - capture antibody
* - figures given are post 1 st inoculation
Effective 
as Cab/ELISA
No
Yes
No
84
from the 2 6 rabbits were titred by the IFAT. Low IFAT titre 
antisera (< 4000 or 4K) did not react with positive control 
T .S.E.-extracted antigen and positive control urines to 
differentiate them from negative control urines in the 
ELISA. Only antisera of higher IFA titres (> 8-128K) which 
reacted with the T .S.E.-extract were of particular interest 
as they were reactive in the ELISA. Antiserum which produced 
low IFA titres (< 4K) only produced a positive slide 
agglutination at low dilution (undiluted or 1/10, table 3) . 
Slide agglutination
This is a very simple test to carry out, but 
agglutination gave no indication of the effectiveness of the 
IgG as capture antibody in the ELISA system, e.g. a serum of 
IFA titre of 16K or more could be diluted 100 fold and would 
still agglutinate formalised whole cells of L.pneumophila 
SG 1 whereas a serum of lower IFA titre (<4K) would only 
agglutinate organisms at a 1 0 fold dilution or less (table 
3). All high IFA titre antisera, including those not 
effective as capture antibody, agglutinated whole cells so 
that this was an unsuitable test for the determination of 
the capture antibody status of isolated IgG.
3.1.4 Purification of IctG by Protein-A
This method was employed in parallel with and then 
chosen in preference to, NH4S04 precipitation and 
fractionation on a DEAE 52 column. It reduced considerably 
the time taken to purify IgG for ELISA testing from > 5 days
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Table 3 IFAT titre and slide agglutination of formolised 
whole cells of L.pneumophila SG 1.
Antiserum Number Titre by
and immunisation IFAT
details (K)
[Effective as 
capture antibody 
in ELISA]
Agglutination of 
formolised whole cells 
in a slide test 
Dilution Factor
Neat 1/10 1/100
No. 21 (Kohler)
R 1/86 [No] 32
No. 27 (Kohler)
R 1/87 [No] 4
No. 30 (Tang and Toma)
R 7/87 [No] 1
No. 40 (McKinney)
R 1/88 [No] 32
No. 43 (McKinney)
R 2/88 [Yes] 32
No. 59 (McKinney)
R 6 / 8 8 [Yes]) 32
Yes
Yes
Yes
Yes
Yes (weak) No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
Yes
Yes
Yes.
No. 139 (Conlan & Ash.)
R 6/89 [No] 32
No. 141 (Conlan & Ash.)
R 6/89 [Yes] 8
Yes
Yes
Yes
Yes
Yes
No
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to < 3 days as well as being more simple to perform because 
whole serum could be applied to the column. The time 
advantage was gained by the omission of the many dialysis 
steps associated with NH4S04 precipitation.
It was observed (table 5) that when Protein-A and 
NH4S04/DEAE 52 methods for the isolation of IgG were run 
in parallel, different ELISA results were observed. This 
stimulated the screening of all antisera with IFAT titres 
>8K which had previously been purified by the NH4S04/ DEAE 
52 method for IgG isolation. The results (table 4) showed 
that IgG from some test bleeds were effective in the role of 
specific capture antibody when purified by Protein-A. This 
was not the case when the same antiserum (except No.43, used 
as a control) was purified by the NH4S04/ DEAE 52 technique.
3.1.5 ELISA testing
As one of the main aims of this research was to produce 
a sensitive and specific ELISA diagnostic system, all 
test bleeds taken from rabbits were evaluated by this 
method. Control positive and negative human urines were used 
so that different IgG preparations could be designated as 
effective or non-effective in differentiating between 
antigen-containing and non-antigen-containing control 
urines.
Initially, the IgG fraction from immune serum was 
tested in the ELISA until the first effective test bleed was 
identified. The time between blood sampling and testing by
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Table 4 Immune sera fractionated by Protein-A for IgG and 
tested by ELISA.
Test bleeds purified by protein-A affinity chromatography 
for-IgG with results of the IgG used as capture antibody at 
neat and at 10 or 25 fold dilutions (in PBS) in ELISA 
testing against positive control antigen (C/Ag T.S.E. 
extract, two wells), five positive "urines” from patients 
with L.D. (Mill., Mun., G.L., J.M. and Co.), two urines 
from patients with a non-Legionella related pneumonia (pn) 
and two specimens of urine from patients with a urinary 
tract infection (UTI).
Test Bleed 
No. (IFA)
C/Ag C/Ag Mill. Mun. G.L. J.M. Co. pn pn UTI UTI
43. 32K ++ ++ + + + + + _ _ _
(control)
25.nt.32K
(1/25
++
dil.) 
++ - - - + - - - - -
1/10 " ++ ++ - - - + - - - - -
28.nt.16K ++ ++ - - - + - - - - -
1/10 " ++ ++ - - - + - - - - -
35.nt.16K ++ ++ - - - ++ - - - - -
1/10 " ++ ++ - - - + - - - - -
40.nt.32K ++ ++ - - - + /- - - - - -
1/10 " ++ ++ - - - + /- - - - - -
41.nt.32K ++ - - - + /- - - - - -
1/10 " ++ ++ - - - + /- - - - - -
42.nt.32K ++ ++ - - - + / - - - - - -
1/10 " ++ ++ - - - + /- - - - - -
43.nt.32K ++ ++ + + + ++ + - - - -
1/10 " ++ ++ + + + + + + - - - -
51.nt.32K ++ ++ + + + ++ + - - - -
1/25 " ++ ++ / / / + + — — _ —
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Table 4 cont.
57 .nt.32K 4-4- 4-4- + /- + /- - 4* - - - - -
1/25 " 4-4- 4-4- + /- 4-/- - 4- 4-/ -
59 .nt.32K ++ ++ / / / 4-4- 4- - - 4-/- -
1/50 " 4-4- 4-4- / / / 4-4- 4- - - - +/-
60.nt.64K 4-4- 4-4- 4-4- 4-4- 4-4- 4- 4-4* 4-4- 4-4- 4-4- 4-4-
1/25 " 4-4- 4-4- + /~ + /- + /- + /- + /- + /- - - 4- / -
62.nt.32K 4-4- 4-4- 4- + 4-4- 4-4- 4- 4- 4- 4- 4-
1/25 " 4-4- 4-4- + - + + /“ 4- - + /- - +/-
63.nt.64K ++ 4-4- + /- + /- + 4- 4- . 4- 4- + /- +
1/25 " 4-4- 4-4- - + /- + /- 4- + /- 4-/- - +
64.nt.32K 4-4- 4-4- - + /- - + /~ + /- + /- - 4-
1/25 " 4-4- 4-4- + /- + /- 4- 4- 4- 4- 4-/- 4-
65.nt.28K 4-4- 4-4- + + 4- 4-4- 4- 4- 4-/- 4-
1/25 " 4-4- 4-4- + /- + /- + 4-4- + /- + /“ - 4-
66.nt.64K 4-4- 4-4- + 4- + 4- 4- 4- 4- 4- 4-
1/25 " 4-4- ++ + + /- + 4- 4- + /- 4- 4-
67.nt.32K 4-4- 4-4- 4- + + 4-4- 4- - -
1/10 " 4-4- ++ 4-4- 4-4- 4-4- 4-4- 4- + /- + /-■ + /-+/“
68.nt.32K 4-4- 4-4- 4-4- 4*4* 4-4- 4-4- 4-4- 4-4- 4- 4-4- 4-4-
1/25 " 4-4- +4- 4-4- 4-4- ++ 4-4- 4-4- + 4- 4- 4-
70.nt.64K 4-4- 4-4- + + + 4- 4- + + 4- +
1/25 " ++ 4-4- + + /- + + /- 4- + /- + /“■4-/—4-/ —
81.n t .32K 4-4- 4-4- + + 4- 4- 4- 4- 4- + /- +
1/25 " 4-4- ++ + + /- + 4- + /- + /- + /-■ + /“ + /-
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Table 4 cont.
139.nt.32K ++ ++ ++ .++ ++ ++ ++ - -
1/25 " ++ ++ + + + + + - -
141.1/25.8K ++ ++ + + /- + + / - -
147.nt.32K ++ ++ ++ ++ ++ + ++ - -
1/25 " ++ ++ ++ ++ ++ ++ ++ - -
148.nt.32K ++ ++ ++ ++ ++ ++ ++ + / - + /
1/25 " ++ ++ + + + + +
 + / -
KEY
nt. - tested at a neat concentration 
1 /1 0 - tested at a 1 / 1 0 dilution 
1/25- tested at a 1/25 dilution 
/ - not tested
++ - O.D.'s > 0.601
+ - O.D.'s 0.201- 0.600
+/--  O.D.'s 0.051-0.200
- O.D.'s < 0.050
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ELISA was important because antibody titres and capture 
efficacy were not always stable. For this reason, whole 
antisera from test bleed Nos.43 and 59 (from R2/88 and R 6 / 8 8  
respectively) were compared with their fractionated IgG 
counterparts. Results showed (table 5) that whole antiserum 
and the derived IgG fractions differed in that only IgG 
fractions were able to differentiate between positive and 
negative urines. It was concluded, therefore, that it was 
necessary to isolate IgG from test bleeds in order to 
determine effectiveness as capture antibody.
A study of fractionated IgG from the first 59 test 
bleeds taken from rabbits/ Rl/8 6 , Rl/87, Rl/8 8 , R2/88,
R3/88, R4/88, R5/88 and R 6 / 8 8 (i.e. from 3 of the 4 
protocols [excluding the Conlan and Ashworth (1986) 
protocol examined in this thesis) produced results which 
allowed division of IgG from individual test bleeds 
produced, into three categories A, B and C. These are 
defined as follows:
Category A was defined as those IgG's which, when used 
as capture antibody in the ELISA, produced an A 492 > 1.751 
when reacted with control antigen (T.S.E. extract of 
L .oneumoohila SG 1) and A 492 values which overlapped when 
tested against both known positive and negative urine 
controls (i.e. no differentiation was observed).
Category B was defined as in A except that an A 492 < 
1.750 was observed with control antigen in the ELISA.
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Table 5 Comparison between whole antisera (Nos. 43 and 59) 
and their IgG fractions in ELISA.
IgG obtained by NH4S04/ | Whole serum
DEAE 52 chromatography | as CAb
Antigen ELISA O.D.492 values with IgG from test bleed
No.43 No.59 No. 43 No. 59
T.S.E.
(positive
control
antigen) 2.77 2.70 2.34 2.43
Mill.
(positive
urine) 0.44 0.44 0.09 0.07
Mun.
(positive
urine) 0.86 0.65 0.53 0.34
89/00382
(negative
urine) 0.04 0.03 0.86 0.40
89/000390
(negative
urine) 0.03 0.04 0.12 0.06
Negative
(non-Legionella
pneumonia) 0.02 0.02 0.00 0.03
Negative
(non-Legionella
pneumonia)0.048 0.02 0.03 0.03
89/00379
(UTI-Proteus)0.039 0.02 0.30 0.18
89/00633
(UTI-E.coli) 0.012 0.30 0.10 0.19
89/00338
(UTI-Klebsiella)0.039 0.05 0.13 0.07
KEY
T .S.E.-positive control antigen 
UTI - urinary tract infection
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Category C was defined as in A except that the IgG 
tested differentiated known positive urine from negative 
urine controls.
The ELISA spectrophotometer was blanked against wells 
with either pre-immune serum substituted for capture 
antibody or where wells were blocked by 2% (w/v) BSA 
solution in PBS [see section 2.12.1]). Typical A 492 values 
with positive urines found to be >0.70 with <0.08 
observed for negative urines with this last value increasing 
to 0.20 with some capture antibodies of category C.
The following four subsections describe results 
obtained when each of the four protocols were assessed.
3.1.6 Method of McKinney et al., (1979^
This was one of the first protocols published for the 
production of antiserum in rabbits (see flowchart, p45, for 
immunisation summary) for use in an ELISA system to detect 
urinary antigen from patients with a L.pneumophila SG 1 
infection, and was found in these studies to be successful 
in producing effective capture antibody in 6/14 (43%) 
rabbits. It was therefore studied in detail as one aim 
of this project was to produce avid antiserum with 
consistency so that a continuous diagnostic service of this 
type could be offered to the N.H.S. in Scotland, at least.
Of the 13 rabbits that were set up by this method, only 
one (R7/88, a 1/2 Lop) failed to produce high titre 
antiserum (16-64K by IFAT were usual) from the first test
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bleed of its inoculation schedule (table 6 ). R7/88 produced 
titres consistently of 4K by IFAT and although this improved 
to 16K upon extended immunisation beyond the standard 6 week 
protocol, it later fell again to 4K. IgG purified from 
blood samples taken from R7/88 was of no diagnostic value 
when evaluated under conditions described in section 2 .1 2 .
IgG produced in 6 NZW rabbits (R2/88, R6 / 8 8 , R8 / 8 9, 
R9/89, R3/90 and R4/90) were effective as capture antibody 
in the ELISA. Of these, four (R8/89, R9/89, R3/90 and 
R4/90) produced avid IgG from blood taken on the 35th day 
after the priming immunisation but none was detectable from 
blood taken at exsanguination 7 days later (table 7). The 
other two of the six NZW rabbits (R2/88 and R6 /8 8 ) produced 
avid capture antibody on two occasions within their 
respective protocols. Blood samples taken from these rabbits 
by IFA testing gave titres > 16K and were therefore purified 
by Protein-A during re-screening. This produced interesting 
results in that R2/88 was found to be producing avid IgG 
which was detectable 7 days after day 35 and R6 / 8 8 was also 
producing avid IgG detected 7 days before day 35 post 
primary immunisation. High titre (> 8K by IFAT) samples of 
blood taken from the other rabbits did not produce avid 
IgG on re-screening with Protein-A to check the results 
produced by the NH4S04/DEAE 52 method of IgG purification.
To investigate the importance of formolisation of the 
organisms two other rabbits (R8/90 and R9/90) were
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Table 6 Titres obtained from test bleeds taken from a
rabbit, R7/8 8 , immunised by the method of McKinney 
upon extended immunisation.
Rabbit Immunogen * Day IFA Bleed No
No. (K)
7/88 (Knoxville-1)
(half lop)
KEY
* -
2 1 4 71
25 4 73
30 4 75
33 8 77
43 16 80
48 16 85
54 16 87
60 16 89
67 4-8 92
8 8 8 93
109 4 97
1 1 2 4 98
figures given are post 1 st immunisation
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Table 7 The transient response of avid IgG production when 
rabbits were immunised by the method of McKinney.
IgG from antiserum taken after 
the priming inoculation and 
tested by ELISA for avidity.
Rabbit No. 4th week 5th week 6th week
8/89 -(143) + (147) -(151)
9/89 -(144) + (148) -(152)
3/90 -(192) + (197) -(2 0 2 )
4/90 -(193) + (198) -(203)
KEY
+ : IgG was effective in differentiating positive
and negative control urines according to the 
conditions described in section 2 .1 2 .
IgG not effective as above.
( ) - Test bleed no.
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inoculated according to this protocol (except that R9/90 was 
inoculated with boiled organisms instead of formalised 
organisms of the same strain) and were exsanguinated on day 
35. However, both rabbits produced IgG not effective as 
capture antibody in the ELISA. The importance of 
formolisation of the organisms in relation to the production 
of capture antibody could not therefore be substantiated. 
Titres produced from both of these rabbits were high ( >16K) 
by IFAT.
3.1.7 Method of Kohler et al., (1981)
Two rabbits (Rl/ 8 6 and Rl/87) were inoculated with 
L.pneumophila SG 1 (Rl/ 8 6 with the Knoxville-1 strain 
before this project was started and Rl/87 with the RH 
(Bellingham type) strain, according to this schedule 
(section 2.5.2). From the test bleeds of Rl/8 6 , only one 
contained avid IgG. This sample was taken 19 months 
after the priming immunisation (many months beyond the 
stated end point of the protocol). Even though this rabbit 
was immunised and its antiserum tested for a further 14 
months, no effective capture antibody for the ELISA system 
was produced. Blood samples taken and tested by IFA from 
both Rl/ 8 6 and Rl/87 showed erratic titres ranging from 1 to 
64K rising and falling over a period of time (tables 8 and 9 
respectively), and this feature persisted even when 
immunisation was extended following the same regime.
This protocol under its more limited evaluation
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Table 8 IFAT titres of R 1/86 whose immunisation after a 
rest period was by that of Kohler.
Rabbit
No.
1/86
(NZW)
Immunogen * Day IFA Bleed No
Autoclaved 
(Knoxville-1) 
whole cells 
(401.U.)
titre
(K)
- 65 7
150 32 9
270 8 10
420 8 19
467 32 2 1
499 32 23
513 32 25
520 16 28
527 16 35
KEY
* - figures given are post 1 st immunisation
Table 9 IFAT titres of antisera during the immunisation 
course of R 1/87 according to the method of 
Kohler.
Rabbit Immunogen * Day IFA Bleed No
No. titre
1/87 Boiled 
(NZW) (Knoxville-1) 
whole cells. 
(40 I.U.)
(K)
42 16 15
63 32 16
147 16 17
165 2 2 0
197 2 2 2
204 4 24
214 4 27
244 4 29
274 1 37
304 4 52
364 64 60
394 64 63
398 64 66
KEY
* - figures given are post 1 st immunisation
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compared, with that of the McKinney (1979) and Conlan and 
Ashworth (1986) schedules yielded no other samples of blood 
containing IgG "effective" in the ELISA even when antiserum 
was screened using Protein-A to purify IgG.
3.1.8 Method of Tana and Toma (1986V
This protocol, with a duration of 13 months (section 2.5.3), 
used formalised organisms as in the McKinney schedule (1979) 
but utilised a different strain of L.pneumophila SG 1 and 
was reported to produce antiserum of broad specificity 
detecting urinary antigen excreted from patients infected 
with different serogroups of L.pneumophila as well as 
L .micdadei and L . loncrbeachae (Tang and Toma, 198 6 , and Tang 
et al. 1989) . In this respect it differed from the other 
three protocols investigated and raised some interesting 
questions (see discussion).
One rabbit (R7/87) was immunised according to this 
protocol. IgG production monitored by IFA testing revealed 
very low titres of 0.128K initially, with this titre rising 
steadily to IK and jumping to 32K five months after the 
protocol was started with this status continuing at this 
level before falling to 2K at the end of the protocol. All 
antisera tested by ELISA before the rise in titre to 32K 
could be described as category B antisera, as would be 
expected, but this changed to category A when all blood 
samples taken had IgG titres of 32K. No positive urine 
controls showed higher A492 values compared with those of
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negative urine controls by ELISA.
3.1.9 Method of Conlan and Ashworth (1986)
This protocol (see flowchart, p45, for immunisation 
summary) was investigated for two reasons; the 
first was that whole organisms used as inocula in the early 
stages of the project in the other schedules did not 
consistently stimulate the production of IgG effective in 
the ELISA. The second was that some support existed for the 
idea of urinary antigen having characteristics like 
lipopolysaccharide (LPS). This concept was an interesting 
development as Harrison and Taylor (1982) claimed that 
antibodies to a major heat-stable, pronase-resistant antigen 
provided a means of serogrouping strains of L.pneumophila 
SG 1. The nature of this serogroup antigen was uncertain, 
although its chemical composition and endotoxicity together 
with its behaviour in two-dimensional electrophoresis and 
SDS-PAGE suggest it may be LPS. ELISA results (table 11) 
using avid IgG (from test bleed Nos. 43 and 59) detected 
urinary antigen in the same specimens whether these were 
boiled or unboiled.
This and other experiments described in this thesis 
lend further support to the concept of urinary antigen being 
related to or derived from LPS, and that it is most probably 
a component of the carbohydrate "0 " side chain.
LPS has been extracted from L.pneumophila SG 1 cells by 
the more common methods for isolation of LPS. The
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phenol/water extraction method (Westphal and Jann, 1965) 
yielded LPS in the phenol phase, the same phase into which 
protein partitions. The methods of Darvaeu and Hancock 
(1983) and Galanos et al. (1969) were used by (Sonesson
et al. 1989) for further studies. These did not include 
antiserum production. Here, saline extracts produced by the 
method of Conlan and Ashworth (1986) were used to raise 
antisera for diagnostic purposes and further attempts were 
made to characterise the extracted material. Three
V^ WQ. f ^ 0 CflA
preparations^from strain Knoxville-1 of L.pneumophila SG 1
4
(SE.I, SE.II and SE.III) because^earlier successes m  
raising avid capture antibody. SE.I was divided into three 
pools of antigen, A, B and C taken by pooling fractions A, 
B, and C (similar to figure 2) respectively after gel 
filtration. A and B were used for inoculating rabbits. Peak 
C was not investigated in this way.
NZW Rabbits (R2/89, R3/89 and R4/89) were inoculated 
with pooled antigen from peaks A and B according to the 
protocol described by Conlan and Ashworth (1986), but with 
R3/89 being given 32ug of carbohydrate,([CH20]n) instead of 
16ug at mid-protocol, as it was observed that R2/89 and 
R3/89 responded poorly to this antigen at 16ug 
concentration (IFAT titres ranged from only 256-2K during 
the course of the protocol). R3/89, after its dosage was 
raised to 32ug [CH20]n produced titres up to 16K by IFAT. 
The schedule for R2/89 continued with 16ug [CH20]n
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Figure 2 Gel filtration of crude saline extract (S.E. I) 
through a bed of Sepharose 4B.
The separation of serogroup antigen reactive in the 
ELISA, detected at A 492 and protein detected at 
A28o ara shown.
ELISA O.D. 492 a m ( + )Absorbance 280nm
2.5
0.8
0.6
0.4
0.2
0.5
1 5 10 15 20 25 30 35 40 45 50 55 60
Fraction No.
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inoculations as a control and R4/89 was then started and 
inoculated with the same dose of antigen (16ug) as R2/89.
Its IFA titre was 64-256 during the protocol. Another saline 
extract (SE.II) from the same strain of Legionella was 
prepared. This antigen was inoculated into three NZW rabbits 
(R5/89, R6/89 and R7/89). R5/89 was inoculated with 16ug 
[CH20]n throughout its schedule and produced titres of only 
512-1K as observed with SE.I at this concentration. Both 
R6/89 and R7/89 were inoculated with 32ug [CH20]n and titres
up to 16K were found on analysis of the test bleeds.
However, only one test bleed (No.139) was specific and 
sensitive when purified IgG was used as capture antibody and 
tested by ELISA. The final saline extract (SE.III) was 
again separated into three pools (A, B and C as before)
after gel filtration using Sepharose 4B (figure 2) . Pool A
and pool B were inoculated into different rabbits; Rl/90 
with pool A and R2/90 with pool B. Fraction nos.13-19 (Pool 
A, figure 2) were found to give the highest ELISA A 492 
values compared with those of other eluted peaks. Pool A 
also coincided with a peak of protein (determined 
spectrophotometrically at A280) from the Sepharose 4B gel. 
Carbohydrate and protein estimates of pool A were 12ug/ml 
and 55ug/ml respectively.
Peak B (fraction nos. 20-35) also gave high 
A492 values but contained little or no detectable (A280) 
protein. Chemically estimated values for carbohydrate and
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protein for pooled fractions in peak B were 2ug/ml and 
5ug/ml respectively. Pool A was inoculated into Rl/90 where 
IFA titres of test bleeds up to 8K were noted at a [CH20]n 
concentration of 16ug.Pool B was non-immunogenic in rabbit 
R2/90 where negative (< 16) titres by IFAT were found.
Another rabbit (Rll/90) was inoculated with pooled 
antigen composed of fractions from peaks A and B where 
titres of 2K were produced with a [CH20] dosage of 32 ug/ml 
per inoculum. This was, however, unsatisfactory for use in 
the ELISA.
Furthermore, one saline extract (a gift from Williams, 
CAMR, Porton Down, Salisbury), which was manufactured by 
Conlan and extracted from the Corby strain of L.pneumophila 
SG 1 (No.74181, originally isolated in this laboratory) was 
also inoculated into two rabbits (R5/90 and R10/90). Its 
composition estimated by Conlan was; protein 0.79 mg/ml and 
0.69 mg/ml [CH20]n.
The extract from the Corby strain (No.74181) of 
L.pneumophila SG 1 inoculated into R5/90 and R10/90 produced 
in each rabbit high titre antisera determined by IFAT.
Only the last two bleeds from R5/90, one taken before the 
final boost and blood taken at exsanguination in the 13th 
week of the protocol, produced effective capture antibody 
which distinguished between positive and negative control 
urines (A492 values from positive controls were > 2 times 
A 492 obtained with negative urines).
105
Rabbit-10/90, produced IgG (purified in the same way as 
IgG from R5/90) that gave greater differential A 492 values 
for positive and negative control urines making IgG from 
R10/90 more desirable for clinical in-vitro testing. These 
A 492 differential values produced by IgG from both R5/90 and 
R10/90 fulfilled the criteria to be described as working 
antisera but the differential was observed to vary between 2 
and 15 times (when A 492 values for positive urines were 0.3 
and negatives, 0 .0 2 ) .
In terms of the A492 differential described, other 
samples of blood (Nos. 43 and 59 in particular) which 
produced IgG effective as capture antibody and obtained 
via the McKinney (1979) schedule gave greater values with 
the same “positive" control urines and may therefore be more 
sensitive. The A 492 values for positive urine controls 
usually exceeded a value of 1 .0 , a colour change easily 
observed by eye without the aid of an ELISA 
spectrophotometer.
3.2 Capture antibody evaluation and ELISA-related studies
Sera identified in the initial screening tests with 
known "positive" and "negative" urine samples in ELISA were 
investigated further. These sera were tested against a 
larger number (77) of clinical specimens. These were 
previously tested using gifted McKinney capture and 
detecting antibody so that their antigen status was known 
(table 10). These control urines consisted of 15 known
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KEY
MSSU - midstream specimen of urine 
CSU - catheter specimen of urine
S.aalactiae- Lancefield group B heamolytic Streptococcus
Ps .
E .faecalis 
E .
SL.
o
Pseudomonas 
Enterococcus faecalis 
Staphylococcus 
Escherichia 
Candida
+ve by ELISA (non-boiled specimen)
-ve on retesting after boiling for 10 min
L.D. - Legionnaires' disease (diagnosed on serological 
or cultural evidence) 
pneu.- non-L.D. pneumonia (no serological or cultural 
evidence of a Lecrionella infection)
( ) - ELISA result
Table 10 Characteristics of test urines used to validate 
ELISA.
Clinical diagnoses are given where these were 
established at the time of each patient's illness.
No. of test 
well.
Lab. No. Patient Date of Diagnos 
specimen/test ELI
1 84/30161 Mill. 02/08/84 L.D. +
2 86/45961 Mun. 2 2 /1 0 / 8 6 L.D. +
3 - Cross. - L.D. +
4 84/38706 McN. 17/09/84 L.D. +
5 83/40233 McSkim. - L.D. +
6 84/25731 Rais. 28/06/84 L.D. +
7 83/41223 Gord. 09/11/86 L.D . +
8 87/15518 Hamil. - L.D. +
9 84/37190 Conn. 29/04/84 L.D. +
1 0 84/46987 Gall. 16/05/84 L.D. +
1 1 82/28418 Duff. 27/08/82 L.D. +
1 2 87/46305 Mell. 30/11/87 L.D. +
13 84/54100 Flee. 24/04/84 L.D . +
14 87/35176 Co. 24/09/87 L.D. +
15 88/06204 Mein. - L.D. +
16 . 85/14398 McClau. 02/04/85 pneu. -
17 * 83/43927 Bowd. 07/12/83 pneu. —
18 86/46637 Ham. 27/10/86 pneu. -
19 84/78798 Hay. - pneu. -
2 0 86/23339 Bark. 23/05/86 pneu. -
2 1 85/06647 Kan. 15/02/85 pneu. -
2 2 - McKen. - pneu. -
23 85/14641 Kell. 16/05/85 pneu. -
24 84/32677 E.St.Hil. 16/08/84 pneu. -
25 84/41371 Gra. 08/10/84 pneu. -
26 -  /37 838 Max. - pneu. -
27 8 6 / - Cad. 19/05/86 pneu. -
28 85/14397 Andr. 02/04/85 pneu. -
29 87/ - Doug. 23/05/87 pneu. -
30 84/77477 Salis. 16/05/84 pneu. -
31 85/06793 •Aitch. 18/02/85 pneu. -
32 85/14906 Kel. - pneu. -
33 84/22344 Hend. 05/06/84 pneu. -
34 85/02147 Rog. - pneu. -
35 85/16348 - 16/04/85 pneu. -
36 85/11899 Brisb. 16/05/85 pneu. -
37 84/41942 Donnac. 10/10/84 pneu. -
38 86/23340 Bark. - pneu. -
39 85/14788 Kel. 04/04/85 pneu/ -
* possible L .D .,IFAT=128 /only one serum tested
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Table 10 cont.
UTI test urines used to validate ELISA
No. of test Lab. No. Specimen UTI-
well. Type causative
organism/s
40 88/45348 MSSU . S .saorophvticus
41 88/45975 MSSU E.coli
42 88/48029 MSSU E.coli
43 88/47462 MSSU E .coli
44 88/46185 MSSU E.coli
45 88/47206 MSSU S .eoidermidis
46 88/45871 MSSU E .coli
47 88/46928 CSU Ps.aeruainosa/C.albicans
48 88/46981 MSSU E.faecalis
49 88/47149 MSSU E.coli
50 88/45850 MSSU E.coli
51 88/46545 MSSU E.coli
52 88/48409 MSSU E.coli
53 88/47511 MSSU E.coli
54 88/47207 MSSU E .coli
55 88/47186 MSSU E.coli
56 88/46927 CSU K .aeroaenes
57 88/47340 MSSU E.coli
58 88/46936 MSSU E.coli
59 88/47271 CSU Acinetobacter/Ps.aeruginosa
60 88/47266 MSSU E .faecalis
61 88/47185 MSSU E.coli
62 88/46984 MSSU S .cralactiae
63 88/47188 MSSU E.coli
64 88/46934 MSSU E.coli
65 88/46139 MSSU E.coli
6 6 88/47646 MSSU E.coli
67 88/47214 MSSU E .coli
68 88/47313 CSU Ps.aeruainosa/C.albicans
69 88/47440 MSSU E.coli
70 88/45872 MSSU Ps.aeruginosa
71 88/48375 MSSU S.eoidermidis
72 88/46930 CSU Ps.aeruginosa/C.albicans/E.coli
73 88/46362 MSSU E .coli
74 88/47464 MSSU E.coli
75 88/47330 MSSU E.coli
76 88/46967 MSSU S .aureus
77 88/45909 MSSU E.coli
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positives, 24 known negative urines from patients diagnosed 
as having pneumonia but where infection by a legionella was 
not demonstrated by serology or by culture, and 38 known 
negative urines from patients with urinary tract infection 
(table 1 0 ) .
No figures are available to quantitate the amount of 
Legionella urinary antigen in each of the 15 positive 
urines. Testing positive urine controls with McKinney 
reagents was used to give an indication of the optimal 
dilution at which antisera produced by the McKinney 
protocols (from R2/88, R 6 / 8 8 etc.) and the Conlan and 
Ashworth protocols (R5/90 and R10/90) should be used.
IgG from both test bleed Nos. 43 and 59 gave optimal 
A492 values at dilutions of 1/50. These were the same as the 
dilution of the McKinney control capture antibody (personal 
communication, McKinney)
The antisera produced by the Conlan and Ashworth 
protocol had an optimal dilution of 10 fold (table 4) when 
used as capture antibody. This difference between 50 and 10 
fold dilution was not connected with production of IgG or a 
measure of its avidity. It was more likely due to the 
method of IgG purification. The Conlan and Ashworth 
protocols were set up with blood samples taken after the 
Protein-A method for IgG purification had been chosen in 
preference to the NH4S04/DEAE 52 method. The protein-A 
method produced a more dilute sample of IgG/ml of antiserum
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purified (about 4-5 times) because only a 2ml portion of 
serum could be loaded onto the column at a time. This 
accounts for the differences seen. Also, no differences were 
observed with protein-A purified IgG from R2/88 (No. 43) 
when evaluated at a dilution of 1 0 and compared with the 
NH4S04/DEAE 52-purified IgG at a dilution of 50.
All of the blood samples taken from the rabbits which 
differentiated positive from negative control urines in the 
screening stages by ELISA did so when tested against these 
77 urines. Each of the 15 positive urine controls was 
detected (100% sensitivity) both by IgG from those blood 
samples (e.g. No. 43, No. 59 etc.) evaluated in addition to 
IgG from McKinney (positive control) and thus all were 
confirmed to contain urinary antigen. However, 3 of these 
urine samples gave lower A 492 results than when they were 
originally tested (urine test Nos. 3, 7 and 8 , table 11) . 
None of the 62 negative control urines tested as positive 
(100% specificity) with any of the capture antibody (IgG) 
assayed at this level. These capture IgG antibodies are now 
in clinical use in an ELISA system and experience here has 
shown no "false positive" test results with boiled specimens 
of urine from patients where investigation by other methods 
has failed to produce evidence of Legionella infection. All 
positive urines identified by the ELISA originated from 
cases where clinical symptoms raised suspicion of Legionella 
infection and most of these have been supported by
KEY
+++ = A 492 > 0.501
++ = A 492 > 0 . 2 0 1 but < 0.500
+ = A 492 > 0 . 1 0 1 but < 0 . 2 0 0
- = A 492 < 0.050
Controls
All A 492 values for +ve control antigen (T.S.E. extract) 
>2.600
Antisera evaluated
Nos. 43 and 59 were raised by the McKinney protocol from 
rabbits 2 / 8 8  and 6 / 8 8 respectively and were both collected 
35 days after the primary immunisation.
No. 231 was raised by the Conlan and Ashworth protocol 
from rabbit 10/90 and was collected 31 days after the 
primary immunisation.
Table 11 Capture antibody evaluation by ELISA using 
urine controls as defined in table 1 0 .
Test urine 
No.
Status 
of urine
Control Test 
(McKinney)No.
Bleeds/Cab 
43 No. 59 No. 231
Dilutions(1/ . 
50 100
.)
50 1 0 0 50 25 1 0
1 +ve 4-4-4- 4-4- 4-4-4- ++ ++ 4- 4-4-
2 u 4-4-4- . 4-4-4- 4-4-4- +++ + + + 4-4- 4-4-4-
3 ii ++ + + + + + + + + 4- 4-4-
4 ii 4-4- 4-4- 4-4-4- + + + + + 4- 4-4-4-
5 H ++ 4-4- 4-4- + + 4* + 4* 4-
6 ti 4-4-4- 4-4-4- 4-4-4- + + + + + + 4-4- 4-4-
7 n 4-4- + + + + + + + 4- 4-4-
8 + + + + + + + + + + - 4-
9 ii 4-4-4- 4-4- + + + + + + + 4- 4-4-
1 0 ii 4-4-4- 4-4-4- + + + + + + + + 4-4- 4-4-4-
11 ii 4-4-4- 4-4-4- *f++ +++ + + + 4- 4-4-
1 2 ii 4-4-4- 4-4-4- +++ +++ + + + 4-4- 4-4-4-
13 ii 4-4-4- 4-4- +++ ++ + + + 4- 4-4-
14 ti 4-4-4- 4-4-4- + + + + + + + + 4- 4-4-
15 ii 4-4-4- 4-4- + + + + + + 4* 4- 4-4-
16 -ve (pn) — - - - - - -
17 H ii - - - — — — -
18 ii ii — — — — — — —
19 it ti — -  ■ - — — — —
2 0 H ii — - - — — — —  ■
2 1 a ti — — — — — — —
2 2 ii H — — — — — — —
23 ii ii — — — — — — —
24 n ii — — — — — — —
25 ii ii — — — — — — —
26 ii it — - — — — —
27 it it — - - — — — —  •
28 it it — — — — — — —
29 ii ii — — — — — — —
30 ii it — - — — — — —
31 it it — - — — — — —
32 H ii — — — — — — —
33 ii ti — — — — — — —
34 ii ii — — — — — — —
35 it ii — — ■ — — — — —
36 ii ii — — — — — — —
37 ii ii — — — — — — —
38 it it — — — — — — —
39 it ti - - - - - -  ■ -
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Table 11 cont.
Test urine 
No.
Status Control Test bleeds/Cab 
of urine (McKinney)No. 43 No. 59 No. 231
50
Dilutions(1/ ..)
100 50 100 50 25 10
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 
61 
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
ve (UTI)
u
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serological and/or cultural evidence implicating 
L.pneumophila SG 1 as the cause of illness.
3.2.1 Reactions of avid antisera with "soluble" antigens of 
L.pneumophila strains
Purified IgG from samples of blood taken (No.43 
from R2/88 and No. 59 from R 6 /8 8 ) was tested as capture 
antibody using soluble antigens of several strains of 
L.pneumophila SG 1 instead of urine (Tang and Toma, 1986). 
These antigens were prepared as in section 2.14.4 and heated 
to 100°C for 15 min to denature heat-labile components 
leaving mainly LPS. The preparations were filter-sterilised 
(0 .2um) which also removed particulate material.
Results by ELISA gave x A 492 values > 1.400 on multiple 
testing for all seven strains used as antigen (table 1 2 ).
Investigations of boiled and non-boiled samples of both 
control urines and test urines (clinical specimens) revealed 
the incidence of false-positive results with unboiled 
samples. For this reason all clinical specimens are heated 
to 100°C for 15 min, centrifuged and the supernate tested.
No false-positive results were identified after all clinical 
specimens were treated in this way and most positives have 
been substantiated with either cultural or serological 
evidence (or both) from sputum and blood respectively.
3.2.2 ELISA optimisation
The ELISA system established as a result of 
successfully raising effective capture antibody was further
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Table 12 ELISA results with sonicates prepared from
seven different strains of L.pneumophila SG 1.
IgG's purified by DEAE 52 at a dilution 
of 1/50 as capture antibody
Strain of O.D492 values (x of 3 values)
L.pneumophila SGI No. 43 No.59 No.231
Pontiac-1 1.426 1.328 1.102
Knoxville-1 1.534 1.388 1.182
Philadelphia 1.632 1.496 1.200
Camperdown 1.57 4 1.430 1.168
RH-Bellingham-type 1.416 1.204 0.980
Olda la 1.524 1.296 1.030
Olda lc 1.560 1.313 1.057
Range 1.416 1.204 0.980
- 1.632 - 1.496 - 1.200
Mean (x) 1.523 1.351 1.102
S.D. 0.078 0.096 0.084
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investigated. It was observed from previous results that the 
majority of high titre antisera could not differentiate 
between positive and negative control urines and were 
grouped as category A. This category could be further 
subgrouped into groups I and II. Group I antisera gave high 
A 492 values with both positive and negative control urines 
and group II gave low A 492 values with both positive and 
negative controls urines.
The efficiency of blocking and also the plate type used 
as the solid phase in the ELISA (using No.43 as avid capture 
antibody) were both investigated. Two types of bovine serum 
albumin (BSA) were compared/ product no. A-70 96, (Sigma) and 
bovine albumin fraction V (Miles Scientific Ltd.) at 1, 2 
and 4% (w/v in PBS) tested on 8 different plates (Immulon F 
III [flat-welled], Immulon Dynatech I [flat-welled], Virion 
F [flat-welled], Nunc, Denmark [flat-welled], Elkay 
000-Mico-Tpu [flat-welled] and three Costar plates, No.
C3590 [flexible, U-shaped well], No. C6595 [flexible, blue, 
U-shaped well], No. C2595 [flat-welled] from Northumbria 
Biologicals Ltd).
The two BSA preparations gave different results.
Bovine albumin fraction V did not block any of the plates at 
each of the three concentrations tested (4, 2 and 1% (w/v) 
in PBS) where A 492 values of 3.00 to 1.40 were obtained 
with the negative control urine. Similar A 492 values were 
observed between each of the eight plates with both the
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positive control antigen (T.S.E. extract), the positive 
(G.L.) and the negative urine. This was due to the conjugate 
binding to unblocked sites in the plastic well. When BSA 
A-7 90 6 (Sigma) was evaluated at each of the three 
concentrations the blocking effect was obvious. Examination 
of the results where the BSA A-7096 was used at 4% (w/v) 
produced A 492 differential values (between the positive 
urine control and the blank) which were no greater than 
those obtained when used at 2% (w/v). BSA used at 1% (w/v) 
produced only slightly raised A 492 values with the negative 
urine control when compared with results where BSA was used 
at 2% (w/v). BSA at 2% (w/v) in PBS was the standard adopted 
for use in the ELISA. Where the results were compared for 
eight different plates all negative urine controls produced 
A 492 values ranging from 0.05 to 0.24 depending on the 
plate evaluated. Only one plate was excluded from the direct 
comparison with the other seven as this plate (Costar 
No.6595) was blue in colour which interfered with the ELISA 
assay. Figures 3-10 show the A 492 values obtained with a 
positive urine (G.L.) when tested at dilutions from neat to 
32. The A 492 value with a negative control urine on each 
plate type is also shown.
The other seven plates would have been acceptable for 
use in the ELISA test with only small differences in A 492 
values for the undiluted positive urine. However, 
differences were observed with the background A 492 value for
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ELISA results with No.43 (CAb)and control antigens on 
different ELISA plate types.
Figure 3
Elkay
Figure 4
Costar No. C2595
Absorbance *  492nmAbsorbance •  492nm
1010
-4-
0.1
Nt 1:2 1:4 ■to
Urine dilution Urine dilution
Figure 5
Costar No. C3590
Absorbance •  492nn»
10
0.1
0.01
1:321:8Nt 1:4 1:181:2
Figure 6
Costar No. C6595
Absorbance e 492nm
0.1
KEY
Nt 1:2
Urine dilution
1:4 te
Urine dilution
t ie  1:32
Positive antigen-containing urine (G.L.) 
Negative control urine : [—+— ]
C —  3
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Ficrure 7
Immulon
Figure 8
Immulon Fill
Absorbance » 492nmAbsorbance e 492nm
10
— i 0 .1
1:32 Nt
0.1 1:32t8 tie1:2 1:41:16Nt 1:2 1:4 tB
Figure 9 Urine dilution Figure 10
Urine dilution
Nunc Virion F
Absorbance e 492nm Absorbance ♦ 492nm
10 10
0.1
_|
1:32
0.01 0.1
Nt 1:2 1:8 1:16 Ntt4 t2 1:4 1:32
Urine dilution Urine dilution
KEY
Positive antigen-containing urine (G.L.) 
Negative control urine : [ — i—  ]
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the negative urine control where these ranged from <0.05 to 
0.239. The latter A 492 value was unacceptably high and 
produced with the Immulon I plate type. However, the 
differential A 492 value between the undiluted positive urine 
and the negative urine controls was high (0.730). The 
greatest A 492 differential between the undiluted positive 
and negative urine controls were obtained with three plates 
(Costar No. 3590 [1.196], Virion F[1.082] and Nunc [1.016]) . 
3•3 Evaluation of commercial test kits: a latex 
agglutination and a RIA for anticren detection in urine 
Twenty-three human control urines whose status as 
either positive antigen-containing or non-antigen-containing 
urines were known (determined by ELISA, and supported by 
studies where other workers had tested some of these
urines by Mab or polyclonal ELISA or by RIA in addition to
clinical details, culture and IFA results where these have 
been available) were used to evaluate this kit. Their 
details are shown (tables 13 and 14).
pH values of all urines (stored at -20°C) examined were
determined with a calibrated pH meter after the urines had 
reached room temperature. Their pH values shown in table 15 
were within the physiological pH range (5-9) recognised by 
the manufacturer not to interfere with test results.
Results of these control urines, each tested three 
times and each boiled and centrifuged before the third test, 
are shown (table 15).
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Table 13 Culture and serological details of patients whose 
urine samples were used to evaluate the "Merigen" 
latex agglutination test.
Lab.
Nos . 1 + ve
i by culture
■I FA (to
L.oneumoohila SGI}
+ ve urine controls
1
84/30296 (Mill.) * I NO 16-64
84/25731 (Ral.) * I YES 16-64
84/54100 (Fie.) I NO 16-256
86/44928 (Mun.) I NO -
87/35176 (Cook) 25/9 I NO -
83/40233 (McSkim.) | - -
83/57751 (McN.) I NO > 512
84/37910 (Con.) 1 “ 16-128
84/96957 (Fen.) I NO 512
87/46305 (Mell.) I NO -
85/18487 (Wats.) I NO -
87/32456 (Go.) I YES 128
82/28334 (Duff.) I NO 16-128
- ve urine controls
84/41942 (Donac.)
1
I NO < 16
88/47149 i - . -
84/78798 (Hay.) I NO -
84/32677 (St. Hil. E.) I NO
1—
1 
V
88/45850 | - -
88/47188 | - -
88/46934 | - -
88/47340 | - -
88/45871 | - -
KEY
* - validated by McKinney in independent tests
( ) - patient
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Table 14 Results of control urines validated.
Monoclonal Ab in ELISA and RIA tests were used to 
determine the presence of urinary antigen by other workers.
Urine RIA titre Monoclonal
(expressed as a 
binding ratio of (ELISA of 
the control) urine)
Tested by McKinney
84/25731 (Ral.) - 1:128
84/30296 (Mill.) - • 1:64
Tested bv Kohler **
84/30296MH1. 6.01 (+ve)
KEY
* These are the mean results of two tests.
** Binding ratios between 1.50 and 2.00 have usually come 
from patients with Legionellosis.
Polyclonal
(ELISA)
Undiluted
urine
0.87* (0.51) 
0.27* (0 .32)
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Table 15 Results of 23 test urines used in the "Merigen" 
latex agglutination kit.
Specimen of urine 
tested
(Lab. Number)
Elisa
£H 1 result 1 st I 2 nd 1 3rd Result
1 .# 84\30296 6 . 0 1 +ve 2 + 1 2 + 1 2 + i
-ve
2 84X25731 6 . 1
1
1 +ve 0 1 o
i
1
1 0 
i
+ve
3. 84X96957 6.3 I +ve 1 +
I
1 1 + i
1 o 
1
+ve
4 . 84X54100 5.9
1
I +ve
i
0
1
1 o
i
1
1 o +ve
5. 83X57751 5.6
!
I +ve
i
1 +
1
1 1 + i
1 2 + +ve\-ve
6 . 82X28334 5.7
1
1 +ve
i
1 +
1
1 2 + 
i
1 2 + 
i
+ve\-ve
7 . * 87X32456 8 . 6
1
I +ve
i
0
1
1 o
1
1 2 + 
i
+ve\-ve
8 . 87X18487 5.7
1
I +ve
i
3+
1
1 3+
1
1 3 + -ve
9. 87X46305 5.2
1
I +ve
i
2 + 1 3 +
1
I 3 + -ve
1 0 . 87X42752 5.5
1
I +ve
i
4 +
1
| 4 + I 4 +
i
-ve
1 1 . 84X37910 5.9
l
I +ve
i
2 + 1 2 + 
i
1
1 24-
i
-ve
1 2 . 83X40233 5.4
1
I +ve
i
2 +
1
1 2 + 
i
1
1 2 + 
i
-ve
13. 87X35176 7.0
1
I +ve
i
1 + 1 1 + 
1
1
1 oi
+ve
14 . 84X41942 7.0
l
I -ve
i
0 I o 
|
1
1 o 
1
-t-ve
15. 84X32677 5.8 I -ve 1+
1
1 o
1
1 o 
1
+ve
16. 84X78798 6.3
1
I -ve 2 +
1
1 1 +
1
1 o 
1
-ve\+ve
17. 88X47149 6 . 1
1
I -ve
i
3+
1
1 3 +
1
1 2 + -ve
18. 88X48375 5.9
1
I -ve
i
1 +
1
1 oI
1
1 o 
1
+ve
19. 88X45850 6 . 8
1
I -ve
1
0
1
1 o
1
1
1 o 
1
+ve
2 0 . 88X47188 5.6 I -ve 3 +
1
1 2 +
1
1 o -ve\+ve
Latex agglutination. 
result on three____
occasions.
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Table 15 cont.
Specimen of urine-1 1 Latex acrcrlutinat ion
tested 1 1 result on three
(Lab. Number) |
Elisa
result
1 occasions.
i
m  1 1 1 st I 2nd I 3rd I Result
2 1 . 88X46934 6.3 |
i
-ve 1 2 + 
i 1 1 + 1 1 oi
I -ve\+ve
I
2 2 . 88X47340 6 . 1 | 
l
-ve
1
1 3+
i
I
1 2 +
i
1 o
I
I -ve\+ve
23. 88X45871 6.3 | -ve
1
1 1 +
1
I 1 + 1 o
1
I +ve
Key
* Culture +ve for L.pneumophila SG 1
N.B. Specimen No.84\30296 was found to be 
+ve by R. Kohler using RIA where the 
RIA titre was 6.01, expressed as a 
binding ratio of the control. Patient 
suffered clinical L.D. with a low 
(16-64) 4 fold rise in IFA titre . 
Culture of the sputum was negative.
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Of the 13 positive control urines tested (table 15), 
only 4 (31%, one of these from a culture positive patient)
_ gave a clear positive result on all three occasions when 
tested by this latex agglutination kit. Six of the 13 
positive control urines (46%) gave a negative result on all
three occasions. One of these urines (84/37910) came from a
patient with a significant rise in IFA titre from 16 to 128 
and another urine (84/30296) was confirmed as positive by 
Kohler (using RIA), Toma (using Mab ELISA) and McKinney 
(using polyclonal ELISA). The three remaining positive 
control urines (23%), including one from a culture positive 
patient (Go.) gave mixed results on repeated testing.
Of the 10 negative control, urines, 4 (40%) gave a
positive result on each of the three occasions. Only one
urine (10%) consistently gave a negative result. The 
remaining five (50%) each gave negative results before 
boiling, and positive results after boiling and 
centrifugation.
These results are clearly unacceptable and show that 
this test is not an alternative to a sensitive and specific 
ELISA system.
3.3.1 "Dupont" Legionella urinary antigen 
r 1 2 5 I 1  radioimmunoassay kit (Lot# PA306)
This kit has already been evaluated by Aguero- 
Rosenfeld and Edelstein (1988) and was a gift from "Dupont" 
for further independent evaluation. There were two reasons
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for further evaluation. The first was to assess the ability 
of the kit to distinguish between control positive and 
negative urines (all previously determined by the "in-house" 
ELISA and one by two other independent groups of co-workers 
using ELISA and RIA techniques (table 14). The second was to 
compare the sensitivity of our ELISA with that of the RIA in 
a simple dose/response investigation as well as to compare 
the specificity of the RIA with that of the ELISA.
Fifteen human control urines were used to test the 
RIA kit: 5 known +ve controls determined by ELISA with No. 4 
(84/30296, table 14) verified by different groups of 
workers to contain detectable levels of antigen and the 
remainder from patients from whom L . oneumoohila SG 1 was r v A *  
isolated.
Four of the 5 positive control urines produced definite 
positive net dpm counts (table 16) with mean (x) ratios 
greater than three times that of the kit-supplied negative 
control. Only one test urine No.5 (Go.) gave a x ratio of
2 . 8  but this increased to greater than three times when its 
net dpm + one standard deviation (S.D.) was considered.
The final 5 control urines negative by ELISA, were from 
patients' with UTI due to a variety of organisms (table 10) . 
One catheter urine (88/46930) produced a mixed flora on 
culture. All gave a negative result by the RIA test.
Tests to establish the sensitivity of the RIA were 
performed with antigen-containing urine by diluting this
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urine in two-fold steps to 128 (table 16). The end point 
at which the highest dilution gave a positive result was 
16 (where the x + 1 S.D. was > three times the negative kit 
control).
The positive and negative controls with the kit 
produced net dpm '(+/- 1 S.D.) counts of 495 +/- 61.7 and
72.8 +/- 20.7 respectively. Background counting (2 tubes) 
was performed with every set of 8 tubes where actual test 
dpm measurements were taken, and the x ratio was calculated 
from the test value divided by the net dpm of the negative 
test kit control.
Concluded from these results is that the RIA kit is as 
sensitive and specific for the detection of Legionella 
antigen in urine as the "in-house" ELISA.
3.4 Effective and non-effective Cab investigated and 
characterisation of urinary antigen
These studies were performed to establish the nature 
of the specific urinary antigen that was captured and 
detected by avid antibody used in ELISA testing with the 
hope that a more successful method to produce diagnostically 
useful capture antibody could be found and the urinary 
antigen further characterised.
3.4.1 Ouchterlonv tests
Agar diffusion tests reacting antiserum taken from 
rabbits inoculated according to different schedules, with 
various antigens are described.
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Table 16 Results of 15 urines tested by the "Dupont
125I RIA kit for the detection of urinary antigen.
Each urine was tested four times and the mean dpm 
and S.D.'s calculated. Results of a positive urine 
(G.L.) diluted two-fold and tested for the presence 
of antigen to compare the sensitivity of the 
capture antibody produced for the ELISA with that 
of RIA are also shown.
1
1
Tube No.I 1 2 3
Assay No.
4 5 6 7 8 x S.D.
Background Range=34-40
(Two readings taken every 1 0 tests )
+ve Ctrl. 429 503 429 566 439 512 530 592 495 61.7
-ve Ctrl. 80 83 102 69 69 90 50 39 72.8 20.7
(Net dpm)
Assay No.
Sample X S.D. Mean ratio
1 2 3 4 (RIA result)
ELISA+ve urines 
(culture +ve)
1 (Smi.)
2 (G.L.)
3 (J.Mcm. 
*4 (Mill.) 
#5 (Go.)
4014 3689 3985 3970 3914 151 53.8
1710 1678 1550 1870 1702 131.6 23.4
277 291 363 282 303.3 40.3
994 1058 523 616 797.8 267.6
223 216 194 188 205.3 16.9
(+ve)
(+ve)
4.2 (+ve) 
5.0 (+ve) 
2.8 (+\-)
ELISA-ve urines 
(+ve pn's, 
non-Legion)
1 (Hay.) 90 98 80 84 8 8 . 0 7.8 1 . 2 (-ve)
2 (E.St.Hil.) 64 69 69 81 70 .8 7.2 1 . 0 (-ve)
3 (Gra.) 72 62 63 83 70.0 9.8 1 . 0 (-ve)
4 (Salis.) 69 83 69 85 76.5 8.7 1 . 0 (-ve)
5 (Brisb.) 81 79 96 1 2 2 94.5 19.9 1.3 (-ve)
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Table 16 cont.
Assay No.
Sample X S.D. Mean ratio
1 2 3 4 (RIA result)
-ve urines
(UTI's)
1 (88X45348) 80 94 60 67 75.5 15.0 1 . 0 (-ve)
2 (88X46927) 89 61 8 6 58 73.5 16.3 1 . 0 (-ve)
3 (88X47266) 65 75 87 71 74.5 9.3 1 . 0 (-ve)
4 (88X46139) 63 70 61 128 80.5 31.9 1 . 1 (-ve)
5 (88X46930) 87 71 56 46 65.0 17.9 0.9 (-ve)
Test Sensitivity Assay (net dpm)
Mean Ratio
(urine) 1 2 3 4 X S .D. (RIA result)
(G.L.)
1X4 dil 598 622 554 565 584.8 31.1 8 . 0 (+ve)
1 X8 251 291 311 347 300 40.0 4.1 (+ve)
1X16 " 218 180 2 1 1 158 191.8 27.9 2 . 6  (+X-)
1X32 " 181 95 163 129 142 38.0 1.9 (-ve)
1X64 " 1 2 1 81 113 99 103.5 17 .5 1.4 (-ve)
1X128 " 113 128 135 85 117 .5 18.2 1 . 6 (-ve)
-ve urines Specimen typeX
(+ve UTI/s) Causative organism(s)
(88X4534 8 ) 
(88X46927) 
(88X47266) 
(88X46139) 
(88X46930)
MSSU-S . saorophvticus 
CSU -K . aerocrenes 
MSSU-E .faecalis 
MSSU-E.coli
CSU -Ps . aerucr .XC.alb.XE.coli
KEY
* - culture -ve, but specimen confirmed by 3 groups of
co-workers to contain antigen using ELISA 
and RIA.
# - culture +ve, ELISA (in-house) +ve, -ve by Merigen latex
agglutination.
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Two antigens, a sonicate (see section 2.14.4 for 
preparation) and known positive and negative antigen- 
containing urines at neat and concentrated xlOO (using a 
macrosolute concentrator, Minicon) were reacted with 
capture antibody from rabbits inoculated according to the 
McKinney schedule.
Figure 11 shows pure IgG (purified by DEAE 52) from 
the sequential test bleeds taken from Rl/ 8 8 (not effective 
as CAb in the ELISA), whose IFA titres fell during the 
protocol (an unusual feature). It was observed from the agar 
diffusion gel that when the IFA titre had fallen to 2K, two 
reaction lines were observed when this test bleed (No. 48) 
was reacted with sonicate prepared from the Knoxville-1 
strain of L .pneumophila.
Figure 12 shows the agar diffusion test of the 
sequential test bleeds (whole serum) taken from R2/88 with 
test bleed No.43 (the only bleed from R2/88 able to capture 
urinary antigen in the ELISA test. Reactions of identity 
with each test bleed (Nos. 41, 43 and 51) against the 
sonicate of Knoxville-1 were observed when these tests were 
performed together with the antigen in the central well.
A similar agar diffusion gel was set up using the 
whole serum from sequential test bleeds from R 6 / 8 8 where 
these were tested against the L.pneumophila sonicate.
The same pattern was observed in this experiment with all 
three test bleeds producing one visible reaction line. Test
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Figure 11 Agar diffusion gel (Ouchterlony) showing
precipitin lines between IgG from test bleeds 
taken from Rl/88.
Precipitin lines between test bleed Nos. 40, 42 and 48 
purified by DEAE 52) and L.pneumophila SG 1 sonicate.
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Figure 12 Agar diffusion gel (Ouchterlony) showing
precipitin lines between IgG from test bleeds 
taken from R2/88.
Precipitin lines between test bleed Nos. 41, 43 and 59 
purified by DEAE 52) and L .oneumoohila SG 1 sonicate.
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bleed No. 59 whose IgG was effective as capture antibody in 
the ELISA produced a diffuse reaction line of identity with 
the test bleeds taken one week either side of test bleed 
No. 59.
Whole serum samples containing IgG effective as capture 
antibody together with the purified IgG were each tested 
against the sonicate to establish whether they were reacting 
with the same antigen in the sonicate.
Figures 13 and 14 show the unfractionated and the 
purified IgG samples from test bleed Nos. 43 and 59 with 
No. 42 as a negative control (ineffective in the ELISA). 
Firstly, the IgG fractions from test bleed Nos. 43 and 59 
produced much clearer results than those using whole serum. 
Only a single line was observed between the antigen and IgG- 
containing wells compared with a diffuse line of 
precipitation observed between whole serum and the sonicate. 
Secondly, this appeared to be a reaction of identity. In 
figure 14 there were two lines between serum IgG from test 
bleed Nos. 43 and 59 and the boiled sonicate. The weaker 
precipitin line was not observed before boiling between 
these two reagents nor was it seen on repeating the test.
The reasons for this are not clear.
All test bleeds which, when fractionated for IgG 
and found to be effective in the ELISA as capture antibody 
together with non avid IgG controls, were tested against 
both negative and positive urine (concentrated lOOx). No
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Figure 13 Agar diffusion gel (Ouchterlony) showing
precipitin lines between whole serum from test 
bleed Nos. 42, 43 and 59.
Precipitin lines between test bleeds Nos. 41, 43 and 59 and 
L .pneumoohila SG I, Knoxville-1 sonicate, non-boiled (1) and 
boiled (2).
Fiaur; 14 Agar diffusion gel (Ouchterlony) showing
precipitin lines between IgG from test bleed Nos 
42, 43 and 59.
Precipitin lines between test bleeds Nos. 41, 43 and 59 and 
L.pneumoohila SG 1, Knoxville-1 sonicate, non-boiled (1) and 
boiled (2).
1 . 2 .
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precipitin lines were observed between any of the antisera 
and the concentrated urines, 
identity.
3.4.2 Crossed two-dimensional immunoelectrophoresis (CIE)
This high resolution technique was performed to 
investigate further the nature of the antigens with which 
the antiserum samples reacted. This method has a resolving 
power which can differentiate between 85 different antigens 
(Collins et al., 1983) in L.pneumophila SG 1. Of these, 11 
antigens were heat-stable. The photographs published by 
these workers provided a reference CIE pattern with 
antigen migration distances clearly defined.
Test bleeds taken from rabbits inoculated according to 
the schedules of McKinney (section 2.5.1) and Conlan and 
Ashworth (section 2.5.4) were reacted with the sonicate of 
L.pneumophila SG 1 (Knoxville-1) prepared as in section 
2.14.4.
The two-dimensional electrophoretic patterns of IgG 
fractions from these test bleed Nos. 43 and 59 (taken from 
rabbits 2 / 8 8  and 6 / 8 8 respectively) are shown in figures 
15 and 16. Only one diffuse peak was observed in each figure 
indicating that under these experimental conditions, IgG 
was raised in response to only one antigen of the formalised 
suspension of L.pneumophila SG 1. The migration distances 
(using the ovalbumin and bromophenol blue as a marker) of 
these two peaks were identical indicating that the antigen
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Figure 15 CIE of L.pneumophila SG 1 sonicate reacting 
with test bleed No. 43 (R2/88).
Only a single precipitin line is observed between the 
antigen and the IgG. Albumin/bromophenol blue marker from 
the 1st dimension shown by - x .
+
&
(2nd)
+
Direction of current (1st)
Figure 15 CIE of L .pneumophila SG 1 sonicate reacting 
with test bleed No. 59 (R6/88).
Only a single precipitin line is observed between the 
antigen and the IgG. Albumin/bromophenol blue marker from 
the 1st dimension shown by - x .
+
(2nd)
+
Direction of current (1st) —>
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in the sonicate with which these two different pools of IgG 
antibodies (purified by DEAE 52 chromatography) reacted was 
the same. Further, using, the figures published (Collins 
et al., 1983a and b) the antigen from the sonicate 
precipitated in the agarose gel was heat-stable 
lipopolysaccharide (group-specific antigen).
To determine why the antibody status had changed from 
being an effective CAb in the ELISA in differentiating 
positive and negative antigen-containing urines (test bleeds 
Nos. 43 and 59) to one which failed to meet this criteria, 
test bleed No. 67 (taken only seven days after No. 59) was 
reacted with the same sonicate (figure 17) of L.pneumophila 
SG 1. Figure 17 shows 8 antigen/antibody peaks indicating 
that IgG's were being produced to other component antigens 
of the formalised whole cell (i.e the immunogen). It was 
noted however, that this bleed was ineffective in the ELISA 
but when the same serum sample was purified for IgG by 
Protein-A chromatography only one major antigen/antibody 
peak was observed on the two-dimensional gel (figure 18) and 
this IgG fraction was able to distinguish between positive 
and negative urines in the ELISA. Faint antigen/antibody 
lines ( ' , figure 18) were also seen above the
most densely-stained peak whose peak apex had identically 
shaped arcs as the faint peaks perhaps indicating reactions 
with other O-specific chains of the LPS where these are of a 
different molecular weight (the heterogeneous nature of
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Figure 17 CIS of L .pneumophila SG 1 sonicate reacting 
with test bleed No. 67 (R6/88).
Eight precipitin lines were observed between the
antigen and IgG (purified by DEAE 52). Albumin/bromophenol
blue marker from the 1st dimension shown by - x.
(2nd) *9
Direction of current (1st)
Figure 18 CIE of L .pneumophila SG 1 sonicate reacting 
with test bleed No. 67 (R6/88).
Multiple precipitin lines are observed between the 
antigen and the IgG (purified by Protein-A).
Albumin/bromophenol blue marker from the 1st dimension shown 
by - x .
(2nd)
Direction of current (1st) 
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which is a feature of LPS).
This is seen more clearly in figure 19 where a control 
test bleed (No. 6 8 ) taken from R5/88 and ineffective as 
capture antibody to detect antigen-containing urines was 
reacted with the sonicate.
Finally, figure 20 shows antiserum (no. 141, IFA=8K ) 
taken from R6/89, inoculated according to the protocol of 
Conlan and Ashworth (1986) and reacted with the 
L.pneumophila sonicate. Only when IgG from this sample of 
blood was purified by Protein-A chromatography was it 
effective as capture antibody in the ELISA. It shows a major 
antigen/antibody peak whose antigen component has the same 
electrophoretic mobility as LPS seen in other figures 
(15 to 19) .
Positive antigen-containing urine concentrated xlOO 
from two different patients was substituted for the 
sonicate of L.pneumophila SG 1. On repeated testing, no 
precipitin lines were observed.
Also, when the saline extract of L.pneumophila SG 1 
(Knoxville-1) was used as the antigen to be electrophoresed 
in the first dimension and then reacted with the IgG in the 
second dimension no reaction lines were observed after 
staining.
3.4.3 Limulus Amoebocyte Lysate (LAL) Assay
Table 17 shows the results when various antigens were 
reacted with Limulus polvohemus crab amoebocyte extract for
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Figure 19 CIE of L.pneumophila SG 1 sonicate reacting 
with test bleed No. 68 (R5/88).
Multiple precipitin lines are observed between the 
antigen and the IgG (purified by Protein-A).
Albumin/bromophenol blue marker from the 1st dimension shown 
by - x .
B.*
■*-
+
Direction of current (1st)
Figure 20 CIE of L .pneumophila SG 1 sonicate reacting 
with test bleed No. 144 (R6/89).
Only a single precipitin line is observed between the 
antigen and the IgG. Albumin/bromophenol blue marker from 
the 1st dimension shown by - x.
(2nd)
o
(2nd)
Direction of current (1st)
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Table 17 Results obtained by testing precipitin lines from 
CIE gels as well as antigen-containing urine in 
the Limulus amoebocyte lysate assay.
Tube No. Contents of reaction tube Result
A 0 .1ml Sonicate of L .oneumophila SG 1 (Knox-1} +ve
A1 Ouchterlony precipitin line 
from McKinneyX sonicate reaction +ve
A2 CIE precipitin line (Mobility 
value of LPS) No.43\ sonicate +ve
A3 CIE (LPS) No.59\ sonicate +ve
A4 CIE (LPS) No.67\ sonicate +ve
A5 CIE (LPS) No.141\ sonicate +ve
A 6 CIE gel only (ctrl.) -ve
A7 0 . 1ml Urine from healthy human (R.F.) -ve
A 8 0 . 1ml +ve by ELISA urine (G.L.) undiluted +ve
A9 1/4 dil. +ve
A10 1 / 8 dil. +ve
All 1/16 dil. +ve
A12 1/32 dil. +ve
A13 1/64 dil. -ve
B1 0.1ml sonicate + 0.1ml LPS (E.coli) 
@ 0.04ng/ml
+ve
B2 CIE crel + 0.1ml LPS (E.coli) +ve
B3 0 .1ml G.L. +ve by ELISA urine (undiluted) 
+ 0.1ml LPS (E.coli)
+ve
B4 0 . 1ml R.F. -ve by ELISA urine (nt.) 
+ 0.1ml LPS (E.coli)
+ve
B5 No. 43/ sonicate precipitin line from 
CIE + 0.1ml LPS (E.coli) +ve
141
Table 17 cont.
c Negative control (0.1ml endotoxin- 
free water) -ve
Endotoxin standard (calibrated vs. USP 
Reference Standard Endotoxin for the semi 
quantitation of LAL assay.
-
2ucr of E.coli LPS serotype no. 055 :B5 
(Activity = 6000 EU per ug) diluted in 
endotoxin-free water (Sigma).
D 0.1ml LPS @ 0.08ng/ml +ve
E 0.1ml LPS @ 0.04ng/ml +ve
F 0.1ml LPS @ 0.02ng/ml +ve
G 0.1ml LPS @ O.Olng /ml +ve
H 0.1ml LPS @ 0.005ng/ml -ve
N.B. 0.1 ml of a working solution of concentrate from 
lysed amoebocytes of the horseshoe crab,
Limulus oolvohemus (E-Toxate ) is added to every 
test.
KEY
+ve - Hard gel formed after 1 hr at 37°C
-ve - soft gel,turbidity or clear liquid after 1 hr at
37°C.
E . coli - Escherichia coli 
(G.L .)/(R.F.) - patients initials
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the detection of endotoxin.
IgG from four antisera (Nos. 43, 59, 67 and 141) was 
reacted with a fresh sonicate of L.pneumophila SG 1, 
Knoxville-1 harvested in endotoxin-free water (Baxter Health 
Care Ltd.). This was carried out in agarose and 
electrophoresed in buffer both made with endotoxin-free 
water. Where the precipitin lines had formed (observed 
without staining), these were cut out with a sterile scalpel 
and transferred to small test tubes (E-Toxa-Clean-treated, 
section 2.9), reacted with horseshoe crab amoebocyte extract 
and incubated at 37°C without disturbance for lh. Controls 
included the CIE gel with no precipitin line and the 
sonicate itself as well as the E .coli LPS (serotype 
No.055:B5).
All the reaction lines suspected to be precipitated LPS 
antigen were positive in the in the LAL assay. The gels 
alone and the negative control where endotoxin-free water 
was added to the Limulus reagent were negative in the test.
Also to obtain a guide to the sensitivity of the ELISA 
system in its detection for urinary antigen, a boiled 
specimen of antigen-containing urine (G.L.) was used as a 
standard and diluted two-fold to 1/64. The E .coli LPS 
standard was diluted from a concentration of 0.08 ng/ml to 
0.005 ng/ml.
The highest dilution at which a positive result was 
obtained with the standard LPS was 0.01 ng/ml and the
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highest dilution of antigen-containing urine was 1:32.
If it is assumed that the sensitivity of the LAL 
assay is the same for both the antigen (LPS) in the urine 
and the E .coli standard LPS then the sensitivity of the 
ELISA might be estimated at detecting as little as 
approximately 0 . 0 2  ng/ml or 2 0 pg/ml .
The negative controls were negative in the LAL assay 
including the urine from a healthy human and all the 
results shown in table 17 were reproduced three times.
3.4.4 Probing immunoblots of "positive" urine and 
oroteinase-K digests with capture antibody
To investigate the components present in ELISA-positive 
urine collected from a patient with Legionnaires' disease 
a sample was concentrated as described in section 2.13.1 and 
electrophoresed alongside Proteinase-K digested whole cells 
of L .•pneumophila SG 1 (Knoxville-1) together with the 
molecular weight standards, SDS-6H (Sigma).
Positive (by ELISA) urine (Co.), seen in figure 21 
gel B, produced a ladder-like profile similar to that 
expected from the analysis of a bacterial lipopolysaccharide 
, with areas of close banding similar to that of the 
L .pneumophila proteinase-K lysate. Gel A was silver stained 
for protein and gel B was stained for LPS. Also in gel B, in 
the area where < 29kD components were resolved at the 
base of lane F (loaded with the positive urine) a smear 
of undefined staining was observed. This was also observed
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Figure 21 SDS-PAGE of proteinase-K digest of L .pneumophila
SG 1 and "positive” urine.
Gel A , containing 10% SDS silver stained for protein and 
showing the electrophoretic profiles of proteinase-K whole 
-cell lysate in lane C, proteinase-K treated antigen 
-containing urine (Co.) concentrated xlOO in lane D, 
molecular weight standards (SDS-6H, Sigma) in lane A and a 
proteinase-K standard in lane B. Gel B, containing 10% SDS 
was silver stained for LPS. Lane E contained proteinase-K 
whole cell lysate. Lane F contained the same sample as lane 
D.
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in gel A in the same area but at the base of lane C (loaded 
with proteinase-K whole cell lysate).
A loopful of positive urine (Co.) was cultured on 
blood agar and incubated at 37°C for 48 h to exclude the 
possibility of other endotoxin-producing bacteria being 
present. No growth was detected.
To determine with which antigens the antibodies raised 
in the animal protocols reacted, the concentrated (lOOx) 
ELISA-positive urine (Co.) as well as a whole cell 
proteinase-K lysate of L.pneumophila SG 1, as before, were 
prepared for analysis by SDS-Page. Lanes of the gel were 
loaded alternately with concentrated antigen-containing 
urine and whole cell proteinase-K lysate. These were 
transferred electrophoretically and immunoblotted 
individually against 4 different antisera effective in the 
ELISA test. These were No. 43, antiserum donated by Williams 
(raised by the Conlan and Ashworth method), McKinney 
antiserum and antiserum donated by Fehrenbach (raised by the 
method described by Kohler).
The results of the developed immunoblot where each of 
these antisera were reacted with the transferred material 
are shown in figure 22. None of the antisera stained blots 
from the positive urine lanes (Co.). However, faint staining 
was observed in three cases with the electrophoresed 
whole-cell proteinase-K lysate. Areas of development with 
No. 43, McKinney and the Williams antisera showed LPS-like
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Figure 22 Immunoblot of 4 different CAbs with proteinase-K
and "positive" urine.
Antibody pools (IgG) No.43 [1], Williams [2], McKinney 
[3] and Fehrenbach [4]) were reacted to proteinase-K 
digested whole-cell lysate of L .pneumophila SG 1, 
Knoxville-1 [B] and concentrated (xlOO) antigen-containing 
urine [A].
Direction of current 
(electrophoresis 
stage)
I
+
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patterns staining more heavily in areas corresponding to 
close banding. Also, an additional two clear, dominant bands 
were observed with No. 43 and the Williams antiserum, which, 
were less clear with the McKinney antiserum. The estimated 
molecular weights of the two immunodominant bands were 
80 and 60 kD.
Figure 23 shows the SDS-Page gel where one positive and 
one negative urine (both proteinase-K treated) were compared 
to examine for any additional banding in the areas described 
which may indicate this to be. the molecular weight of the 
urinary antigen detected by the ELISA. One band noted with 
the positive urine (Mill.) and absent from the negative 
urine was a band estimated to be 60kD. When the contents of 
this gel were transferred to nitrocellulose membrane and 
immunoblotted against both the McKinney and No. 43 antisera 
no binding of these antibodies was shown by staining. The 
urines were concentrated by the the Minicon method but no 
LPS-like profile was observed.
This experiment was repeated and extended by the 
examination of a further 1.2 specimens of urine - of which 
6 were positive for urinary antigen and 6 were negative (by 
ELISA). Of the 6 negatives, 3 were from healthy people and 3 
were confirmed UTI's due to Escherichia coli. Klebsiella 
aerogenes and Proteus species respectively. All 12 urines 
were treated with proteinase-K at 56°C for lh. The 
whole-cell proteinase-K lysate of L .pneumophila was
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Figure 23
+
Direction
of
current
1
10% SDS-Page gel containing saline extract, 
"positive" and "negative" urines and silver 
stained for LPS.
Lane A contains molecular weight standards (SDS- 
6H), proteinase-K digested whole-cell lysate of 
L .pneumophila SG 1 in lane B, Saline extract I 
(non proteinase-K treated) in lane C, a positive 
urine (Mill.) in lane D and a negative urine (by 
ELISA), 89/00391 in lane E (both proteinase-K 
treated), both concentrated (xlOO).
A B
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overloaded to show the 60 and 80kD bands observed by the 
previous immunoblot (figure 24).
The saline extracts of L.pneumophila SG 1. before and 
after proteinase-K digestion were examined with no notable 
differences being observed between them. The predominant 
bands were similar to those seen in proteinase-K digests of 
whole cells. The control for the LPS-specific stain was a 
lane containing LPS (lug) from S.minnesota (Sigma). Also, 
proteinase-K alone was electrophoresed so that common bands 
observed between the enzyme and the urines treated by this 
enzyme could be eliminated. Two or three bands seen in 
proteinase-K-treated urines were derived from the enzyme. 
Only enzyme-derived bands were evident in enzyme-treated 
negative urines.
Proteus and E .coli infected urines shared 2 common 
bands but an additional one was seen in the Proteus infected 
sample. Only one band was noted with UTI urine infected with 
K .aeroaenes. All these urines were concentrated by the 
Minicon method (section 2.14.2) using 3% (w/v) SDS in the 
rinsing solution to extract the concentrate from the Minicon 
chamber. Still no LPS pattern was revealed by silver 
staining. When the urines were electrophoresed onto 
nitrocellulose and reacted with No. 43 and McKinney antibody 
at dilutions of both 1/100 and 1/50 and developed, again no 
staining was observed.
When samples of the same 12 urines, which were not
150
Figure 24 10% SDS-Page gel of 12 concentrated "positive" and 
"negative" urines silver stained for LPS.
The gel was loaded with molecular weight standards (SDS-6H) 
in lanes A and S; proteinase-K digested whole-cell lysate 
of L .oneumoohila SG 1, Knoxville-1 in lane B, saline 
extract III (non-proteinase-K digested) in lane C, saline 
extract III (proteinase-K digested) in lane D, Salmonella 
minnesota LPS (lug) in lane E, proteinase-K control in lane 
F, 6 positive (by ELISA) urines, Mill., Mun., McN., Co., 
Wat., and 84/86987 in lanes G to L respectively, 3 urines 
from healthy patients; 89/00382, 89/00390, 89/00391 in 
lanes M to 0 respectively and 3 UTI urines; 89/00279 
(Proteus), 89/0063 (Eschericia coli and 89/00338 
(Klebsiella aerocenes) in lanes P to R respectively where 
all urines were proteinase-K treated.
Mol
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exposed to proteinase-K, were analysed by SDS-Page, bands 
(figure 24) identical in molecular weight to those found 
(to be unique) in the L.D. antigen-positive urines (figure 
23) were seen. Therefore these characteristic bands may 
reflect incomplete digestion of urinary components common 
to these specimens. They could not be further differentiated 
by immunoblotting.
3.4.5 Affinity chromatography used to isolate urinary 
antiaen and analysis by SDS-Paae and immunoblottincr
It.was the purpose of this experiment to capture the 
antigen found in urine with the hope that it may be further 
charactrerised.
Cyanogen bromide (CNBr)-activated-Sepharose 4B was 
coupled with polyclonal rabbit antibodies raised in earlier 
experiments to capture the antigen in antigen-containing 
urine (tested by ELISA). IgG fractions from test bleeds 
No. 43 (category C antisera), 221 (category A antisera),
228 (category A antisera); all raised by the McKinney 
protocol and a positive control antisera, PI (category C 
antisera donated by Fehrenbach and raised according to the 
method of Kohler, see section 3.1.5 (p93) for definitions.
Each of these antibody pools were reacted with enough 
CNBr-activated-Sepharose 4B to produce two columns. Four 
columns, each with bound antibodies from one of the pools, 
were loaded with positive antigen-containing urine (G.L.) 
and a parallel four were loaded with urine which was boiled
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and centrifuged (from a healthy person). Samples of the 
eluate were taken after collection of 1ml, 1 0ml and 2 0 ml of 
column effluent-. These samples were then tested in duplicate 
by ELISA for unbound antigen. Also, before the antibodies 
were coupled to the CNBr-activated-Sepharose 4B, they were 
tested in the ELISA system against two different positive 
antigen-containing urines (Mill, and G.L.) as well as a 
negative urine (R.F.).
The ELISA results are shown in table 18 and the 
microtitre tray in figure 25. The controls consisted of both 
the positive (G.L.) and negative (R.F.) test urines where 
these were not exposed to any of the columns. Positive urine 
produced a mean O.D.492 of 1.189 and the negative urine, a 
value of 0.046 where these were tested in duplicate.
Where positive urines were passed down each of the 
four columns, binding was indicated by each 
antibody/Sepharose combination giving reduced O.D.492 
results when the fractions at 1ml and 1 0 ml were tested.
These O.D. 492 values increased as more of the positive 
urine was passed down the column indicating saturation of 
the binding sites. The O.D.492 values and therefore the 
amount of antigen bound did vary between the 
antibody/Sepharose complexes. As this value for the 
Pl/Sepharose started at a relatively high value of 0.777 
(mean, x) and rose to 1.189 (x) after 20ml had passed 
through the column, it suggested that relatively little
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Table 18 ELISA assays of urine from Sepharose-4B/antibody 
columns.
O.D.492 values of eluted urine 
(+ve) from columns
Fraction Pl/+ve 43/+ve 221/+ve 228/+ve
No. (ml) urine urine urine urine
1 0.780 0 .155 0 .687 0 .091
1 0.774 0 .106 0 .497 0 .072
10 1.089 0 .051 1 .054 0 .261
10 1.085 0 .049 0 .916 0 .276
2 0 1.190 0 .087 1 . 1 2 0 0 .434
2 0 1.188 (f) o.033 1 .117 (f) 0 .414 (f
0 .D . 492.values from eluted urine 
(-ve) form Ab/Sepharose 4B column
Fraction 
No. (ml)
Pl/-ve
urine
43/-ve
urine
2 2 1 /-ve 
urine
2287-
urine
1 0.074 0.067 0.035 0 .050
1. 0 .055 0.041 0.039 0 .047
10 0.030 0.026 0.024 0.039
10 0.019 0.029 0 .017 0.008
2 0 0.034 0.041 0 .017 0 .008
2 0 0.052 0.035 0.013 0.003
Controls O.D. 490 Rancre Mean (x) S .D. n
Control antigen - 2.131 2.264 0.068 1 2
-2.376
Positive urine
(G.L.) 1.137 1.189 0.073 2
-1.241
Negative urine
(R.F.) 0.034 0.046 0.016 2
-0.05 8
KEY (f) -free anticren eluted
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Figure 25 ELISA testing of effluent collected from 8 
affinity columns after 1, 10 and 20ml.
Samples of both positive (G.L.) and negative urine (R.F.) 
where these had not been exposed to the columns were also 
included in the ELISA as controls. Capture antibody was 
No.43 at a dilution of 1/50.
Sampl
-ve
10ml
ina
1ml
20ml
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antigen was bound. This was probably due not to the lack of 
avidity of the antibody for the urinary antigen but because 
the antibody concentration in the coupling solution was very 
weak (3mg/ml protein). This is substantiated by the high 
O.D.492 values obtained using the PI antibody in the ELISA 
at a concentration of 2 0 ug/ml-the same concentration at 
which Nos. 43 and 59 are used in the ELISA for clinical 
purposes. The Sepharose/No. 43 complex captured relatively 
more antigen from the urine since the O.D.492 values were 
very low with the 1ml and 1 0 ml fractions (these values 
approach those obtained with the negative urine controls). 
When No. 221 was tested for its ability to capture antigen 
in the ELISA, it produced low 0 . D .492 values with positive 
control urines which reflected the binding of antigen. The 
antibody coupled to Sepharose, also showed poor binding of 
urinary antigen as high 0 .D.492 values were detected in all 
eluate fractions by ELISA. When IgG from test bleed No. 228 
was tested in the ELISA, high O.D.492 values were produced 
with both positive and negative urines showing poor 
specificity. When complexed with Sepharose, this IgG bound 
antigen from the positive urine as suggested by the ELISA 
results (table 18). When the equivalent columns were treated 
with urine devoid of antigen, 0. D . 492 values ranged from 
0.019 to 0.067 which are background levels in this assay. 
These results are summarised in table 18.
A sample of each antibody/Sepharose coupled mixture was
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analysed directly after chromatography of urines by 
electrophoresis on 10% SDS-Page for bound urinary antigen 
and immunoblotted onto Immobilon-P or nitrocellulose 
membranes before being developed in antibody solutions of 
Nos. 43, 59, and McKinney each at dilutions of 1/50, 1/100 
and 1/200. No staining developed using any of these 
antibodies at each of the dilutions, even with the 
Immobilon-P polyvinylidene difluoride membrane which is 
claimed to have increased protein binding properties, 
although level of LPS binding is unknown (personal 
communication, Millipore). This claim was substantiated by 
a test blot (figure 26) where 4 drops of different antigen 
solutions were spotted onto both Hybond-C (Amersham) and 
Immobilon-P (Millipore) membranes. These antigen solutions 
were T.S.E. (used as the positive control in the 
ELISA test), two saline extracts, one produced from 
L .pneumophila SG 1 (Knoxville-1), the other from the Corby 
strain of L.pneumophila SG 1 (donated by Williams) and 
concentrated (xlOO) urine, positive by ELISA. Only the first 
three antigen solutions reacted with both McKinney and No. 43 
antisera/donkey anti-rabbit IgG-HRP in this test blot (blot 
1). No reaction was observed with the concentrated urine 
when either nitrocellulose or polyvinylidene fluoride 
(Immobilon-P, Millipore) membranes were used. Also in a 
similar experiment when the non-ionic detergent Tween 20 was 
included in the blocking buffer, the immunoblot reaction
Ficrure 2 6 Test immunoblots where test antigens were reacted 
with different detecting antibody systems.
T.S.E.(A), saline extracts from Knoxville-1 (3) and from 
Corby-1 (C) strains of L .pneumophila SG 1 and concentrated 
(xlOO) urine (D) (Co.) were spotted onto two different
membranes; nitrocellulose (1, Hybond-C) and polyvinylidene 
difluoride (2, Millipore). Blots la and 2a were treated with 
McKinney conjugate (1/200) before development and blots lb 
and 2b were treated with No. 43 IgG (1/50) and then donkey 
anti-rabbit IgG-HRP (1/100) before development.
la. 2a.
lb. 2b.
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was very weak indicating some dissociation of the antigen 
from the membrane (results not shown). When the SDS-PAGE gel 
(figure 27) was silver stained for LPS after the transfer 
stage of immunoblotting, two bands were observed (50 and 
80 kD) from samples of antibody/Sepharose complex taken from 
columns treated with positive urine. This pattern was also 
observed when SDS-PAGE was developed in silver stain with 
the omission of the immunoblotting stage.
IgG is made up of Fc and Fab fragments and may explain 
why these two bands were observed when samples of antibody/ 
Sepharose/positive urine complex were analysed by SDS-PAGE. 
The combined effect of 2-mercaptoethanol, SDS and boiling 
may affect the structure of whole rabbit IgG to produce a 
fragment represented as one of these two bands.
The heavier of the two bands is unique to Sepharose loaded 
with positive urine and it may be that this is related to 
the antigen found in urine. Highlighted bands were also 
noted at the buffer interface of the SDS-PAGE gel at 
approximately 20kD but these were common to both positive 
and negative urine-treated columns.
When samples were prepared in buffer without 
mercaptoethanol no bands were observed in the gel.
A further experiment to determine whether either of the 
two bands (60 and 80kD) was related to rabbit IgG was done. 
The above experiment was repeated but with an additional 
lane containing control rabbit antibody (No. 43). The gel
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Figure 27 10% SDS-PAGE gel of components bound by affinity 
columns loaded with "positive" and "negative" 
urine.
The gel silver stained for LPS was loaded as follows: Lanes 
A to D were loaded with PI/, 43/, 221/, and 228/Sepharose 4B 
treated with positive urine (G.L.) and lanes E to H with 
PI/, 43/, 221/, and 22 8/Sepharose 4B complex treated with 
non-antigen-containing urine (R.F.).
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was immunoblotted and developed with Donkey anti-rabbit IgG 
(SAPU) at a dilution of 1/100. The anti-rabbit IgG reacted 
only with two bands (50 and 55kD) in the lane where No. 43 
control rabbit antibody had been loaded (figure 28). No 
reaction with any components of the other samples was 
observed.
3.5 Urinary antigen excretion profile of a patient with 
classical Legionnaires7 disease
This case history is included as an example of the 
successful use of the ELISA where it produced evidence of 
infection with L.pneumophila SG 1 before antibodies 
manufactured by the patient's immune system were detectable 
and before any organisms were cultured by the investigating 
laboratory.
This patient (J MCM), a male of 47 years who had a 
history of smoking, developed asthma in 1984 and who used 
an inhaler, returned prematurely from holiday in Gran 
Canaria with a one week history of febrile illness, cough 
rigors every hour, aches and pains and generalised 
lethargy. He was admitted to Ruchill Hospital where he was 
noted to be confused and febrile with diarrhoea and 
weakness together with consolidation of the right lung, 
demonstrated by x-ray. Specimens of sputum, blood and urine 
were taken for culture, IFA testing for antibodies and ELISA 
testing for antigen respectively.
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Figure 2 8 Immunoblot stained with Donkey anti-rabbit-HRP 
antibody.
Figure A shows a 10% SDS-PAGE gel where Lane A was loaded 
with molecular weight markers SDS-6H (Sigma). Figure B: Lane 
3 of the stained blot contained No.43 rabbit IgG. Lane C was 
loaded with No. 43/Sepharose/+ve urine complex, Lane D with 
Pl/Sepharose/+ve urine complex, Lane E with No. 43/ 
Sepharose/-ve urine complex and Lane F with Pl/Sepharose/-ve 
urine complex.
A. B.
3
3
o
Direction
of
current
(electrophoresis
stage)
Figure 29 shows, in graphical form, the results of 
tests for urinary antigen from specimens voided every few 
hours. IFAT results of the patient's
serum taken 8 days later on testing for antibodies to 
Lecrionella resulted in a positive four fold rise in titre to 
256.
Initially the patient's urine tested positive with a 
high O.D.492 i.e. > 0.8. No organisms had grown at this 
early stage nor was antibody to L.pneumophila detectable at 
a dilution of < 16 fold (i.e. negative).
Erythromycin (500mg) was administered to the patient. 
Intravenous erythromycin was continued and oral 
rifampicin therapy introduced. The patient's condition 
improved three days later, although urinary antigen was 
still detected. On this third day after admission and with 
antibiotic therapy given the level of urinary antigen 
dropped significantly to an O.D492 of 0.2 although this rose 
slightly hours later. This 0 . D . 492 of 0.2 is technically 
positive as it was > 2 times O.D.-492 of a negative control 
urine.
On the fourth day after admission, the route of 
erythromycin therapy was changed from IV to oral.
The patient improved now having low grade pyrexia and 
tiredness. Seven days after admission L.pneumophila SG 1, 
Pontiac-1 strain was isolated from sputum. On the following 
day (i.e. eight days after admission) the patient's antibody
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Figure 2 9 Urinary antigen excretion profile of a patient 
with L.D. showing IFAT results obtained on the 
date of admission (Time Oh) and 8 days later.
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titre by IFAT was found to be 256 to L.pneumophila SG 1. The 
patient was eventually discharged 1 0 days after admission on 
oral ciprofloxacin. No further specimens of urine were 
tested after the patient was discharged.
SPECIES IDENTIFICATION
Fattv acid extracts from the Leaionellaceae analysed by GLC
Fatty acids are important components of bacterial cell 
membranes and form the long hydrophobic tails of lipid, 
mainly phosopholipid molecules. They are released as free 
acids from the cell envelope upon hydrolysis and are 
generally 1 0 - 2 0  carbon atoms in length and have structures 
illustrated in figures 82-85 (p205-206).
In the unsaturated fatty acid the double bond(s)
occurs near the middle of the backbone of the molecule.
These structures may be represented in shorthand notation 
e.g. nl6 :l. The n = normal or straight-chained carbon 
backbone (other possibilities are a (anteiso) and i (iso) 
where these refer to the position of the subterminal CH3 
group), 16 = No. of C atoms and :1 = no. of double bonds 
within the molecule. It is the total complement of fatty 
acids which can be used to identify organisms at the genus
and even at the species level.
FA's can be analysed using thin-layer chromatography 
(TLC), high performance liquid chromatography (HPLC) and 
gas-liquid chromatography (GLC). The latter is the most 
commonly used and the most convenient method to analyse the
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complex mixture of FA's found in the Legionellaceae. 
Derivatives of the FA's are made (methyl esters) prior to 
chromatographic analysis as the carboxyl group is polar 
and would otherwise retard the progress'of the molecule 
through the GLC column. The resultant peak "tailing" would 
obscure other peaks. Also, resolution is improved as a 
result of increasing the volatility and stability 
by methyl esterification of the FA.
Such derivatives have been used in the routine 
analysis of Legionella FA's.
3.6.1 Derivitisation of fattv acids
Methyl esters can be prepared by several methods, most 
of which are rapid and simple. All methyl esters of FA's in 
this thesis are produced by the acid methanalysis method.
Other methods, e.g. alkaline saponification procedure 
suffer from disadvantages where the release of amide linked 
acids may be incomplete (Jantzen et al, 1978) and 
unsaturated compounds may be artefactually produced from 
O-substituted 3 (OH) acids (Reittschel et al. 1972), although 
hydroxylated acids are present in only small quantities in 
the legionellae.
Acid methanalysis has only one disadvantage in that 
cyclopropane acids may be degraded (Lambert and Moss, 1983). 
As cyclopropane 17 is a component of Legionella, and was 
found to vary in quantity between species, it was important 
to preserve it in the derivitisation procedure.
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Most published methods recommend transesterification at 
80°C but to prevent destruction of cyclopropane FA's the 
temperature .was reduced to 54°C where quantitative analysis - 
produced detectable and consistent quantities of eye 17. The 
FA's of the Legionellaceae have been studied extensively 
here where variation and reproducibility has been 
investigated under a range of different conditions.
3.6.2 Technical points
Gas-liquid chromatography using capillary columns is 
considered the analytical method of choice. The vitreous 
silica phase is immobilised by cross-linking thus reducing 
column "bleed" (loss of liquid phase from the column) and 
increasing column life.
The use of a capillary column excludes the use of N2 as 
a carrier gas as its optimum efficiency is attained only at 
low linear velocities (the linear velocity in cm s-1 (u) is 
given by u = L /tm where L is the column length in cm and tm 
is the retention time of methane in seconds) leading to long 
analysis times. Both He and H2 produce maximum 
chromatographic efficiency at higher linear velocities 
(20-30 cm s-1 for He, and slightly higher for H2) and when 
increased beyond this range of optimum velocity their 
separating abilities are only slightly reduced. Analysis 
times with longer columns are therefore only slightly 
increased. Although He is more expensive than H2 it is 
safer to use.
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A split injection system where only a fraction of the 
total sample is introduced onto the column was employed.
This is because a much higher flow rate can be maintained 
through the injector than through the column so that the 
sample is flash vaporised by the high temperature of the 
injector (270°C) and swept onto the column as a narrow band. 
This is then separated by the column phase as the sample 
migrates down the length of the column where the FA's are 
finally detected at the end of the column by the hydrogen 
flame ionisation detector (FID).
FID-type detectors respond linearly over several 
orders of magnitude of sample concentration and also respond 
to nearly all organic compounds with similar sensitivity. 
These are therefore the detectors of choice for FA detection 
and quantitation.
3.6.3 Calculation of results
In these studies all the FA profiles were obtained by 
GLC analyses (whose temperature conditions were optimised by 
experimentation) operated under identical conditions.
As part of the study, other factors were varied (e.g. 
time of incubation of the organisms, growth media, different 
batches of the same medium type) to examine their effect on 
the FA profile.
Data produced via the Chromatopac CR6A (Shimadzu) 
integrator was in the form of a chromatogram accompanied by 
figures relating to the following parameters: the retention
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time (R.T.) of each peak (or a fluctuation detected by the 
FID) the area under each peak during the 35 min program and 
the total area under the curve.
For every chromatogram produced, 0.5% of the total area 
was calculated. Each peak >0.5% of the total area was 
identified (by comparison of its R.T. with known peaks of an 
L.pneumophila standard and other commercial bacterial FAME 
standards [Supelco, Sigma]) where possible and its 
individual peak area noted. The area of these individual 
peaks were summed (corrected total area, this removes the 
areas for the solvent peak, and any contamination peaks and 
other peaks <0.5% of the total area under the curve). Then 
each peak (>0.5%) was individually divided by the corrected 
total area and the resultant figure was = Mole % nonhydroxy 
fatty acid composition, for each fatty acid >0.5%.
All legionellae (unless stated) were analysed in this 
way at least three times and each fatty acid (>0.5%) for 
each profile entered into calculations to determine its mean 
(x) and its standard deviation (S.D.). from the formula:
\
Sum of (X£- x) 2
S.D. (n-1)
n- 1
Experiments were performed to determine the optimum
169
conditions for reproducibility of FA profile under which the 
legionellae should be grown before FA extraction, 
methylation and analysis. Once these conditions were 
established they were adopted as the "standard conditions" 
for growth of the organisms for analysis. Strict adherence 
(unless stated) to these conditions, described below, was 
necessary for the consistency of results so that comparisons 
could be drawn up between any environmental or patient 
isolate and the library of all described Legionella species 
including proposed and possible new species, described to 
date.
3.6.4 Analysis of fatty acid after growth of legionellae 
on BCYE after 24 and 96h
Two legionellae, L.pneumophila and L .cincinnatiensis 
were grown on the same batch of BCYE for incubation times of 
24 and 9 6h at 37°C and the FA's analysed by GLC.
Table 19 shows the mole % nonhydroxy fatty acid 
composition of these two organisms grown after 24 and 96h.
It was observed that FA's may vary both qualitatively 
and quantitatively with the length of incubation.
L.pneumophila produced some nl9:0 and n20:0 but no al7:0 
after 24h incubation whereas at 96h incubation no nl9:0 or 
n20:0 but some al7:0 was evident. This latter FA profile is 
similar to that previously published (Wait,in Harrison and 
Taylor, 1988) for this organism.
After 96h incubation, L.cincinnatiensis produced nl9:0
170
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and n20:0 in addition to those FA's observed after 24h 
growth.
The growth of most legionellae on BCYE was limited in 
amount after 24h incubation. Cultures were therefore 
harvested at 96h incubation where there was no further 
growth detected, even with slow growing species.
3.6.5 Analyses after growth on different media
FA profiles produced by a number of legionellae grown 
on two different media were investigated.
FA profiles of cells grown on Oxoid BCYE, which was 
found to be particularly useful in the primary isolation of 
legionellae (unpublished observations), was compared with FA 
profiles of legionellae grown on BCYE.
Table 20 shows the FA content of 7 Legionella strains 
isolated in Australia (Wilkinson et al.. 1990) including one 
proposed new species, L .adelaidensis, and 6 possible new 
species (A/36, B/8 6 , C/449, D/500, D/532 and E/594).
Only minor qualitative differences between the same 
strains grown on the two media were observed perhaps 
supporting the concept that the organisms are in the 
stationary phase after 96h incubation. However, there were 
major quantitative differences evident when different 
strains are compared e.g. il6:0 in A/36, al5:0 in E/594).
Other strains (e.g. 86/35784, an environmental isolate, 
table 23) showed no qualitative and only small quantitative 
differences of up to 5% between FA profiles when grown on
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Oxoid or "in-house” BCYE media.
This is within the limits observed for some FA's produced by 
a single species grown on the same media. As the production 
of in-house BCYE could be carefully controlled (i.e. Oxoid 
came as a preconstituted dehydrated powder) and was less 
expensive to produce, it was the medium of choice on which 
the legionellae were grown for analysis. It was only during 
the course of the production of the library of FA 
profiles that three Legionella species (L .adelaidensis,
L .aeestiae and 86/35784 after passaging) failed to grow on 
"in-house" BCYE. Their profiles after 96h growth on Oxoid 
BCYE at 37°C are therefore included (tables 20, 21 and 23 
respectively).
3.6.6 In-house BCYE batch-induced differences of fatty acids 
Different batches of BCYE (using identical ingredients)
were used to culture various serogroups of L.pneumophila 
(SG2, SG3, SG6 [Chicago-2 strain] and SG10) to examine any 
differences in FA profiles due only to the BCYE batch. All 
the strains tested (table 2 2 ) showed only minor differences 
when grown on different medium batches which were no 
greater than differences observed between the same strains 
grown on the same batch of medium on different occasions.. In 
addition the differences were less than the variations 
observed between different isolates of the same species.
3.6.7 Fatty acid library of the Legionellaceae
Once the standard conditions for the preparation of
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cultures and derivitisation and analysis of fatty acids of 
the Lecrionellaceae had been established, a library of FA 
content for each of the 42 species (including proposed and 
possible new species Wilkinson et al.. 1990) was constructed 
(table 21). L .adelaidensis (strain designation F/636) and 
six possible new species (Wilkinson et al., 1990) are shown
in table 20 (their GLC profiles are shown graphically in
figures 30 to 78) i
A further investigation was performed to discover 
whether the 3 DNA groups of L.pneumophila described by 
Brenner et al. (1988) could be differentiated also by their
FA profiles. All L .pneumophila strains allocated to one of 
the three DNA groups as defined by Brenner et al. (1988) and
their x and S.D. values for FA's recalculated.
Although quantitative differences in FA's were observed 
(e.g. al5:0 and nl6:0 values, table 24) between strains of 
each of the 3 DNA groups, these were not substantial. The
addition or subtraction of one S.D. from each x value for a
particular fatty acid allowed mole % values to overlap 
between strains of each DNA group. Therefore, it was not 
practicable to draw any further conclusions other than DNA 
groups defined by Brenner et al. 1988 analysed for their FA 
content could not be distinguished on this basis.
3.6.8 Fatty acid variation in L .•pneumophila
It was observed that type strains representing three 
serogroups of L.pneumophila; SG4, SG5 and serogroup
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Key for figures 30-78 where FA's represented by peaks are 
labelled with letters for their identification.
Notation Key Notation Ke'
i 14 : 0 a al7 :1 j
il5 :0 b il7 :0 k
al5 :0 c al7 :0 1
nl5 :1 d eye 17 m
nl5:0 e nl7 :0 n
il6 :1 f nl8 :0 0
il6 : 0 g nl9:0 P
nl6 :1 h n2 0 :0 q
nl6 : 0 i
100 i
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Lansing-3 (table 25) produced higher than the x values (7 
mol%) for the FA al5:0 than in other serogroups of 
L.pneumophila (table 21). L.pneumophila SG's 4 and 5 were 
similar to each other in producing up to 26 mole % of al5:0. 
The un-numbered serogroup Lansing-3 also produced up to 24.5 
mole % of the FA, al5:0. In addition, L.pneumophila SG10 
showed greater amounts of nl6 :l than observed in other 
serogroups of L.pneumophila (table 25).
Where environmental strains representing these 
serogroups (identified by cultural characteristics and 
serological evidence only) have been available, their FA's 
have been analysed and mole % of FA's calculated (table 25) .
The serogroup 5 strains (89/29805 and 89/03289) 
produced unremarkable FA profiles with essentially no 
differences noted when compared with serogroups of 
L.pneumophila (table 22) which were not 4, 5, 10, or 
Lansing-3. However, U7W, a SG 5 strain, produced a FA 
profile similar to serogroups of L.pneumophila other than 
4, other 5's, 10 and Lansing -3. A feature of this 
particular serogroup (5) may be its variable FA 
composition with respect to the fatty acids described.
Strain 88/42151 (table 25) showed increased amounts of 
the FA nl6 :l of a quantity similar to that of the Leiden-1 
type strain and may be a distinguishing feature of this 
serogroup. This needs to be substantiated by the isolation 
and analysis of other L.pneumophila SG10 strains.
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The other serogroups (SG 4 and Lansing-3) were not compared 
with environmental isolates.
3.6.9 Confirmation of fattv acids bv GC-MS
Although the peaks produced on test chromatograms can 
provisionally be identified by comparison of retention times 
(R.T.) with those FA's in standard mixtures (table 26) . 
Confirmation of identity can be by mass spectrometry. 
However, this is not practicable for every peak of every 
chromatogram produced in view of the specialised equipment 
and the time involved.
Fatty acids were extracted, hydrolysed and methylated 
as previously described (section 2.16.5) from five different 
legionellae for analysis by GC-MS. These were 
L .iamestowniensis, L .iordanis, L .oakridaensis,
L.pneumophila and an environmental isolate, 86/35784. On 
GC-MS apparatus each produced a profile identical with that 
obtained when extracts of the same organisms were analysed 
on the 50m CPSil 5CB column (Chrompack) except that 
retention times (R.T.) for each peak were much reduced on 
the 25m SGE BP 1 column (Supelco) of the GC-MS apparatus.
This was expected as both columns separated volatile 
components of a mixture due to the different 
boiling points of these components. Figure 7 9 shows the GLC 
profile of L .iordanis obtained by GC-MS with the x-axis 
labelled with both the scan number and the R.T. at which 
each peak is eluted from the GC and analysed by the mass
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Table 26 Table of retention times of FAME standards obtained 
by gas-liquid chromatography.
Methyl ester of fatty anid 
(Standards)
Bacterial acid Methvl esters 
CP Mix Cat No. 4-7080 
Suoelco Inc.
Shorthand
designation
Retention
Times
(min)
Me. undecanoate nll:0 8.533
Me. 2-hydroxydecanoate 2-OH 10:0 8.758
Me. dodecanoate nl2:0 10.900
Me. tridecanoate nl3:0 13.558
Me. 2-hydroxydodecanoate 2-OH 12:0 13.883
Me. 3-hydroxydodecanaote 3-OH 12:0 14.617
Me. tetradecanoate nl4:0 16.333
Me. 13-methyltetradecanoate i-15:0 18.117
Me. 12-methyltetradecanoate a-15:0 18.350
Me. pentadecanoate nl5:0 19.117
Me. 2-hydroxytetradecanoate 2-OH 14:0 19.508
Me. 3-hydroxytetradecanoate 3-OH 14:0 20.233
Me. 14-methylpentadecanoate il6:0 20.858
Me. cis-9-hexadecanoate nl6 :l 21.217
Me. hexadecanoate nl6:0 21.817
Me. 15-methylhexadecanoate i-17:0 23.500
Me. cis-9,10-methylenehexadecanoate eye 17 24.025
Me. heptadecanoate nl7:0 24.433
Me. 2-hydroxyhexadecanoate 2-OH 16:0 24.883
Me. cis-9,12-octadecadienoate nl8 :2 26.042
Me. cis-9-octadecanoate nl8 :l 26.250
Me. trans-9-octadecanoate & nl8 :l
Me. cis-ll-octadecanoate nl8 :l 26.417
Me. octadecanoate nl8:0 26.917
Me. cis-9,10-methyleneoctadecanoate eye 19 28.992
Me. nonadecanoate nl9:0 29.333
Me. eicosanoate n20:0 31.733
Cross-reference Standards (Siama)
Me. undecanoic acid 
Me. pentadecanoic acid
nil: 0 
nl5:0
8.502
19.085
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Figure 7 9 GLC profile of FAME'S of L .iordanis obtained by 
GC-MS.
DB90 Chromo-togrorr. report RUN: 1SFW1E0003, 1 l/'S?/’88 18:03
L.JCRDMMIS
30764128TIC
1221
40
Scon
R.T. ’ 10:23 15:48 21:13
K&y
Scan - Scan No.
R.T. - Retention time 
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spectrometer. The 5 legionellae analysed by GC-MS, between 
them, demonstrated every nonhydroxy FA so far found in the 
Leaionellaceae. Examples of the results produced by GC-MS 
analysis are shown in figures 80, 81 and 82. These show the 
mass spectra of three of the major peaks observed in the FA 
profile of L .iordanis, al5:0, il6 :0 and al7:0 observed at 
scan nos. 857, 1026 and 1221 and whose R.T.'s are 14min 15s, 
16min 5s and 18min 12s respectively. These fragmentation 
patterns with their molecular ions at mass numbers 256, 270 
and 284 are typical of these fatty acids. The difference 
between these figures equate to the mass of a -CH2 group 
i.e . 14.
Difficulties exist in the structural identification of 
some FA's even by GC-MS. Methyl esters of iso (non 
methylated FA is shown in figure 83) and normal FA (non 
methylated FA shown in figure 84) produce nearly identical 
mass spectra.
Similarly unsaturated (figure 85) and cyclopropane FA's 
(figure 8 6 ) cannot be distinguished easily, nor can the 
position of the double bonds and cyclopropane rings be 
established. However the preparation of picolinyl esters, 
followed by mass spectrometry allows the structure of all 
types of fatty acid compound to be confirmed in a single 
experiment (Harvey, 1982), but this was not investigated.
However it has been shown using this technique that of 
the FA's extracted from the legionellae, nl6 :l is always
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Figure 3Q Mass spectra of the FA al5:0 from L .iordani* by
GC-MS showing its fragmentation pattern and
molecular ion at m/e 256.
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Figure 81 Mass spectra of the FA i!6:0 from L .iordanis by
GC-MS showing its fragmentation pattern and
molecular ion at m/e 270.
DS90 13FAME0003-. 1026 RT= 16:03 +EI SLFP 11 /29 /80  18:09 
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Figure 82 Mass spectra of the FA al7:0 from L .iordanis by
GC-MS showing its fragmentation pattern and
molecular ion at m/e 284.
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Figure 83 Structures of Bacterial Fatty Acids
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Figure 85 Structure of bacterial fatty acids cont.
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9-hexadecanoic acid, and that the cyclopropane 17 (eye 17) 
is 9,10-methylene hexadecanoic acid (Wait et al. 1988).
3.7 Ubiquinones analysed by reversed-ohase thin layer 
chromatography (RPTLC)
Figure 87 shows the relationship between the number of 
isoprenoid units and the relative mobility (RF) of 
ubiquinones on RPTLC plates. To obtain qualitative 
information some plates were examined under U.V. light (254 
nm) and areas of U.V. absorption representing ubiquinones 
were observed. Although absorption patterns were seen, it 
was difficult to estimate relative concentrations of 
ubiquinones. The phosphomolybdate spray, although not 
specific for ubiquinones, did yield more detail in the areas 
where ubiquinones were expected from Rf values. This greater 
sensitivity and the resultant semi-permanent RPTLC plate 
made results easier to read and record. This outweighed the 
disadvantage of other lipids being stained by the 
phosphomolybdate (figure 8 8 ).
The method used for the saponification of the extracts 
removed many of the other lipids observed on the RPTLC 
plate (figure 89) which chromatographed beyond the area 
where ubiquinones were resolved. Results by this method were 
compared, for 10 strains, with direct extraction. One strain 
(L.maceachernii) showed less Q-10 in the saponified extract 
(figure 89, lane D) than in the direct extraction (figure 
90, lane D). The direct extraction procedure took less time
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Figure 87 Plot of the Rf values on RPTLC (log scale) of 
ubiquinones against the number of isoprenoid 
units.
A - purified standards, Q- 6 and Q-10 (Sigma)
B - ubiquinones extracted from L.pneumophila SG 1 
Q - No. of isoprenoid units
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Figure 83 RPTLC plate of profiles of ubiquinones extracted 
by the direct extraction method from 14 type 
strains of L .pneumophila.
Lanes A-N were loaded with extracts from SG's 1-14 
respectively, lane E; SG 5 [Dallas IE strain] together with 
Q-6 (lane 0) and Q-10 (lane P) standards (Sigma).
Directio.
of
solvent
flow
(non­
ubiquinone
material)
Q-10
Q-ll,
Q-12
Q-13
q q q q q q O Q O Q Q O Q Q
\
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Figure 8 9 RPTLC plate of Legionella ubiquinone profiles 
(where all extracts were saponified).
Legionella species were loaded as follows: L . israelensis 
(lane A); L .lonobeachae SG 1 (lane B); L .lonobeachae SG 2 
(lane C); L .maceachernii (lane D); L.micdariei (lane E);
L .moravica (lane F); L .nautarum (lane G); L .oakridgensis 
(lane H); L.oarisiensis (lane I); L .guateriensis (lane J); 
L .rubrilucens (lane K); L .oneumoohila SG 1 (Knoxville-1, 
lane L); and two ubiquinone standards (Sigma) Q-6 (lane M) 
and Q-10 (lane N).
Direction
of
solvent
flow
Q-10
Q-ll
Q-12
Q-13
A B C D E F G H I  J K L M N
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and thus was chosen to compile the library of ubiquinone 
profiles of the Leaionellaceae.
Table 27 was compiled from the results of ubiquinone 
analyses by RPTLC of 36 Legionella species. All analyses by 
RPTLC were repeated at least twice to confirm ubiquinone 
profile stability, with identical results being obtained for 
each Legionella strain tested. All strains analysed 
contained ubiquinones with 10-13 isoprenoid units in their 
side chains. Fourteen of the strains had trace to small 
amounts of Q-14, but L .feeleii SG 1 & 2 and "L .geestiae” had 
substantial amounts of this ubiquinone. Q-9 was found in 27 
of the strains analysed including L .lonobeachae SG 1 and 2, 
and seven strains of L .auinlivanii (table 27). However, Q-9 
was more difficult to detect on a RPTLC plate since it ran 
close to Q-10 and other lipid components. Visually, the 
other ubiquinones were more easily distinguished.
There were no qualitative or quantitative differences 
detectable in the ubiquinone profiles of the L.pneumophila 
strains analysed (figure 8 8 ) but in contrast many 
differences, both qualitative and quantitative were evident 
when profiles of some of the other Legionella species were 
examined (figures 90 and 91).
The ubiquinone profiles of 78 Legionella including possible 
new species (Wilkinson et al., 1990) allowed each strain to 
be placed in one of five groups designated A-E (table 27). 
This system of grouping legionellae according to their
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Figure 90 RPTLC of Legionella ubiquinone profiles extracted 
by the direct extraction method of 11 Legionella 
species .
These were loaded as follows: L .londoniensis (lane A);
L .lonobeachae SG 1 (lane B); L .lonobeachae SG 2 (lane C);
L.maceachernii (lane D); L .micdadei (lane E); L .moravica 
(lane F); L ,nautarum (lane G); L .oakridoensis (lane H);
L .oarisiensis (lane I) ; L . cruateriensis (lane J) ;
L .rubrilucens (lane K); L .oneumoohila SG 1 (Knoxville-1, 
lane L); and two ubiquinone standards (Sigma) Q-6 (lane M) 
and Q-10 (lane N).
Direction
of
solvent
flow
Q-10
Q-ll
H••••••
H J K M N
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Figure 91 RPTLC plate of ubiquinone profiles extracted by 
the direct extraction method of 12 strains of 
Leaionella.
These were loaded as follows: L .dumoffii (lane A); L .ervthra 
(lane B); L .feeleii SG 1 (lane C); L .feeleii SG 2 (lane D);
11L . geestiae" (lane E) ; L . aormanii (lane F) ; L . hackeliae SG 1 
(lane G); L .hackeliae SG 2 (lane H); L .israelensis (lane I); 
L .iamestowniensis (lane J); L .iordanis (lane K);
L .oneumoohila SG 1 (Knoxville-1) (lane L) together with two 
ubiquinone standards, Q-6 (lane M) and Q-10 (lane N).
Direction
of
solvent
flow
Table 27 Ubiquinone profiles of the Lecrionellaceae
Ubiquinone content
SPECIES Q-9 Q-10 Q-ll Q-12 Q-13 Q-14 Groi.
L .adelaidensis - 4 4 4 1 - 2 — E
L.anisa tr- 1 4 2 3 2 - D
L . birmincrhamensis 1 2-3 4 2 1 - C
L.bozemanii SGI & 2 - 3-4 2 4 1 - 2 - E
L.brunensis tr 2 3 2 4 tr- 1 A
L.cherrii tr- 1 4 2 4 2 - E
L . cincinnatiensis 4 2 2 2 - D
L .dumoffii 1 3 3 4 2 - B
L.erythra 1 3-4 3 2-3 2-3 tr D
L.feeleii SQl £ 2 - 2 1 1 4 3-4 E
"L.aeestiae" (1308) 1 2-3 1 1 4 4 E
L.aormanii - 2-3 2 4 1 - 2 - B
L.hackeliae SGI & 2 - 2-3 2-3 2 4 1 A
L .israelensis tr 3 3 4 4 tr E
L .iamestownsiensis tr 4 3 2-3 2-3 - D
L .iordanis - 3 2 3 4 1 A
"L.londoniensis"(1224) 1 3 2 1 - 2 4 tr A
L .lonobeachae SGI &2 1 3 2 3-4 1 - E
L .maceachernii 1 4 1 - 2 1 - 2 4 1 - 2 E
L.micdadei 1 4 2 o 4 - E
L .moravica 1 2 1 1 4 1 A
"L.nautarum" (1477) - 1 1 4 2 - B
L .oakridaensis - 4 1 - 2 1 2 - D
L.oarisiensis - 3-4 3-4 4 1 - E
L.oneumoohila A - 2 1 4 2-3 - B
"L.quateriensis" (1335)1 2 3 2 4 tr- 1 A
L . cruinlivanii 1 2 2 4 1 - 2 - B
L .rubrilucens - 2 2 4 1 - B
L .sainthelensi - 3-4 3 3-4 2 - E
L .santicrucis 1 4 3 3 2-3 - D
L .soiritensis - 1 1 - 2 1 4 tr A
L . steicrerwaltii - 2 2 4 1 - B
L .tucsonensis 1 3 3 4 2 - . B
L .wadsworthi i - 4 2-3 2-3 1 - D
"L . worsleiensis11 (1347) - 1 - 2 1 3 4 - A
* A/36 - 2 3 4 1 - B
* B / 8 6 - 4 2 1 3 - D
* C/449 - 3 4 2-3 1 - 2 - C
* D/500 - 2 2 4 2 - B
* D/532 - 3 2 4 2 - B
* E/594 - 2 1 1 - 2 4 - A
KEY
Proposed new species tr-trace amounts detected
* Possible new species 1,2,3,4- arbitrary value to
A SG 1-14 and SG Lansing-3 estimate quantity of Q
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predominant ubiquinone is simple both in terms of definition 
of a group and of allocation of strains to a group. It 
should not be confused with that of Lambert and Moss (1989) 
where 23 Legionella species were placed in groups according 
to their ubiquinone profiles as analysed by HPLC. The 5 
groups dividing the Leaionellaceae are distributed as 
follows; group A, 9 species (21%); group B, 12 species (28 
%); group C, 2 species, (5%); group D, 9 species (21 %) and 
group E, 11 species, (25%) . Legionella species assigned to 
any one group may be further differentiated if necessary on 
the relative amounts of ubiquinones other than that which is 
dominant.
All the strains of L .pneumophila including 
L.pneumophila subspecies pneumophila (DNA group 1),
L.pneumophila subspecies fraseri (DNA group 2) and 
L.pneumophila subspecies pascullei (Brenner et al. 1988) 
produced ubiquinone profiles which were indistinguishable.
These were assigned to group B (table 27) as Q-12 was 
present in the highest relative quantity. Groups A, C, and D 
contained species whose highest relative ubiquinone 
concentration was Q-13, Q-ll and Q-10 respectively. Group E 
contained species where no one ubiquinone predominated i.e. 
two or more ubiquinones were observed in the highest 
quantity.
Ubiquinone profiles analysed by RPTLC may also be 
used to discriminate between the blue/white autofluorescent
215
and the red autofluorescent species where these may be 
difficult to identify serologically. Of the eight currently 
described blue/white autofluorescent species, L .dumoffii,
L .aormanii, L .steiaerwaltii, and L .tucsonensis were 
designated members of group B by their ubiquinone profiles 
and could be differentiated from L.bozemanii, L .cherrii and 
L.oarisiensis of group E and L .anisa of group D. The two red 
autofluorescent species L .erythra and L .rubrilucens could 
also be differentiated as they were assigned to groups D and 
B respectively.
The reproducibility of ubiquinone profiles was 
investigated in two legionellae, a human pathogenic strain 
L.pneumophila SG 1 (Knoxville-1 strain) and 
an environmental strain "L .creestiae" . The relative amount 
of each component was constant whether cultures were 
incubated for 48, 96, 192 or 240 h at 37°C and also whether 
grown on Oxoid or in-house BCYE.
RPTLC has been used to analyse strains other than the 
stock strains shown in table 1. Six legionellae 
isolated from the environment reacted with unabsorbed 
L.hackeliae SGI rabbit antiserum (IFA titre = 512, 
positive control with the homologous organism 1024) . Their 
ubiquinone profiles (figure 92), matched closely those of 
L.pneumophila and not those of L.hackeliae. Further studies 
of fatty acids by GLC supported these findings and the 
organisms were subsequently identified using serogroup
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Figure 92 RPTLC plate of ubiquinone profiles from six
legionellae isolated from environmental samples.
The plate was loaded as follows: extracts from environmental 
samples, (lanes A-F) ; and two type strains, Lane G,
L .hackeliae SG 1; lane H, L.pneumophila SG 1 (Knoxville-1); 
lane I Q-6 standard (Sigma) and lane J, Q-10 standard 
(Sigma).
Direction 
of solvent 
flow
o o o o o u
1
specific rabbit antisera to be L'.pneumophila SG 1 (2 
strains), SG6 or SG12.
Comparisons of -ubiquinone profile for 10 Legionella ' 
species have been made with those of two other groups 
of workers who used HPLC (table 28) . One group (Collins and 
Gilbart 1983, Gilbart and Collins, 1985), expressed their 
HPLC peaks of ubiquinones as percentages of the total 
ubiquinone content. The other group (Lambert and Moss,
1989) reported their relative concentrations of ubiquinones 
based on a visually estimated scale of 1-4. As the 
method of presentation between these workers differed, 
comparison of results was achieved by applying the simple 
method of grouping based on the recognition of predominant 
ubiquinone for 10 Legionella species. Where only the 
predominant ubiquinones were used to group the legionellae, 
the method of RPTLC compared well with the results produced 
by HPLC. However, it was noted that some differences were 
observed between the quantities of ubiquinones of some 
legionellae both between RPTLC and HPLC results and also 
between HPLC results where these were carried out in 
different laboratories. We observed greater amounts of Q-10 
in 3 out of 10 of these species (L.iordanis, L .longbeachae 
and L.micdadeiV than reported by other workers. The reason 
for this is unclear but the possibility that it could be due 
to a lipid component of Rf value similar to that of Q-10 
warrants further investigation including mass spectrometry.
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Table 28 A summary of the groups into which 10 Legionella 
species fall when analysed by three groups of 
workers using HPLC or RPTLC to determine ubiquinone
profiles.
Collins and Lambert and Mitchell and
Gilbart 1983, Moss 1989 Fallon 1990
1985 [HPLC] [HPLC] [RPTLC]
Species
L.bozemanii E E E
L .dumoffii B E B
L.aormanii B E B
L .iordanis A E A
L .lonabeachae B E E
L,micdadei A A A
L .oakridaensis D D D
L.oneumoohila B B B
L .sainthelensi B E E
L .wadsworthii D D D
Letters A-D represent the groups into which Legionella 
species have been compiled based on the predominant 
ubiquinone(s ) in each of their profiles (Mitchell and 
Fallon, 1990)
Predominant ubiquinone: group A, Q — 13 ; group B, Q - 1 2 ; 
group C, Q— 11; group D, Q-10; group E, species with 
two or more ubiquinones present in equally high 
cocncentration.
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Differences between analytical methods may account for other 
minor differences noted between laboratories.
3.7.1 Confirmation of ubiquinones by FAB-ms
The contents of hexane-soluble extracts were complex 
and although these crude extracts were analysed on RPTLC 
plates and the ubiquinones tentatively identified by 
comparing Rf values of the resolved spots to that of known 
ubiquinone commercial standards (Q-6 , Q-10, Sigma) and a 
previously defined ubiquinone profile of L.pneumophila SG 1, 
it was desirable to provide confirmation of the presence of 
ubiquinones in some of these extracts. Mass spectrometry 
using a direct insertion probe is often employed to identify 
ubiquinones where a base peak at m/z 235 (mass/charge 
ratio) is observed, with a further intense peak at m/z 197 
and strong molecular ions at even mass numbers corresponding 
to the molecular weight of each ubiquinone species are 
present (e.g Q-ll, Q-12 and Q-13 have molecular ions at m/z 
930, 998 and 1066 respectively). Here, an alternative 
technique was used - negative-ion Fast Atom Bombardment 
(FAB) mass spectrometry. This technique has not previously 
been applied to the identification of ubiquinones, but from
eurA.
the results produced, gave unequivocal data^quite good 
sensitivity (Wait, personal communication , Wait and Hudson, 
manuscript in preparation). The complexity of the crude 
extract would have caused problems in the interpretation of 
data produced by FAB-ms and so a preparative step to remove
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other non-ubiquinone components was included (section 
2.16.3) .
Figure 93 shows the data produced for a ubiquinone 
standard (Sigma), Q-10 with a molecular ion at 863; a value 
indicating that the ubiquinone has been reduced.
Normally under negative ion conditions deprotonated 
molecular ions (i.e. [M-H]“) are observed. In the case 
of ubiquinones in triethanolamine, deprotonated molecular 
ions of the reduced quinones (shown below) are observed 
so that Q- 6 and Q-10 standards produce molecular ions at 
m/z (mass/charge) 591 and 863 respectively. The technique 
was applied to TLC-purified extracts of L.iamestowniensis 
and intense signals at m/z 1067 and 999 (figure 94)
OH
CH
Structure of reduced ubiquinone (Q-n)
corresponding to reduced protonated molecular ions of Q-13 
(M.W. = 1066) and Q-12 (M.W. = 998) dk&Qjrtok-.
Loss of methyl groups from the species generates the ions
221
Figure— Mass spectra of a Q—10 ubiquinone (Sigma) standard 
analysed under negative-ion FAB conditions.
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Figure 94 Mass spectra of TLC-purified ubiquinones of
L .iamestowniensis analysed under negative-ion FAB 
conditions.
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m/z 1052 and 984. A weaker signal at m/z 931 corresponded to 
Q-ll (M.W. = 930).
Ubiquinones, Q-10, Q-ll, Q-12 and Q-13 were also 
detected in the TLC-purified extract of L.pneumophila SG 1 
(Knoxville-1) by FAB-MS with very weak signals at m/z ratios 
corresponding to Q-9 and Q-14. Therefore, care must be taken 
in handling ubiquinone material to prevent its loss during 
purification before mass spectrometry.
3 .8 Identification of Legionella isolates from the 
environment and from humans
The purpose of a library of FA profiles of type strains 
of each species of the Legionellaceae was to allow the FA 
profiles of environmental and clinical isolates to be 
compared with those of the library as an aid to 
identification. Possible new Legionella serogroups or 
species could also be detected.
3.8.1 Environmental isolates
Table 29 shows the FA data of twelve environmental 
Legionella isolates identified by serological methods.
All FA's of the first eight strains, except one, are 
within the range x +/- one S.D.. This FA, il4:0 of 87/31871 
is only 1.9 % greater than the upper limit (i.e. x + one 
S.D.) of the same FA determined from 49 analyses (table 21) 
of 24 strains of L .pneumophila (table 1, Materials and 
Methods).
Six of these strains (88/42791, 88/42787, 88/42784,
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88/42785, 88/42788 and 88/42783) have previously been 
studied to determine their ubiquinone profiles (Mitchell and 
Fallon, 1990) as they cross-reacted with unabsorbed rabbit 
antiserum raised to L .hackeliae SGI.
GLC of their respective FA's produced profiles 
indistinguishable from those of L.pneumophila type strains 
as did the ubiquinone profiles. The identification by IFAT 
with specific antisera confirmed their identity as 
L.pneumophila SGI (three strains), SG6 (two strains) and 
SG12 (one strain).
The last four strains in table 29 had profiles similar 
to those of known type strains. However, some differences 
between the isolate and the type strains were obvious. The 
isolate identified serologically as L . loncrbeachae SG 2, 
89/42869, showed twice the amount of il4:0, 7% less al5::0 
and no al7:0, compared with 9.2% of al7:0 in the type 
strain, Tucker-1. By RPTLC analysis of its extracted 
ubiquinones, it produced a profile indistinguishable from 
that of L .lonabeachae (but was also similar those of 
L .cherrii, L .oakridaensis and L .sainthelensi. also members 
of group E). The isolate, 89/13077, serologically identified 
as L.hackeliae SG 1 showed 2% less il4:0, no nl5:0 and 
nl5:l, 4.6% less nl6 :l and 8.5% more al7:0 than the type 
strain, Lansing-2. The ubiquinone profile of 89/13077 was 
indistinguishable from that of the type strain of 
L.hackeliae SG 1 (in addition to other legionellae
including L .quateriensis also of group A). Isolate-89/20794, 
serologically identified as L .quateriensis produced a FA 
profile with half the al5:0, 2% less nl5:l, no nl5:0, 9% 
more nl6 :l, 3% less al7:0 and no nl7:0 than found with the 
type strain (proposed new species no. 1335, see table 1). 
Isolate-88/1058 was serologically identified as L .micdadei 
and was the organism responsible for the biggest outbreak of 
Pontiac fever outside North America (Goldberg et al.. 1989 
Fallon and Rowbotham, 1990) which occurred at Lochgoilhead 
on the west coast of Scotland in January 1988. Its FA 
profile, when compared to that of the type strain (figures 
95 and 96, p231>) , Tatlock, showed detectable amounts i.e. 
>0.5% of n!5:0 and nl5:l, 9% less al7:0 and 1.2% less eye 17 
(table 29). Its ubiquinone profile determined by RPTLC was 
identical to that of the L.micdadei type strain (table 27).
FA and ubiquinone profiles were examined for strain 
ML-7 6 without any previous information being available about 
this strain. Its ubiquinone profile was indistinguishable 
from the ubiquinone profile of L .spiritensis (Mt. St. 
Helens-9). This was easily identified as it had Q-13 as its 
major ubiquinone present in very high concentration compared 
with other ubiquinones in the profile. Also, by FA analysis 
it appeared to show a profile identical with that of the 
type strain (table 30). It was later revealed that ML-76 was 
an environmental isolate and restriction fragment length 
polymorphisms (produced by digesting the extracted bacterial
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DNA with the restriction enzyme Nci 1 followed by separation 
using agarose electrophoresis) showed the Legionella to be 
L .soiritensis, with this confirmed by DNA homology (Harrison 
et al., 1988) .
3.8.2 Patient isolates
The FA profiles of two legionellae (table 31) isolated 
from different patients were investigated.
Isolate-88/24485 was from the sputum of a male 
patient and identified serologically as L .anisa. The FA 
profile differed quantitatively from type strain (table 2 1 ) 
where il4:0 was increased by 0.8 mole %, al5:0 by 3.4 mole 
%, il6:0 by 1.7 mole %, nl6 :l by 2.5 mole %, al7:0 by 5.1 
mole %. The following were present in decreased amounts; 
nl6:0 by 4.6 mole % and eye 17 by 4.7%. The only qualitative 
difference found was that the patient isolate produced less 
than 0.5% nl5:0 which was therefore not included as part of 
the overall profile. The type strain of L .anisa produced 1.7 
mole % of this FA.
Another patient strain, 85/46768, identified 
serologically as L.pneumophila SG 1. When its FA profile 
was compared with those compiled in table 19 for the same 
species, the only difference found was that the patient 
isolate produced no nl7:0, 1.4 mole % less than a typical 
L.pneumophila strain. Quantitative differences are almost 
all eliminated if the environmental and patient isolates are 
compared to x +/- two times S.D. for each FA of the type
229
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strains.
In this laboratory, FA (table 21) and ubiquinone 
profiles (table 27) of either environmental or patient 
isolates can in most cases be readily matched to those of 
the type strains. This would support that the GLC of fatty 
acids and RPTLC of ubiquinones are indeed useful methods to 
aid in the identification of Legionella species.
3.8.3 86/35784: A new subspecies of L . cruinlivanii
This environmental isolate identified as a Legionella 
species by routine bacteriological methods (i.e. by its 
growth on BCYE medium but not on horse blood agar, 
weak staining as Gram-negative rods, etc.) was extracted 
from the pan of a cooling tower at Glasgow Royal Infirmary.
Serological studies indicated that 86/35784 shared 
heat-stable antigens with L .sainthelensi and L .oakridgensis 
but also had a unique antigen (table 32) .
In addition, when L .quinlivanii was isolated (Benson 
et al.,1989) and forwarded to this laboratory, it was used 
as an immunogen to produce polyclonal rabbit antiserum. This 
antiserum reacted in IFAT tests to 6 other strains of 
L .guinlivanii, the homologous organism and 86/35784. The IFA 
titres (table 33) showed only a weak reaction between the 
unabsorbed serum raised to strain 1442-AUS-E and 86/35784 
compared to higher titres which varied when reacted to 
different strains of the same species. FA's were extracted 
from 86/35784, derivitised and analysed by GLC. Its mole %
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Table 32 IFA titres of absorbed rabbit antisera reacted to 
Legionella organisms.
Antigens 
L .sainthelensi 
L .oakridaensis 
86/35784
Antigens 
L .sainthelensi 
L .oakridaensis 
86/35784
L .sainthelensi 
absorbed with 
L .oakridaensis
3200/6400
<100
2048/4096
Antiserum
L . sainthelensi 
also absorbed 
with 86/35784
4096
<100
16
L .oakridaensis 
absorbed with 
L .sainthelensi
<100
25000
4096
Antiserum
L . oakridaensis 
also absorbed 
with 86/35784
86/35784
absorbed
with L .sainthelensi
<100 128
2048 128
<16 4096
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Table 33 Anti-L .auinlivanii rabbit antiserum reacted to 
doubling dilutions of different strains of 
L .quinlivanii and also isolate-86/35784 in IFAT.
Organism
L .auinlivanii
it
1442-AUS-E antisera 
(IFA)
1442-AUS-E 32k
1448-AUS-E 4096
144 9-AUS-E 4096
1450-AUS-E 4096
1451-AUS-E 4096
1452-AUS-E 4096
2359-AUS-E 2048
86/35784 64
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FA content is shown in table 21 together with the FA content 
(x + /- one S.D.) of L .auinlivanii calculated from all seven 
strains. The GLC profiles of 86/35784 when grown on in-house 
and Oxoid BCYE are shown (figures 4^ - and 9$ respectively) .
It can be seen that the FA composition of 86/35784 
is similar to that of L.auinlivanii (table 21). However, it 
differs significantly from L .oakridaensis and 
L .sainthelensi. 86/35784 has three times less i14:0 than 
L .sainthelensi whereas L .oakridaensis produces less than
0.5% il4:0. 86/35784 produces nine times more al5:0 than 
L .oakridaensis. There are also minor quantitative 
differences in FA profile between these three organisms.
When the ubiquinones are extracted from these organisms 
and analysed by RPTLC the profiles produced by 8 6/35784 and 
L .auinlivanii are identical both having Q-12 as their major 
ubiquinone and both therefore designated as group B. The 
other ubiquinones in each of their profiles are also present 
in similar quantities (according to the densities observed 
on the RPTLC plates). L .oakridaensis however, has Q-10 as 
its major ubiquinone and therefore belongs to group D. It is 
easily differentiated on this basis and is therefore not 
likely to be of the same species. L .sainthelensi is a member 
of group E, as both Q-10 and Q-12 are equally dominant and 
therefore again is easily differentiated from 86/35784 by 
its RPTLC profile. It is therefore not related at species 
level.
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Key for figures 95-98 where FA's represented by peaks are 
labelled with letters for their identification.
Notation Key Notation
i14:0 a al7:l j
il5:0 b il7:0 k
al5:0 c al7:0 1
nl5:l d eye 17 m
nl5:0 e nl7:0 n
il6 :1 f nl8 :0 o
il6 :0 g nl9:0 p
nl6 :1 h n2 0 :0 q
nl6 :0 i
prornes or lAMLb or 4 Legionella strains
FID Detector Response
100
Time (rain)
Figure 95
L. nrLcdadei (88/1058)
FID Detector Response
100
ef
30
Figure 96
L. raicdadei 
(Tatlock)
■Time (mm)
FID Detector Response
100
^  i» ■ A ' L j.
Figure 97
86/35784 (BCYE)
: ID Detector Response
100
Time (rain)
Figure 98
86/35784 (Qxoid)
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Guinea pig antiserum to 86/35784 organisms reacted 
poorly with 6 strains of L .auinlivanii giving IFA titres <16 
with four strains, 32 with one strain and <1000 with the 
type strain 1442-AUS-E (table 34). The titre with the 
homologous organism was 8192.
There was some indication from these studies that 
86/35784 was serologically distinct each of the 
L .auinlivanii strains tested.
Quantitative DNA hybridisation (SI nuclease method) 
studies were performed in which 36 Legionella strains 
were reacted with 32P-labelled DNA from strain 86/35784 
(figure 89).
DNA (32P-labelled) from 86/35784 hybridised to 
unlabelled DNA of L.birminahamensis and L .steiaerwaltii with 
% relatedness values of 17 and 7 % calculated, respectively 
(table 35).
The FA's and ubiquinones of these two organisms were 
compared with that of 86/35784 but even though 
L .steiaerwaltii belonged to ubiquinone group B and produced 
a ubiquinone profile identical to that of 86/35784, its FA 
profile differed markedly in that L .steiaerwaltii produced 
30% more al5:0, 20% less il6:0 and 60% less nl6 :l. It also 
differed qualitatively in that it produced eye 17 unlike 
86/35784. L.birminahamensis contained Q-ll as its 
predominant ubiquinone and is the only member of group C 
(table 21). Its FA profile differed qualitatively and
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Table 34 Anti-86/35784 guinea pig antisera reacted to 
strains of L .auinlivanii in IFAT.
Organism 1
1
86/35784 antisera 
(IFA)
86/35784 8192
L .auinlivanii 1442-AUS-E < 1 0 0 0
it 1448-AUS-E < 1 6
i 144 9-AUS-E < 16
it 1450-AUS-E < 16
ii 1452-AUS-E < 16
ii 2359-AUS-E 32
Table 35 Quantitative DNA hybridisation (SI nuclease* method} 
carried out on the most reactive DNA's.
Source of unlabelled DNA % Relatedness with
labelled DNA from strain 
86/35784
86/35784 1 0 0
L . steiaerwaltii 7
L.birminahamensis 17
L .quinlivanii (1442-AUS-E) 68
Information kindly provided by Grimont, personal 
communication.
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quantitatively from that of 86/35784.
Further DNA hybridisation experiments by the SI 
nuclease method (Grimont et al., 1980) revealed that 
unlabelled DNA from the type strain 1442-AUS-E of 
L .quinlivanii hybridised strongly (6 8 %) with 32P-labelled 
DNA of 86/35784 (table 35). This level of hybridisation is 
defined by Brenner et al. (1988) as that of a sub-species
level.
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DISCUSSION
4.1 Production of immunodiaanostic antisera to detect 
urinary antigen bv ELISA
Rabbits were employed in .these studies as they are 
widely used for the production of antisera, they usually 
respond well to immunisation and convenient volumes of blood 
can readily be collected. Mice and guinea pigs are less 
suited to this type of work as they do not satisfy the 
requirements in the way that rabbits do and although avid 
antibody has been raised in a goat (Berdal et al., 1979), 
these animals cannot be accommodated in our animal house. 
Innumerable immunisation protocols have been described in 
the literature but few have been based on comparative data.
Four protocols, two of which used both NZW and Half Lop 
breeds of rabbit have been employed to raise antibody for 
Legionella antigen detection. The most simple of these 
protocols is the method described by McKinney et al. (1979) .
The duration of six weeks is more acceptable than that of 
the other three, some of which last for many months even 
though we detected the production of avid antibody in some 
instances before their respective end points.
The method of McKinney et al. (1979), (see flowchart
p45) utilising formolised whole cells plus adjuvant and 
stimulated very good IFAT responses from an initial 
intracutaneous immunisation followed three weeks later by an 
intramuscular injection and then by weekly intravenous 
immunisations where 2ml of 4 x 109 cells/ml without adjuvant
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were used for each inoculation. This volume and density of 
cells at 40 IU may have been excessive as Mackie and 
McCartney (1989) advise that 0.5ml doses at this 
concentration are sufficient for immunising rabbits. It was 
notable that R's 8/89/, 9/89, 3/90 and 4/90 appeared to have 
circulating avid antibody detectable on the 35th day when 
blood was collected before the second intravenous 
immunisation. The titres by IFAT were high throughout the 
protocol, probably due initially to IgM from the primary 
response and then after immunoglobulin switching, due to the 
increase of IgG after further immunisation. However, avid 
antibody was not obtained from blood taken only 7 days after 
the bleed which showed avid antibody to be present. The 
reason for this is obscure but there are several 
possibilities:
1. It is conceivable that the class of IgG produced is 
important. If this is the case, it may also have some 
bearing on the explanation as to why avid antibody was 
eluted when test bleeds were purified by Protein-A whereas 
no avid antibody eluted after DEAE 52 purification of the 
same test bleeds (e.g. Nos. 67, 139). The technical 
department at Pharmacia could not guarantee the binding of 
both rabbit IgG subclasses to DEAE 52 but were more 
confident in the abilities of Protein-A to do so. 
Unfortunately, no anti-IgG class antibodies to detect rabbit 
IgGx or IgG2 are commercially or privately available and
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therefore this hypothesis could not be tested 
experimentally.
2. Another possibility is that the carbohydrate moeity 
(the heat-stable component) of Legionella LPS is a poor 
immunogen and is less likely to produce an appropriate 
antibody response. Carbohydrate analysis of L.pneumophila 
(Fox et al.> 1990) revealed the presence of unusual and 
unique sugars including quinovosamine- 2 -amino 2 , 6 
dideoxyglucose. It is very likely that quinovosamine, like 
the other 2 , 6 dideoxyhexoses so far described in 
Gram-negative bacteria, occur as components of the "0" 
specific units of the repeat unit of LPS. These may be the 
components subsequently detected in the urine by avid 
antisera. If this is so, then "false” positive reactions 
observed with known "negative" urine may be explained by the 
detection of sugars of similar structure to those unique 
sugars found in L.pneumophila (quinovosamine is an isomer of 
fucosamine -detected in a number of bacterial species) .
3. The cellular component found in positive urine may have 
been modified after exposure to host catabolic or metabolic 
modification whilst circulating in the human body, where its 
detection in urine after excretion requires an antibody of 
unusual affinity or avidity. Such modifications are not 
unknown. For example, the serum resistance of some gonococci 
is due to sialylation of the bacterial LPS by indigenous 
Sialyl Transferases in serum using CMP N-acetyl neuraminic
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acid of host origin as the sialic acid donor (Parsons et al, 
1989) .
This immunisation schedule utilised complete Freund 
adjuvant which contains killed Mycobacterium tuberculosis 
and to be sure that no possible cross-reaction would be 
produced when IgG was used in the diagnostic environment, 
avid IgG was reacted with heat fixed M.tuberculosis cells 
which were then examined by IFAT. No fluorescent 
Mycobacterium when avid IgG raised by this or by the other 
protocols examined in this work was tested.
It may be argued that as L.pneumophila itself was 
reported to be a good adjuvant (Wong and Feeley, 1984) that 
the use of Freund Complete adjuvant was not necessary. 
However, it was important not to depart from the published 
protocols' conditions when these were being compared and 
evaluated. The only variation introduced was the use of a 
different breed of rabbit.
4.1.1 Using non-NZW rabbits to raise antisera
When a Half Lop rabbit, described in section 2.5.1, was 
used instead of a NZW, differences in the avidity of the 
antibody produced by the same immunisation protocol were 
noted. Also, the antibody titre as determined by IFAT, of 
R7/88 (table 6 ) appeared to be less predictable than those 
produced in NZW rabbits inoculated according to the 
McKinney protocol. No Half Lop rabbits produced any 
working antiserum for the ELISA by either of the two
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immunisation schedules in which they were used (6 rabbits in
the McKinney and 1 in the Kohler). In fact, it is notable
that when only NZW rabbits are considered, the success rate
calculated from :
No. of rabbits producing avid IgG 
which worked in the ELISA
Total No. of rabbits inoculated
for the McKinney protocol was 6 / 8 rabbits (75%), a figure 
remarkably different from 6/14 (43%) when the Half Lop 
rabbits were included.
4.2 Antigen/ IgG reactions
Further work was performed to investigate the antigen 
with which these antibodies were reacting. Ouchterlony 
double diffusion tests were done. They showed that IgG from 
antisera Nos. 43 and 59 (purified by DEAE 52 and effective 
in the ELISA) gave a single precipitin line with either the 
boiled or non-boiled preparations of sonicated L.pneumophila 
(figure 14). Both antisera reacted with the same antigen as 
shown by the reaction line of identity. However whole serum 
(No. 42) which wasvAef fective in the ELISA, produced no 
precipitin line with either of the sonicates. This lack of 
reaction may have been due to the IgG being too dilute after 
purification by protein-A. A line of identity was observed 
when greater quantities of the same serum (No.42) were 
purified for IgG by either the DEAE 52 or the Protein-A 
method and reacted in an identical Ouchterlony test. When
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this antigen/antibody system was investigated by CIE it was 
confirmed that the IgG fractions from Nos. 43 and 59 
(figures 15 & 16) reacted with only a single antigen and 
that this was the same antigen in each case. The peaks 
produced from these antigen/antibody reactions closely 
matched peak No. 61 of the CIE reference system which was 
identified as a heat-stable antigen, giving a positive LAL 
reaction. (Collins et al., 1983).
It was notable that when IgG (purified by DEAE 52) from 
two samples of antiserum taken only 7 days apart were 
compared at the same protein concentration by CIE, quite 
different patterns of precipitin arcs were obtained. 
Antiserum No. 59 (figure 16) produced only one peak whereas 
No. 67 (collected 7 days later from the same rabbit, R 6 /8 8 ) 
produced eight peaks on staining. Similar such differences 
in counter-immunoelectrophoresis results have been observed 
(personal communication, Brown,W.) also, when antisera 
raised in rabbits to Neisseria meningitidis and collected 
only days apart were reacted with meningococcal 
polysaccharides. These results indicate the possible changes 
in serum/ antibody composition which can take place over a 
short time which may account, at least in part, for .the 
difficulty encountered in producing avid IgG. The single 
peaks observed in the CIE experiments were excised and 
tested in the LAL assay, which has a high affinity for 
endotoxins including that of L.pneumophila LPS (Wong et al.,
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1979, Fumarola, 1979). Such preparations were strongly 
reactive, indicating the presence of LPS. Although 
peak No.61 was LAL positive (Collins et al.f 1983) it did 
not stain by lipid or polysaccharide stains although in 
mobility and morphology, it resembled the LPS of other 
Gram-negative bacteria (Esperson et al.. 1980, Schoitz 
et al., 1979). Studies by other investigators suggest that 
the lipopolysaccharide of L.pneumophila contains the 
serogroup-specific antigen (Conlan and Ashworth, 198 6 , Joly 
and Kenny, 1982). The use of a purified antigen for 
immunising rabbits is discussed later. Interestingly, CIE 
gels incorporating IgG from test bleeds (e.g. No. 6 8 ) whose 
IgG was not effective in the ELISA system also showed 
precipitin arcs to LPS (figure 19). LPS, is a complex and 
heterogeneous molecule which has several epitopes. It is 
conceivable that antibodies can be raised to other epitopes 
of this immunodominant antigen which are not those found in 
urine accounting for IgG reacting with LPS in the CIE and 
not urinary antigen.
The method of raising antibodies described by Kohler 
et al. (1981) used boiled or autoclaved whole cells. Avid
IgG was present in only one test bleed when this heated 
antigen was used as the immunogen. Although only two 
rabbits were immunised according to this protocol, they were 
rested from immunisations for a few months, then 
re-immunised and effective Cab (test bleed No. 11) from the
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NZW rabbit (Rl/8 6 ) was only then obtained, 19 months after 
the first immunisation. The reasons for these results are 
unclear but IgG class switching may be involved.
The method of Tang and Toma (1986) used formolised 
whole cells as in the McKinney et al., (1979) protocol but
antigen was administered in the first inoculation as 1 2  
intradermal injections (lml total) followed 30 days later by 
intramuscular and dorsal subcutaneous injections, after 
which each monthly boost was followed two weeks later by 
bleeding. As this protocol lasted for 8 months it was much 
longer than the protocol of McKinney et al. (1979). It used 
a different strain of L.pneumophila (Philadelphia-1), but in 
the one rabbit which was immunised in this way, initially 
very low IFAT titres (up to IK) were obtained and it was 
only from the 5th month onwards that the IFAT titre rose to 
32K. No avid IgG suitable for the ELISA was detected. The 
protocol was extended for a further 1 1 months but again no 
avid IgG was detectable. Although R7/87 did not produce avid 
IgG in our hands, the authors claim that antibody raised by 
this method, when used as capture antibody and as conjugate 
bound to alkaline phosphatase produced an ELISA which 
detected not only soluble antigens from culture extracts 
of L.pneumophila SG's 1-8 as well as L.micdadei and nine 
other Legionella species (Tang and Toma, 1986) but also 
urinary antigen from a patient with L.pneumophila SG 12 
(Tana et al., 1989) . The reason for this ELISA having such a
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broad spectrum of reactivity may be due to the size of the 
epitope to which IgG has successfully been raised. If it 
was a large epitope spanning several sugars and some 
(though not necessarily all) of these are constituents 
common to LPS repeat units of other Legionella strains then 
this could account for the detection of urinary antigen from 
a patient with L .pneumophila SG12. No other urinary antigen 
diagnostic system reports antigenuria detectable in patients 
who have Legionella infections other than than those caused 
by L.pneumophila SG 1. Furthermore, effective capture 
antibody (Nos. 43 and 59) has been used in the ELISA to test 
for antigenuria in two patients with serum IFA titres > 128 
to L .iordanis. Both were negative.
4.3 Soluble antigens for raising antisera
The ideal situation for rai.sing avid antisera is to 
use a purified and characterised antigen as the immunogen, 
and in an effort to reduce the chances of raising IgG to 
cellular antigens not found in the urine, the method of 
Conlan and Ashworth (1986) was adopted. The preparation of 
serogroup antigen (Conlan and Ashworth, 1986) differed in 
its preparation from other more conventional methods of LPS 
preparation, e.g. a phenol-water extraction where Legionella 
LPS was reported to partition into the phenol phase making 
it more difficult to separate from other cellular proteins. 
When Conlan and Ashworth compared the phenol extract with a 
saline extract of the Corby strain of L.pneumophila SGI,
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similar patterns of banding typical of smooth LPS were 
observed by SDS-PAGE. The staining method used did not, 
however, reveal the levels of contaminating protein in each 
preparation. The band with highest mobility is thought to 
represent the rough LPS and then the next band the LPS plus 
one repeat unit, the third band with two repeat units etc.
An identical, smooth-type LPS banding pattern was obtained 
(figure 21) with a proteinase-K digest of whole cells of the 
Knoxville-1 strain and when this digest was electroblotted 
and probed with 4 different IgG preparations, all effective 
as capture antibody in the ELISA, immunostaining of the 
proteinase-K digest corresponding to the LPS pattern (figure 
22) was observed with three of the antisera. In addition to 
this, two intensely stained bands at 60 and 80 kD were 
revealed in two of these blots (figure 22). These bands were 
observed on the blots probed with IgG fractions from No. 43 
and the Williams antiserum, yet these differed in their 
characteristics as CAb in the ELISA where No. 43 reacted 
more strongly with "positive" urine compared with IgG from 
Williams antiserum. When the IgG fraction of No. 43 was 
reacted in the CIE only one precipitin arc was observed.
The IgG fraction from the McKinney antiserum produced the 
highest. O.D.492 values with the same "positive" test urines. 
Unfortunately, no McKinney antisera was available for 
testing in the CIE. One reason which may explain why two 
bands stained more intensely with IgG fractions from test
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bleed No.43 and the Williams antiserum, may be that these 
bands transferred more efficiently or bound more strongly 
under the conditions used.
None of the 4 IgG fractions reacted with positive 
urine even when this was concentrated 100 fold. It may be 
that there are technical problems with the urinary antigen 
not sticking to the transfer membrane or dissassociating 
from it after binding. Radiolabelling experiments could be 
useful to determine the fate of the urinary antigen.
However, it seems most probable that there simply is not 
enough urinary antigen in urine concentrated 
even 100 fold for a reaction to be observed either as a 
precipitin line in the CIE or as a band on immunoblotting 
with avid IgG.
The three saline extracts produced were each separated 
into fractions (A, B, [A+B]) and used as immunising 
antigens in a total of nine rabbits produced avid antiserum 
(test bleed No.139) three weeks after the priming 
immunisation in only one of these, R6/89. As before, with 
the McKinney protocol, the avid IgG was not isolated from 
subsequent test bleeds. When peaks A and B (figure 2) were 
used individually as immunogens, peak B which contained no 
protein by A2go measurement was non-immunogenic at 16ug 
[C(H20)n] concentration and failed to produce antibody 
detectable by IFAT. Peak A at the same concentration was 
mildly immunogenic with IFA titres up to 4K detected by IFAT
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(e.g. Rl/90). A higher titre of 16K by IFAT was produced 
when the concentration of antigen was doubled. This may 
have been due to protein, which co-eluted with peak A of 
the serogroup antigen, providing an adjuvant-like activity. 
Fractions from peaks A and B combined at 32ug [C(H20))n] 
concentration, produced one test bleed which contained avid 
IgG from R6/89 where the IFA titre was 32K. No other bleeds 
from this rabbit produced as high an antibody level. Another 
rabbit, R7/89, inoculated with the same dosage and the same 
combined pools of antigen (A+B) produced only low titres and 
no avid IgG was isolated as would be expected when titres as 
low as 2K were found. Therefore, only high titre antisera 
produced when the immunising dose of carbohydrate was 32ug 
may contain enough avid IgG effective in the ELISA.
When a portion of the saline extract described by 
Conlan and Ashworth (1986) was provided for use in this 
project and used as an immunogen for two rabbits (R5/90 and 
R10/90), titres by IFAT of 32K were obtained from each 
rabbit and both of these produced avid IgG, in each case on 
two occasions when test bleeds were taken 7 days apart.
In conclusion, particulate antigens were the easier to 
prepare and in general produced higher antibody titres, due 
in part presumably to the adjuvanticity of L.pneumophila 
itself. The soluble antigen prepared according to the Conlan 
and Ashworth (198 6) protocol was less immunogenic and where 
the antigens were made in this laboratory, less successful
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than results obtained with the McKinney et al. (1979)
protocol. The two rabbits immunised with donated saline 
extract of the Corby-1 strain of L.pneumophila provided 
effective antisera. However, the IgG obtained from these 
test bleeds produced a higher background O.D.492 with 
negative control urines than that obtained with any of the 
IgG raised by the McKinney protocol, perhaps as a result of 
presenting the rabbit with a purer form of LPS where 
antibodies might be produced to sugars found in the LPS of 
other Gram-negative bacteria.
The protocol which yielded the best results from 
this work to produce avid IgG of diagnostic potential was 
that described by McKinney et al. (1979) where IgG could be
made in 75% of NZW rabbits and collected on the 35th day 
after the priming immunisation. Protein-A was also the 
method of choice to purify IgG for use as capture antibody.
A combination of these two methods produced avid IgG where 
the background O.D.492 was low (generally less than 0.05) 
which increased the differential between positive and 
negative antigen-containing urine and so provided 
unequivocal results even without the aid of an ELISA plate 
spectrophotometer. This ELISA was as sensitive as the 
commercial RIA (Dupont), detecting antigen in the urine at 
a 16 fold dilution from a patient (G.L.) with cultural and 
serological evidence of L.pneumophila SGI infection. The 
latex agglutination test (Meridian diagnostics) was found to
be unreliable in our hands and is not recommended for 
diagnostic purposes.
Another ELISA has been developed in the U.K. 
since the start of this project (Birtles et al. , 1990) . It 
utilises a finite supply of capture antibody donated by 
Fehrenbach and uses a conjugate consisting of a monoclonal 
antibody (LCK-2b) coupled to fluorescin isothyocyanate 
(FITC). This is amplified by another monoclonal directed to 
FITC and conjugated to HRP for development in the normal 
way. Preliminary experiments (results not shown) using 
capture antibody (No. 43) and the above described monoclonal 
amplification system works to differentiate positive from 
negative control urines. The same monoclonal antibody system 
to detect L .pneumophila SG 1 urinary antigen but modified by 
using luminol instead of O-phenylenediamine in the presence 
of H202 in a chemiluminescence ELISA has also been described 
(Samuel et al.. 1990) . Light emission produced by the 
catalysed oxidation of luminol was recorded as a 
photographic print. Advantages claimed by the authors over 
the conventional ELISA are that it takes less time to 
perform than the colorimetric assays without any loss in 
sensitivity. However, quantitative results are not obtained 
with the chemiluminescence ELISA.
4.4 ELISA optimisation
Two variables in the ELISA assay were investigated, the 
binding properties of different microtitre plates, and the
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effectiveness of different BSA preparations in blocking 
non-specific interactions.
Demands of this test on plate-type were low as the test 
appeared to be satisfactory on all eight plates tested, 
although three plates from different manufacturers were 
marginally superior in producing greater differential 
0 • D . 492 results between "positive" and "negative" control 
urines. These were Costar plate No. 3590, made from 
polyvinylchloride (PVC). The other two (Virion F and Nunc) 
were made from rigid polystyrene. As the other plates which 
were slightly less satisfactory plates were made from either 
of these polymers, it appeared that the small differences in 
affinity observed did not originate from polymer type, but 
probably reflected differences in manufacturing methods or 
in sterilisation methods. For example, gamma-irradiation is 
known to affect binding properties.
BSA from different sources may be produced by 
different methods such as alcohol precipitation, heat shock, 
salt fractionation or a combination of these methods. Two 
types were used, BSA from Sigma (No. 7 90 6 ) and BSA fraction 
V (Miles Scientific). Each was tested at different dilutions 
and the BSA from Sigma performed satisfactorily and was 
adopted for routine use whereas BSA Fraction V (Miles 
Scientific) was not effective. No blocking activity was 
evident at concentrations which were effective with the BSA 
from Sigma. Fraction V preparations are not 100% albumin and
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impurities may^been the reason for the lack of binding 
activity (personal communication, Sigma).
4.5 Sensitivity and specificity testing of capture antibody 
The final evaluation of capture antibody (table 11) 
involved the use of 77 clinical specimens of urine. Only one 
of the negative controls (No. 39, table 10) was obtained 
from a patient whose clinical diagnosis of pneumonia may 
have been due to L.pneumophila infection. Circumstantial 
evidence came from IFAT testing where a titre of 128 to 
L.-pneumophila SG 1 was observed in one serum sample only.
The significance of this is uncertain since there was no 
conclusive evidence that this antibody titre was raised 
against L.pneumophila. However, no false positives were 
obtained by ELISA.
Cross-reactions were reported by Collins et al. (1983)
between sonic extracts of 18 non-Legionella bacterial 
species and L.pneumophila SG 1 when examined by CIE. Antigen 
No . 6 6 of the reference system (not LPS) of L.pneumophila 
SG 1 was similar to antigens found in many Gram-negative 
bacteria e.g. Pseudomonas aeruginosa. Bordetella pertussis 
and Heamoohilus influenzae). The causative organisms 
isolated from patients diagnosed as having pneumonia 
included Klebsiella and H .influenzae. No raised O.D.492 
values using urine from patients infected with these 
organisms were detected in the ELISA. The pathogens isolated 
from the urines of patients with urinary tract infection
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included Escherichia coli. P .aeruginosa and Acinetobacter 
but none of these produced "false positives" in the ELISA.
Some antisera yielded IgG which was avid as CAb in the 
ELISA yet the whole serum was not effective. This was 
probably due to interference in the ELISA by other serum 
proteins (including IgM, albumin, transferrin etc.).
Some of the sera raised using each of the four protocols 
yielded IgG which, when used in the ELISA reacted with both 
positive and negative urines. The reason for this is not 
clear but it could be due to IgG of low avidity for 
Legionella-antigen cross-reacting with other antigens in 
urine from indigenous flora.
4 .6 Concentration and analysis of urinary antigen
The investigative methods, were all standard and 
established systems with little or no modification from 
those originally reported to obtain satisfactory results, 
with three notable exceptions. These were:
1. Concentration of urine produced inconsistent results 
when the concentrate was analysed by SDS-PAGE. The use of 
macrosolute concentrators may have been a factor in not 
being able to isolate LPS consistently. The incorporation of 
3% (w/v) SDS into the rinsing solution to extract LPS from 
the macrosolute chamber would also have solubilised any 
adsorbed protein. However, the 29kD heat-stable protein 
described by Gosting et al. (1984) was not observed in any
gel stained by either silver staining method for protein or
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LPS. If Legionella urinary antigen is LPS, then a better 
method for its concentration may be by precipitation using 
cold ethanol (Zanen-Lim and Zanen, 1988) since this method 
has been used to isolate LPS from L .pneumophila SG 12 cells, 
though not from urine. Also immobilised lectin in an 
affinity column or Detoxi-Gel (Pierce) might be used to 
isolate LPS for further experiments.
2. It is possible that the failure to reproduce the 
detection of LPS in SDS-PAGE gels may have been due to an 
inadequacy of the staining procedure. The sensitivity may 
not have been sufficient to detect LPS or other antigens in 
urine after 100 fold concentration. Fomsgaard et al. (1990) 
only recently described a modified silver staining technique 
for certain LPS types which improved their detection. The 
presence of bound fatty acids in some LPS preparations 
accounts for their poor chemical detection by conventional 
silver staining, as much of the LPS is washed out of the gel 
at the fixing stage. As the whole cell FA profile of 
legionellae is so complex (and some of these FA's will have 
been cleaved from the lipid part of LPS) this may be a 
reason for not detecting LPS on more than one occasion.
It is possible that the detection of Legionella-LPS in 
gels of concentrated urine could be improved, by omitting the 
fixing stage and increasing the oxidation time from 5 to 
20min as recommended by Fomsgaard et al. (1990).
3. The other experimental procedure where problems were
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encountered was that of immunoblotting where after the 
transfer of one "positive" urine (Co.) no reaction on 
immunostaining with avid antisera was seen. This suggested 
that Ag was not efficiently transferring or binding to the 
membrane. When different membrane types were used and where 
these had different binding properties (although the binding 
capability of LPS was unknown), immunostaining experiments 
still produced disappointing results. It would be worthwhile 
experimenting with other methods of LPS transfer (e.g. 
semidry electroblotting, Fomsgaard.et al., 1990) to 
establish the best results for staining with specific 
antiserum.
4.6.1 The nature of urinary antigen
Different methods were employed in attempts to 
concentrate urinary antigen for the purpose of its 
identification, mainly by SDS-PAGE. SDS-PAGE was the first 
choice for analysing urine as highly sensitive stains for 
protein (Hitchcock and Brown, 1983) and for LPS (Tsai and 
Frasch, 1982) have been described will detect ng quantities 
of these components. Methods for the concentration of urine 
(section 2.13) included the use of a macrosolute 
concentrator with a molecular weight exclusion limit of 
15kD. The advantage of such a system was that during 
concentration, salts were removed which interfere with the 
distribution of electric field across the polyacrylamide 
gel. This was the method chosen to concentrate a positive
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urine (Co.) which although sterile, produced an LPS 
ladder-like pattern (figure 2 1 ) after electrophoresis and 
LPS staining. Silver staining for protein revealed little or 
no detectable protein (Gel A). This type of pattern from the 
analysis of concentrated urine has not been reported in the 
literature before and unfortunately could not be repeated. 
Confirmation of the LPS pattern to be that of L.pneumophila 
SG 1 by immunoblotting using avid IgG was not achieved even 
when two different membrane types were used. This was due to 
one or a combination of three factors:
1. The methods for the concentration of urine were not 
suitable. Even after modification of the method for 
concentrating urine by including 3% (w/v) SDS in the rinsing 
solution to wash the chamber of the concentrator in case LPS 
or other components were adsorbed to the plastic chamber, no 
bands were observed on the SDS-Page gel in lanes loaded with 
"positive" urines which were not also seen in concentrated 
urine from healthy people. However, similar bands were seen 
in concentrated urine obtained from patients with UTI 
infections. These bands may have been globulin (perhaps from 
locally-secreted IgA, albumin or even bacterial components. 
Immunoblotting against avid anti-Legionella antiserum 
produced no staining.
2. The method of transfer of the electrophoresed urinary 
antigen components was not suitable.
3. The urinary antigen may be a modified cellular component
where the affinity of the antibody is important and this 
may be difficult to show by immunoblotting or indeed by CIE.
One urine (Co.) produced an LPS pattern by SDS-Page 
which differed from the proteinase-K digest of L.pneumophila 
when reacted with avid antisera after immunoblotting 
(figure 22). This supports the idea that any Legionella LPS 
components found in urine are modified from the bacterial 
form of LPS. No staining was observed on immunoblotting with 
avid antisera. On repeating this experiment with other 
positive urines (figures 23 and 24) a pattern similar to 
that in figure 2 1 was not observed.
Finally, affinity chromatography was adopted to try to 
overcome the difficulties in transfer of urinary antigen 
onto nitrocellulose for immunostaining. Avid IgG antibody 
was bound to Sepharose 4B and this was exposed to both 
antigen and non-antigen containing urines. Eluted urine, 
tested by ELISA showed that the affinity columns were 
binding the urinary antigen. This was further confirmed with 
increasing O.D.492 values on the ELISA plate (figure 25) as 
the IgG in the columns became saturated with antigen with an 
increasing quantity of urine.
However, although a unique band (80 kD) was observed 
on an SDS-Page gel silver stained for LPS (figure 27) in 
lanes loaded with Sepharose, IgG and bound antigen from 
"positive" urine, neither this nor the other band (60kD) 
common to both positive and negative urines were
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immunostained with avid IgG (No. 43) after electrophoretic 
transfer onto nitrocellulose or PVDF. This was probably due 
to no or poor binding of the urinary antigen to either of 
the two membranes (figure 26), although a reason for this is 
not obvious. However, it may indicate that the antigen is 
hydrophobic in nature. When SDS-PAGE of Sepharose/IgG bound 
urinary antigen were probed with sheep anti-rabbit IgG, only 
two bands in the control rabbit IgG lane were stained. These 
were 50 and 55kD in molecular weight and therefore not of 
the same molecular weight as the two bands previously 
reported (80 and 60 kD).So it remains possible that the 
unique band observed on the SDS-PAGE gel was indeed a 
component only found in "positive" urines.
4.7 Urinary antigen excretion in a patient with L.D.
The details of a case history of one patient (J.McM) 
diagnosed as having Legionnaires' disease highlighted the 
benefit of a working and reliable diagnostic test which 
provided evidence of a Legionella infection before either 
cultural or serological methods.
It can be seen from this and other published 
information (Kohler et al.. 1984) that the test is best 
suited to the early diagnosis of L.D. where urine is 
collected in the early stages of infection and tested in the 
ELISA to detect urinary antigen before either cultural or 
even serological evidence is obtained. The sharp decline in 
the amount of antigen after 57h from the time of admission
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(day to day experimental ELISA controls produced similar 
values and these results were confirmed when retested on one 
ELISA plate) is probably more marked as a result of the 
patient responding to intravenous (and later oral) 
antibiotics. Antigen excretion may be prolonged after 
infection in some cases where this is not related to the 
clinical condition of the patient. The possible recurrence 
of infection in such cases cannot be determined by this 
test.
SPECIES IDENTIFICATION
4 .8 Fatty acid (FA) profiles of the Leaionellaceae
Total cellular FA composition has been shown to be 
useful in the identification and classification of 
bacteria (Moss and Dees, 1975). This is particularly so for 
the Leqionellaceae, and as a result, an increase of interest 
in this area is evident with more comprehensive information 
on FA profiles of many legionellae being published. Usually, 
as in the most recent publication (Lambert and Moss, 1989) 
it is information on the nonhydroxy FA profiles which is 
available. However, studies on hydroxy FA's of a limited 
number of Legionella strains, representing only 10 species 
have also been published (Mayberry, 1981, 1984). Hydroxy FA 
analysis can differentiate between some species of 
Legionella (e.g. L.pneumophila and L.micdadei. Mayberry, 
1984). However, these two species also have easily 
distinguishable hydroxy FA profiles. Most new species
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have their nonhydroxy FA composition described (e.g.
L.moravica and L.brunensis in Wilkinson et al.. 1988) 
but in a few cases the 'hydroxy FA composition is also 
described (e.ct.L .tucsonensis in Thacker et al., 1989) . As 
more information on nonhydroxy FA profiles is available for 
comparative purposes, these were studied in detail in this 
thesis.
It was found that the FA profile within a Legionella 
species varied with the period of incubation. This study of 
growth rates in different species varied, even on the same 
medium (BCYE). Most species showed confluent growth on BCYE 
agar after 48-72 days, but a few species grew only to form 
distinct colonies which ceased to increase in diameter after 
72-96 days. The length of incubation for reproducible 
results was therefore judged to be 96h. Table 19 shows 
mainly quantitative differences in FA between identical 
strains after 24 and 96h. However, some qualitative 
differences were also noticed. Similar observations were 
made when strains were grown on two different media. 
Fortunately, growth under "standard” conditions (96h at 37°C 
on BCYE) on different batches of the same medium (BCYE) 
resulted in little or no differences in the nonhydroxy FA 
profiles, making these analyses useful and reproducible. 
Unlike the ubiquinone profiles, it was decided not to 
group species of the Legionellaceae on the basis of their 
predominant FA as they were extremely complex and minor
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variations of strains representing the same species were 
found. Species which could be confused with one another on 
the basis of their GLC profiles include L .dumoffi,
L.maceachernii, L.micdadei. and L .wadsworthii, but a closer 
examination of quantitative differences in their nonhydroxy 
FA's aids in their differentiation. It is recommended that 
where differences are small, the unidentified Legionella is 
grown along with the known species which it resembles, and 
the FA profiles are assessed together with table 21. This is 
especially important because quantitative differences in 
some FA are evident between some strains identified to be of 
the same species (e.g. L.micdadei Bari 2/158, Moss and 
Lambert, 1989 and L.anisa isolated from a patient). Members 
of the three DNA groups of L.pneumophila as proposed by 
Brenner et al. (1988) could not be distinguished on the
basis of FA data (table 24). Type strains representing four 
serogroups of L.pneumophila (4, 5, 10 and Lansing-3) 
produced some variation in FA from other L.pneumophila 
strains, particularly in al5:0 and nl6 :l. These differences 
were not substantiated when the type strains were compared 
with serologically identified environmental strains of the 
same serogroup.
The use of mass spectrometry to confirm the structure 
of FA found in the legionellae is a widely used technique 
and all FA's reported in this study in the Legionellaceae 
were found within the four strains analysed (including
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86/35784). Only one or two very small peaks (< 0.5%) present 
in FA profiles were identified as contaminating 
hydrocarbons. These were not significant since they were not 
included in calculations. Retention times of standard FA's 
in a commercially available mixture were determined along 
with each batch of analyses to allow identification.
Differences in the FA composition for the same species 
have been reported by different laboratories. These may 
reflect differences in growth conditions, methods used to 
prepare FAMES, or conditions for analysis.
It is apparent that the analysis of FA profiles will be 
of value to a laboratory with a large throughput of 
Legionella isolates, most of which will be identified by 
this and by RPTLC without the need for DNA homology or 
RFLP analysis.
However, if new species continue to be identified at 
the current rate, it is likely that the family will become 
very large. Comparing FA analyses will prove to be 
difficult. This is more likely as the number of isolates 
from cooling towers will increase as a result of safety 
guidelines being enforced.
4.9 Ubiguinone profiles of the Legionellaceae
Ubiquinones were extracted from all the Legionella 
strains shown in table 1 (Materials and Methods) 
representing L.pneumophila SG 1-14 (and one proposed new 
serogroup) and other strains representing 29 species, 7
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proposed new species and 6 possible new species.
These were analysed by the method of reversed-phase 
thin-layer chromatography.' Ubiquinone profiles as determined 
by this method (Mitchell and Fallon, 1990) were 
reproducible, both qualitatively and semi-quantitatively, 
and results were compiled to produce a useful reference 
"library" (table 27).
As minor quantitative differences between laboratories 
were noted in ubiquinone profiles of the same species (even 
those who used HPLC, table 28) it is recommended that 
unless identical conditions and equipment are used, a 
laboratory should produce its own standard reference library 
of ubiquinone profiles.
RPTLC is a cheap and simple method of obtaining 
reliable results and therefore a realistic alternative to 
HPLC, which requires expensive and sophisticated equipment.
New information is presented (table 27) on the 
ubiquinone profiles of seven Legionella species:
L.birminghamensis. L.brunensis. L .cincinnatiensis f 
L.moravica, L .guinlivanii, L .tucsonensis and proposed new 
species No. 1347, "L .worsleiensis".
As with the FA profiles of the autofluorescent species, 
ubiquinone profiles are also useful as a differential 
character in their identification. Other species, whose 
FA profiles are similar e.g. L .longbeachae and L.pneumophila 
(figures 50 and 58 respectively) can also be differentiated
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by their ubiquinone profiles.
However, some species e.g. L .anisa and L.bozemanii are 
impossible to differentiate either by their GLC or RPTLC 
profiles. Serologically, L.bozemanii SG 2 and L .anisa are 
not easily separated. They can however be distinguished by 
using absorbed antisera or by other methods such as DNA 
homology.
Mass spectrometry does not provide an accurate method 
for the quantitative determination of ubiquinone mixtures. 
The intensity of peaks attributable to molecular ions may 
vary considerably, and does not always accurately reflect 
the relative proportions of ubiquinones in a mixture 
(Collins and Gilbart, 1983). This problem becomes 
particularly acute when complex mixtures are analysed and 
this may explain why the peak heights of each of the 
ubiquinones in figure 93 do not correspond to the 
semi-quantitative result as determined by RPTLC (table 27) . 
Other possible reasons for the loss of ubiquinone material 
before mass spectrometry may be that the recovery of 
ubiquinones from the TLC plate (purification step) < 100% 
due to incomplete elution or more simply by 
photodegradation.
4.10 Patient and environmental isolates: GLC and RPTLC data 
compared with data from type strains
Many strains from both patient and environmental 
sources have now been analysed for their FA and ubiquinone
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content. L.pneumophila strains, which represent the most 
commonly isolated species of this family, have consistent 
profiles whether isolated from the environment or from 
patients. These closely resemble profiles compiled in table 
21. Other species e.g. L .lonabeachae and L .quateriensis 
(table 29) showed minor differences in FA from their 
respective type strains. Such minor variations may also be 
observed in legionellae isolated from patients when these 
are not L.pneumophila. Strain-88/24485 (table 31), 
serologically identified as L .anisa produced, on FA 
analysis, some minor quantitative differences from the type 
strain (up to 4 mol%). In addition to this, variation of 
hydroxy FA within the type strain was also recorded (up to 
5%). The L.micdadei strain (88/1058), which caused the 
Lochgoilhead outbreak, also showed some differences in FA 
from those of the type strain. Variation in some FA's (up to 
10 mol-%) of isolated L .micdadei strains and the type strain 
(Tatlock) has also been reported (Moss and Lambert, 1989).
It may be that any variation observed in FA composition 
analysed under "standard" conditions between an isolate 
whether from a patient or a water sample and its 
corresponding type strain is determined by the species 
itself and is governed at a genetic level.
Where this FA and ubiquinone data may also be of use is 
in the identification of a new species, strain or 
sub-species. An example where one isolate (86/35784), was
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deduced to be a new sub-species of L .quinlivanii (section 
3.8.3) has already been detailed.
4.11 Future work
The production of diagnostic antisera for the purpose 
of detecting Legionella antigen in urine has obvious 
commercial value. Experiments to investigate the McKinney 
protocol (the most successful immunisation protocol from 
this work) further, might include varying some of the 
conditions within the protocol. Modifications to the 
protocol could include using boiled whole cells as the 
inoculum, increasing or decreasing the dose used for 
immunisation and investigating the influence of different 
strains of L.pneumophila SG 1 (e.g. Pontiac-1).
The relative proportions of different subclasses of IgG 
in test bleeds obtained from the same rabbits only days 
apart, which differed in their ability to capture urinary 
antigen should be investigated further. In addition, the 
ability of DEAE 52 to bind both IgG subclasses could be 
tested.
The eventual aim should be to use a purified and well 
characterised antigen to raise the specific capture antibody 
for ELISA testing of positive urines samples. This problem 
may be approached by using various fragments of LPS (after 
acid or alkali hydrolysis. It may be necessary to look for 
other carbohydrate-containing antigens in the outer membrane
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of L.pneumophila# which may be comparable to the 
enterobacterial common antigen in structure.
If such fragments are haptenic rather than antigenic, 
then effective immunisation may be achieved by coupling to 
diptheria or tetanus toxoid via an amide bond under acidic 
conditions.
The concentration of urinary antigen by cold ethanol 
precipitation used in conjunction with a modified silver 
stain may be the key to consistently identify Legionella 
antigen in urine and the blotting of this may afford 
detection after immunoblotting. However, the electroblotting 
process also merits further investigation. Standard 
preparations of LPS and its fragments should be used to 
monitor transfer efficiency, probably by using radiolabelled 
LPS in order to determine whether failure to detect urinary 
antigen by immunoblotting was due to poor transfer or poor 
fixation to the membrane.
Finally, the FA and the ubiquinone libraries should be 
assembled onto a computer database where a software package 
can compare these with data from new Legionella isolates. 
This is likely to make the process of comparing results less 
difficult and the methods of identification described in 
this thesis more widely available.
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APPENDICES
APPENDIX I 
Buffers used for IaG purification 
IcrG purification on DEAE 52-cellulose 
0.3 M Phosphate buffer :
Part A
NaH2P04 (0.3M) 46.77g
dH20 ad 1.0 L
Part B
Na2HP04 (0.3M) 42.58g
dH20 ad 1.0 L
0.1 M Phosphate buffer pH 7.5 :
160ml Part A + 840ml Part B + 9 L dH20
IcrG purification on Protein-A Fast-Flow 
Buffer A - pH 8.0 (with HC1)
Boric acid (0.016M) 4.95g
NaCl (0.012M) 3.5g
NaOH (0.025M) 5 . Og
Phenylmethyl sulfonyl fluoride (O.lmM) 0.085g 
(PMSF, Sigma)
NaN3 (0.02%) l.Og
dH20 ad 5 L
Buffer B - pH 3.0(with HC1)
Glycine (0.1M) 37.5g
PMSF (O.lmM) 0.085g
NaN3 1. Og
dH20 ad 5 L
Buffer A (dialysis)
As Buffer A excluding 
PMSF and NaN3.
APPENDIX II
Buffers for ELISA 
0.01M PBS pH 7.4 
Part A 
NaH2P04 :2H20 
Part B 
Na2HP04
19ml Part A + 81ml Part B +
+ 3.8 L 0.85% (w/v) NaCl
Substrate
Mix together in order just before use.
dH20 8.5ml
4% o-Phenylenediamine (in dH20) 0.5ml
Substrate buffer 1.0ml
3% H202 50ul
Substrate Buffer
Citric acid (170mM) 3.57g
NaH2P04 (650mM) 9.23g
Thiomersal (0.1%) O.lg
dH20 ad 0.1 L
Per 4 L 
31.2g/L 
28.39g/L
0.1 L dH20
APPENDIX III
Buffers for conjugation
PBS pH 7.2
Na2HP04
NaH2P04
NaCl
dH20
1% BSA Tris-HCl. 0.05M pH 8 .0 
Trizma base (Sigma)
Bovine albumin (Sigma A-7 90 6 )
NaN3 (0.02%)
ad
cone. HC1 
dH20
10.96g 
3.15g 
85. OOg 
10.0 L
ad
30 .27g 
5.OOg 
0.1.g
5.0 L
NaCl
KH2P04
Na2HP04 .12H20
KC1
dH20
Tris-HCl. 0.05M pH 8 
Trizma base (Sigma) 
conc. HC1 
dH20
ad
.0
40g
ig
14.4g
ig
5L
ad
30 .27g
5.0 L
APPENDIX IV
Freezing medium for leaionellae
Peptone water (Oxoi'd, Code CM9)
(Formula; Peptone L37 [lOg]
NaCl [ 5g])
dH20 ad
(Autoclaved at 121°C for 
15 min., pH 7.2 approx.)
15.Og
1L
APPENDIX V 
Barbital buffer for electrophoresis 
0.05M,. pH 8.4, ionic strength = 0.1
Sodium barbitone 10.
Barbitone 1.
dH20 ad 1L
(Dissolve using a magnetic stirrer)
May crystallise on storage, especially at
3g
84g
4°C.
